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Abstract 
 
 
 
 
Volumetric muscle loss (VML) typically results from traumatic incidents; such as those 
presented from combat missions, where soft-tissue extremity injuries account for approximately 
63% of diagnoses.  These injuries lead to a devastating loss of function due to the complete 
destruction of large amounts of tissue and its native basement membrane, removing important 
biochemical cues such as hepatocyte growth factor (HGF), which initiates endogenous muscle 
regeneration by recruiting progenitor cells.  Clinical strategies to treat these injuries consist of 
autologous tissue transfer techniques, requiring large amounts of healthy donor tissue and 
extensive surgical procedures that can result in donor site morbidity and limited functional 
recovery.  As such, there is a clinical need for an off-the-shelf, bioactive scaffold that directs 
patient’s cells to align and differentiate into muscle tissue in situ.  In this thesis, we developed 
fibrin microthreads, scaffolds composed of aligned fibrin material that direct cell alignment 
along the longitudinal axis of the microthread structure, with specific structural and biochemical 
properties to recreate structural cues lost in VML injuries.  We hypothesized that fibrin 
microthreads with an increased resistance to proteolytic degradation and loaded with HGF would 
enhance the functional, mechanical regeneration of skeletal muscle tissue in a VML injury.  We 
developed a crosslinking strategy to increase fibrin microthread resistance to enzymatic 
degradation, and increased their tensile strength and stiffness two- to three-fold.  This 
crosslinking strategy enhanced the adsorption of HGF, facilitated its rapid release from 
microthreads for 2 to 3 days, and increased the chemotactic response of myoblasts twofold in 2D 
and 3D assays.  Finally, we implanted HGF-loaded, crosslinked (EDCn-HGF) microthreads into 
a mouse model of VML to evaluate tissue regeneration and functional recovery.  Fourteen days 
post-injury, we observed more muscle ingrowth along EDCn-HGF microthreads than untreated 
controls, suggesting that released HGF recruited additional progenitor cells to the injury site.  
Sixty days post-injury, EDCn-HGF microthreads guided mature, organized muscle to replace the 
microthreads in the wound site.  Further, EDCn-HGF microthreads restored the contractile 
mechanical strength of the tissue to pre-injured values.  In summary, we designed fibrin 
microthreads that recapitulate regenerative cues lost in VML injuries and enhance the functional 
regeneration of skeletal muscle. 
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Chapter 1: Overview 
 
 
 
 
1.1 INTRODUCTION 
Skeletal muscle injuries typically result from traumatic incidents, such as combat injuries, 
where soft-tissue extremity injuries account for 63% of diagnoses.1,2  Additionally, about 4.5 
million reconstructive surgical procedures are performed annually as a result of car accidents, 
cancer ablation, or cosmetic procedures.3,4  These combat- and trauma-induced skeletal muscle 
injuries are characterized by volumetric muscle loss (VML), where large amounts of tissue and 
its native basement membrane is removed or destroyed, profoundly impacting the quality of life 
of patients.5  While skeletal muscle has an innate repair mechanism, it is unable to compensate 
for VML injuries, resulting in the formation of scar tissue to fill the void created by the muscle 
defect, and ultimately leading to a loss of mechanical function and disfigurement.  The current 
standard of care for large volume skeletal muscle injury is an autologous tissue transfer from an 
uninjured site.4  This complicated surgical procedure yields limited restoration of muscle 
function and can result in complications such as donor site morbidity, infection, and graft failure 
due to necrosis in as many as 10% of these surgeries.4,6,7  Thus, there is a need to develop an off-
the-shelf, biomimetic scaffold that directs functional skeletal muscle tissue regeneration within 
VML injuries. 
Skeletal muscle regeneration is mediated by local progenitor cells known as satellite cells 
(SCs), which reside between the sarcolemma and basal lamina of muscle fibers.8  Typically 
quiescent, SCs enter the cell cycle after an injury, proliferate, and fuse into new myofibers to 
repair the injury.9  Upon mechanical injury of a muscle fiber, hepatocyte growth factor (HGF) is 
rapidly released from the extracellular matrix (ECM) of the muscle fiber itself in the first 48-72 
hours after injury, stimulating the activation and proliferation of SCs as well as the chemotaxis of 
SCs to migrate towards the wound site.10-13  Because it inhibits SC differentiation, HGF will 
inhibit muscle regeneration if present for more than 4 days.9,13,14  Traumatic loss of the basal 
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lamina in VML injuries eliminates this HGF reservoir that recruits SCs; therefore, we 
hypothesize that the addition of HGF to an intervention in these large defects will promote the 
endogenous skeletal muscle regeneration pathway by facilitating the recruitment of SCs to the 
injury site. 
Two of the most important criteria for the design of materials to guide skeletal muscle 
regeneration are that scaffolds must facilitate uniaxial alignment of myoblasts,15 and that the 
scaffolding material must remain mechanically stable throughout the regenerative process to 
ensure that the regenerating tissue does not rupture or become damaged due to premature 
degradation of the scaffold.16,17  A variety of materials have been investigated for use as a 
scaffold for skeletal muscle regeneration including poly(glycolic acid) (PGA),18,19 alginate,20,21 
decellularized ECM,22-24 and fibrin.25-27  Synthetic materials such as PGA or poly(ε-
caprolactone) (PCL) can be fabricated with tuned mechanical and structural properties and, due 
to their fibrous structure, readily direct myoblast alignment.28  Decellularized ECM scaffolds 
have demonstrated some success in enhancing skeletal muscle regeneration when the 
decellularization process conserves the bioactivity of the material.24  A limitation of many of 
these materials is that their bulk structure and randomly polymerized internal fibrillar networks 
do not consistently promote uniaxial alignment of myoblasts, generating disorganized 
regenerated tissue which will impair the muscle’s ability to efficiently contract.  As such, there is 
a need to create biomimetic materials that are capable of aligning myoblasts within an injury site 
to promote skeletal muscle regeneration. 
Our laboratory has developed a method to control the polymerization process of fibrin to 
create microthreads, discrete cylindrical structures that direct cell alignment.29  These fibrin 
microthreads can bind growth factors, such as fibroblast growth factor 2 (FGF2), using the 
protein-binding domains present on fibrin.30  When implanted into a mouse model of VML, 
fibrin microthreads, as well as cell-seeded fibrin microthreads, increased the functional recovery 
of the defect.27  However, these studies showed that the fibrin microthreads completely degrade 
within two weeks in vivo,27 suggesting that their degradation rate would need to be decreased for 
use as a scaffold for skeletal muscle regeneration to facilitate increased organized regeneration of 
muscle tissue. 
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1.2 OVERALL GOAL and HYPOTHESIS 
The ultimate goal of this project was to develop a scaffold material that was mechanically 
stable in situ to guide aligned, myoblast ingrowth and that will incorporate growth factors, 
delivered at clinically relevant times, to direct mechanically functional skeletal muscle tissue 
regeneration of VML injuries. 
We hypothesize that fibrin microthreads with an increased resistance to proteolytic 
degradation and loaded with HGF will enhance the functional regeneration of skeletal muscle 
tissue in a VML injury model. 
To systematically test this hypothesis, this dissertation was separated into three specific 
aims.  We investigated crosslinking and post-polymerization processing conditions in Specific 
Aim 1 to develop fibrin microthreads with increased resistance to proteolytic degradation.  In 
Specific Aim 2, we developed strategies to incorporate HGF onto fibrin microthreads.  Finally, 
in Specific Aim 3, we investigated the restoration of mechanical function of the mouse tibialis 
anterior (TA) muscle after the generation of a critically sized VML defect.  The expected 
outcome of this dissertation was the identification of post-fabrication modifications such as 
chemical crosslinking, controlled uniaxial stretching, and growth factor adsorption to fibrin 
microthreads to match scaffolds with known structural and biochemical properties to site-
specific tissue properties (e.g. skeletal muscle) to recapitulate regenerative cues lost in traumatic 
injuries. 
 
1.3 SPECIFIC AIM 1: DEVELOP MICROTHREADS WITH TUNABLE STRUCTURAL 
PROPERTIES WHILE MAINTAINING CELLULAR VIABILITY 
A significant challenge in the design of biomimetic scaffolds is combining 
morphological, mechanical, and biochemical cues into a single construct to promote tissue 
regeneration.  The goal of this study was to develop fibrin microthreads with controlled 
degradation rates to decrease the rate of proteolytic degradation to generate scaffolds designed 
for directional cell guidance with increased mechanical stability.  In Chapter 3 of this thesis, we 
analyzed the effects of different crosslinking conditions on fibrin biopolymer microthreads to 
create scaffolds with tunable mechanical and structural properties to increase in vivo scaffold 
persistence.  Fibrin microthreads were crosslinked using carbodiimides in either acidic (EDCa) 
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or neutral (EDCn) buffer, and changes in the mechanical, structural, and biochemical properties 
of the microthreads were investigated.  EDCa microthreads had significantly higher tensile 
strengths and moduli than all other microthreads, and failed at lower strains than all other 
microthreads.  EDCn microthreads were also significantly stronger and stiffer than uncrosslinked 
(UNX) microthreads and were comparable to contracting muscle in stiffness.  Swelling ratios of 
crosslinked microthreads were significantly different from each other and uncrosslinked controls, 
suggesting a difference in the internal organization and compaction of the microthreads.  Using 
an in vitro degradation assay, we observed that EDCn microthreads degraded within 24 hours, 
six times slower than UNX control microthreads, but EDCa microthreads did not show any 
significant indication of degradation within the 7 day assay period.  Microthreads with higher 
stiffnesses supported significantly increased attachment of C2C12 myoblasts, as well as 
increases in myoblast proliferation without a decrease in viability.  Taken together, these data 
demonstrate the ability to create microthreads with tunable mechanical and structural properties 
that differentially direct cell functions.  Ultimately, we anticipate that we can strategically exploit 
these properties to promote site-specific tissue regeneration.  Grasman JM, Page RL, Dominko T, 
Pins GD. Crosslinking strategies facilitate tunable structural properties of fibrin microthreads. 
Acta Biomaterialia 2012;8(11):4020-30. 
As an alternate to exogenous crosslinking agents, we analyzed fibrin microthread 
processing conditions in Chapter 4 of this thesis to determine the effects of static axial stretching 
on the proteolytic degradation of these materials.  Our hypothesis was that increased amounts of 
stretch on fibrin microthreads would decrease the rate of proteolytic degradation, which was 
based upon previous work demonstrating that stretched fibrin clots had increased resistance to 
proteolytic degradation.31  Fibrin microthreads were extruded, dried, rehydrated, and static 
axially stretched 0-200% of their original lengths; then the mechanical and structural properties 
of the microthreads were assessed.  Stretching significantly increased the tensile strength of 
microthreads threefold, yielding scaffolds with tensile strengths and stiffnesses that equaled or 
exceeded values reported in Chapter 3 for EDCa and EDCn microthreads without affecting 
intrinsic material properties such as strain hardening or Poisson’s ratio.  Interestingly, these 
stretching conditions did not affect the rate of proteolytic degradation of the microthreads.  The 
swelling ratios of stretched microthreads decreased, and scanning electron micrographs showed 
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increases in grooved topography with increased stretch, suggesting that stretching may increase 
the fibrillar alignment of fibrin fibrils.  The average myoblast alignment with respect to the 
longitudinal axis of the microthreads increased twofold with increased stretch, further supporting 
the hypothesis that stretching microthreads increases the alignment of fibrin fibrils on the 
surfaces of the scaffolds.  Together, these data suggest that stretching fibrin microthreads 
generates stronger materials without affecting their proteolytic stability, making stretched 
microthreads ideal for use as implantable scaffolds that require short degradation times and large 
initial loading properties, as opposed to use in long term implantation.  Further modifications to 
stretched microthreads, such as carbodiimide crosslinking, could generate microthreads to direct 
cell orientation and align tissue deposition, with additional resistance to degradation for use as a 
long-term scaffold for tissue regeneration.  Grasman JM, Pumphrey LM, Dunphy M, Perez-
Rogers J, Pins GD. Static axial stretching enhances the mechanical properties and cellular 
responses of fibrin microthreads. Acta Biomaterialia 2014;10(10):4367-76. 
 
1.4 SPECIFIC AIM 2: QUANTIFY THE EFFECTS OF INCORPORATING HGF ONTO 
FIBRIN MICROTHREADS TO INCREASE SATELLITE CELL RECRUITMENT 
There are almost 100,000 reconstructive maxillofacial surgical procedures performed 
annually as a result of traumatic injury, cancer ablation, or cosmetic procedures, profoundly 
impacting the quality of life of patients.  These procedures result in the destruction of the basal 
lamina, which removes important biochemical cues such as the release of HGF, which initiates 
endogenous skeletal muscle regeneration.  The goal of this study was to develop a system to 
rapidly release HGF from fibrin microthreads to mimic the rapid release of HGF in minor muscle 
injuries.  In Chapter 5 of this thesis, we investigated the effect of adsorbing HGF onto UNX, 
EDCn, or EDCa microthreads on myoblast proliferation and recruitment in an in vitro model 
designed to mimic in vivo SC recruitment.  EDCn microthreads facilitated the most HGF 
adsorption, the release of which was able to significantly elevate the number of proliferating 
myoblasts for at least 2 days.  This active release also increased the two-dimensional migration 
and three-dimensional outgrowth of myoblasts twofold.  UNX microthreads supported HGF 
adsorption as well; however, it was completely released within 24 hours and only enhanced 
myoblast proliferation, not migration, possibly due to low concentrations of HGF adsorbed to the 
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surface.  While EDCa microthreads did not facilitate the adsorption of HGF, medium 
conditioned from these microthreads stimulated myoblast proliferation, possibly due to the 
release of fibrin degradation products that resulted from the crosslinking procedure.  Regardless 
of the amount of HGF adsorbed on the microthreads, significantly more myoblasts were 
proliferating on crosslinked, stiffer microthreads 4 days after myoblasts migrated along the 
microthreads.  The ability of EDCn microthreads to adsorb HGF in a way that facilitated its 
rapid, active release is ideal for VML injuries, and we hypothesize that these HGF-loaded EDCn 
microthreads will enhance the functional regeneration of these injuries.  Grasman JM, Page RL, 
Dominko T, Pins GD. Adsorbed Hepatocyte Growth Factor on Crosslinked Fibrin Microthreads 
Enhances Cell Recruitment. In preparation 2014. 
 
1.5 SPECIFIC AIM 3: ASSESS MICROTHREADS’ ENHANCEMENT OF SKELETAL 
MUSCLE REGENERATION IN VIVO 
VML injuries typically result from traumatic incidents; such as those presented from 
combat missions, where soft-tissue extremity injuries account for 63% of diagnoses.1,2  These 
injuries can result in muscle loss, which lead to cosmetic deformities and devastating loss of 
function.  In Chapter 6 of this thesis, we evaluated the ability of HGF adsorbed, EDCn 
microthreads to guide functional regeneration in VML-sized defects in an in vivo animal model  
created by excising approximately 40-50% of the TA muscle, reducing the force output of the 
muscle by 50%.  Fourteen days post-injury, there were significantly more myogenin positive 
nuclei present in the defect site of HGF-loaded EDCn microthreads, suggesting an increased 
number of myoblasts were differentiating into myotubes.  There was also a significantly higher 
number of blood vessels present in microthread (UNX, EDCn, and HGF-loaded EDCn) implants.  
Sixty days post-injury, HGF-loaded EDCn (EDCn-HGF) microthreads facilitated significant 
functional recovery of the skeletal muscle defect that approached pre-injury values.  
Histomorphometrically, EDCn and EDCn-HGF microthreads persisted 60 days post-injury, and 
mature, organized muscle tissue replaced the microthreads in areas of the injury site instead of 
disorganized muscle, or adipose infiltration observed within the injury site of negative controls.  
The amount of Pax7 positive SCs and myogenin positive nuclei present in the injury site returned 
to values similar to uninjured muscle, suggesting that much of the injury site has resolved at this 
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time. Together, these data suggest that the scaffold materials are being remodeled with functional 
muscle tissue, and that we designed fibrin biopolymer microthreads that recapitulate several of 
the regenerative cues lost in VML injuries and enhance the functional regeneration of skeletal 
muscle.  Grasman JM, Do DM, Page RL, Pins GD. Hepatocyte Growth Factor Adsorbed onto 
EDC Crosslinked Microthreads Restores Mechanical Function in Mouse Model of VML. In 
preparation 2014. 
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Chapter 2: Background 
 
 
 
 
2.1 CLINICAL NEED FOR SCAFFOLDS TO REGENERATE SKELETAL MUSCLE 
Large skeletal muscle defects, while not life threatening, profoundly impact the quality of 
life of patients.  Skeletal muscle injuries typically result from traumatic incidents; such as those 
presented from excessive exercise, contusions, lacerations, surgical resection or reconstruction, 
or combat injuries.1-3  Approximately 35-55% of all sports injuries are due to skeletal muscle 
damage, typically as a result of myofiber and/or connective tissue damage.4  Further, there are 
about 4.5 million reconstructive surgical procedures performed annually as a result of traumatic 
injury, car accidents, cancer ablation, or cosmetic procedures.5,6  On the battlefield, extremity 
injuries account for 63% of diagnoses, with most of these wounds involving soft tissue 
damage.7,8  Many of these injuries involve the loss of at least 20% of a given muscle’s mass, 
which is termed volumetric muscle loss (VML).9,10  These injuries result in billions of dollars in 
health care expenses, as well as the development of different surgical techniques and medical 
devices, to repair them,11-14 and are characterized by a significant loss of muscle volume and 
mechanical function.9,15 
While skeletal muscle has an innate repair mechanism that can repair small wounds such 
as those incurred through exercise, VML defects and injuries are beyond the ability of this 
mechanism.1  Further, there are no treatments available that attempt to harness or direct this 
endogenous regenerative pathway.  There are several established protocols for the treatment of 
small-scale skeletal muscle injuries, such as RICE (resting the wound with a combination of ice, 
compression, and elevation),13,14,16 however, larger-scale injuries such as those presented by 
VML often require more specialized surgical solutions.17  The current standard of care for large-
scale VML injuries is an autologous tissue transfer from an uninjured site, where surgeons 
remove the damaged muscle tissue and graft healthy muscle from a donor site unaffected by the 
traumatic incident.6,18  While autologous tissue transfers are the best available treatment option, 
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as many as 10% of these surgeries undergo complete graft failure, due to complications such as 
infection and necrosis, demonstrating the need for an alternative treatment.18,19  Regardless of the 
level of success of these procedures, there is always a loss of muscle strength and function, 
usually due to the formation of scar tissue.10,15,17  Additionally, in the case of extensive traumatic 
injuries such as those presented by military personnel, there may be limited donor site 
availability.15,20  In the case of extensive traumatic injury to a limb, amputation is the standard of 
care, requiring the use of a prosthetic device to regain limited functionality.10  As such, there is a 
significant need to develop off-the-shelf biomimetic materials that can direct skeletal muscle 
tissue formation within these large defect sites to facilitate functional tissue regeneration. 
 
2.2 SKELETAL MUSCLE ANATOMY 
Skeletal muscle is one of the most abundant tissues in the human body, accounting for 
40% to 45% of the total body mass.21  It induces coordinated locomotion through attachment 
points to the skeleton, and its macroscopic structure consists of organized networks of myofibers, 
blood vessels, nerves, and connective tissue.  The working contractile unit of skeletal muscle is 
the sarcomere, which consists of interposing filaments of actin and myosin.22  Multiple 
myoblasts fuse together to form myofibrils, which are structures with repeating sarcomeres along 
the length of the myofibril.  
A bundle of myofibrils form 
the basic structural element 
of muscle: the myofiber 
(Figure 2.1).  Myofibers 
range between 20-100 µm in 
size, and are the 
conglomeration of multiple 
myofibrils.21,22  Ultimately, 
the nuclei of these myoblasts 
translocate to the periphery 
of the myofibers, residing 
just beneath the sarcolemma, 
Figure 2.1. Anatomy of skeletal muscle tissue.  Skeletal muscle tissue is a 
highly organized series of cable like structures, with the smallest functional 
unit referred to as a myofibril.  Bundles of myofibrils form myofibers, which 
in turn are grouped together to form fascicles, which are bundled to form the 
muscle belly. Image courtesy of M Zayas.
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or cell membrane of myofibers.  Myofibers organize into larger structures referred to as 
fascicles,21 and in general, the anatomical structure of skeletal muscle can be thought of as a 
series of self-contracting cables that organize into a complex hierarchical structure. 
Each myofiber is surrounded by a basement membrane referred to as the basal lamina 
(Figure 2.1).  This dense structure is composed of a variety of basement membrane proteins such 
as type IV collagen and laminin-2, and is essential for guiding the endogenous regenerative 
pathway of skeletal muscle.23,24  Skeletal muscle progenitor cells, termed satellite cells (SCs), 
reside in the interstitial space between the sarcolemma of myofibers and the basal lamina.  These 
cells are identified by expressing paired box gene 7 (Pax7), and are typically quiescent in mature, 
healthy tissue.1,25,26  Satellite cells account for 2-7% of all myofiber nuclei, but they are the 
primary cell type responsible for the regeneration of skeletal muscle tissue.27 
 
2.3 NATIVE REGENERATIVE PATHWAY OF SKELETAL MUSCLE 
Skeletal muscle regeneration is a complex process that involves an inflammatory 
response, growth factor signaling, SC repair of the injury, and fibroblast infiltration, ultimately 
leading to either functional regeneration, or scar tissue formation.  These processes have been 
loosely classified into three phases: (1) the destruction/inflammatory phase, (2) the repair phase, 
and (3) the remodeling phase (Figure 2.2).10,13,21,28,29 
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Figure 2.2. Schematic representation of native skeletal muscle regeneration.  SCs can be identified by their 
position between the sarcolemma and basal lamina of mature skeletal muscle (A).  Upon injury, SCs are recruited 
to the wound site and begin to proliferate (B).  These proliferating SCs will eventually begin to fuse together to 
form immature myofibers (C), which will fuse with the existing healthy myofibers, and will then mature by 
expressing more contractile proteins to regenerate functional tissue (D).  Image courtesy of M Zayas. 
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2.3.1 Destruction/Inflammatory Phase 
Traumatic injury to skeletal muscle leads to the rupture of the sarcolemma, which 
exposes the intracellular contents of the myofiber to large amounts of extracellular calcium.  This 
triggers the activation of calcium-dependent proteases, initiating myofiber necrosis.21,29  Necrosis 
occurs along the length of the damaged myofiber until it reaches a contraction band, a dense 
band of cytoskeletal material that is designed to halt the necrosis of injured myofibers.13,30,31  
Almost immediately after injury, neutrophils migrate to the injury site and assist in the 
degradation of damaged myofibers.  Macrophages quickly migrate to the injury site and become 
the predominate cell type present in as little as two days post-injury.32  One of the most critical 
cytokines secreted from the inflammatory cells is nitric oxide, whose functions include: (1) the 
facilitation of further degradation of myofibers present in the wound environment,28,32 (2) the 
facilitation of the release of growth factors such as hepatocyte growth factor (HGF) from the 
surrounding matrix,28,33-35 and (3) the induction of vasodilation of nearby blood vessels to recruit 
additional inflammatory cells.13,36  While macrophages migrate to the wound site within two 
days of injury, they also modulate the cytokines they release over time.  Initially, pro-
inflammatory M1 phenotype macrophages assist in the phagocytosis of necrotic myofibers, and 
also support satellite cell survival and proliferation.28,32  Over the next 3-7 days, M1 
macrophages are replaced by M2 macrophages, which are believed to enhance the regenerative 
response of tissues by promoting myoblast proliferation, growth, and differentiation.10,28,32 
 
2.3.2 Repair Phase 
The repair phase of skeletal muscle regeneration is comprised of two sub-phases: the 
recruitment and proliferation of SCs (Figure 2.2B), and the differentiation of SCs into mature 
muscle tissue (Figure 2.2C).  The recruitment/proliferation phase is initiated upon mechanical 
injury of muscle fibers, when HGF is rapidly released from the extracellular matrix (ECM) of the 
muscle fiber itself, stimulating the activation and proliferation of SCs as well as the chemotaxis 
of SCs to migrate to the injury site.34,35,37,38  HGF has been found to be the sole growth factor 
capable of bringing SCs back into the cell cycle.39-41  Other factors, such as fibroblast growth 
factor 2 (FGF2) and fibroblast growth factor 6 (FGF6), are also released from the ECM, and also 
stimulate SC proliferation to gather enough progenitor cells to repair the injury.13,38,42-46  Because 
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of their location between the sarcolemma and the basal lamina, SCs typically migrate 
longitudinally from the same myofiber to the injury site, rather than laterally from other, intact 
fibers.1,25,47  However, once injuries result in the rupture of the basal lamina, lateral migration of 
SCs to the injury site does occur.48,49  SCs are extremely efficient at repairing muscle, and are 
capable of generating thousands of myoblasts from a small number of satellite cells.50,51  Once 
SCs reenter the cell cycle (i.e. activate), they begin to express myogenic factor 5 (Myf5), and 
will express myogenic differentiation factor-1 (MyoD) when they are committed to myogenic 
differentiation.1,52-55  Additionally, once SCs are committed to differentiation they are referred to 
as myoblasts, and begin to lose Pax7 expression.56 
The second sub-phase of regeneration, the differentiation phase, occurs when myoblasts 
begin to express myogenin, fuse with other myoblasts, and mature into myofibers (Figure 
2.2C).53,56  This process is inhibited by the growth factors associated with the proliferation phase 
of muscle regeneration, mainly HGF, FGF2, and FGF6, highlighting the importance of the 
temporal expression of growth factors in skeletal muscle regeneration.1,38,57,58  Specifically, there 
is evidence that prolonged, systemic supplementation of HGF will inhibit healing, showing a 
need for the growth factor to be present for no longer than 48-72 hours.38,59,60 Instead, the process 
of myoblast differentiation is stimulated by the insulin-like growth factor (IGF) family.61,62  This 
family (consisting of members IGF1 and IGF2) is unique in that each growth factor will 
stimulate both the proliferation, and subsequent differentiation, of myoblasts.63-66  Both in vitro 
and in vivo studies have suggested that IGF1 is more potent in skeletal muscle regeneration than 
IGF2, either due to growth factor activity or the increased availability of its receptor, insulin-like 
growth factor receptor-I (IGFR1).67,68  Neutralizing the function of IGF1 was found to inhibit 
skeletal muscle regeneration, highlighting the importance of this factor in the regenerative 
response.69  Further, injections of exogenous IGF1 into skeletal muscle injuries in aged animals 
have been shown to restore the proliferative ability of SCs, marking it as a potent factor in 
skeletal muscle regeneration, and indeed a necessary factor for use in enhancing the endogenous 
regenerative response of skeletal muscle.70-72  IGF-mediated cell-fusion events occur after the 
initiation of myogenin expression, which also terminates MyoD/Myf5 expression.1,26,56  Nascent 
myofibers are characterized by centrally aligned nuclei, and as these cells mature and generate 
more contractile proteins the nuclei gradually translocate to the periphery of the myofiber.1,13,26,54 
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2.3.3 Remodeling Phase 
The final stage of muscle regeneration is the remodeling phase and is a balance between 
the culmination of the differentiation sub-phase of muscle regeneration and the infiltration of 
fibroblasts into the injury site.  Regenerating myoblasts will fuse with the existing musculature at 
the interface of the injury, or to the ECM (Figure 2.2D).10  The infiltration of fibroblasts, which 
can begin as early as the inflammatory phase, supports regeneration by repairing and replacing 
connective tissue that was damaged by the injury.13  While the connective tissue synthesized by 
fibroblasts is important in providing stability for the regenerating tissue and replacing damaged 
or lost ECM, collagen deposition often remodels into scar tissue and limits the organization of 
the regenerated tissue (Figure 2.3).10,13,73  The balance between these two antagonistic responses 
dictates the functional outcome from the regenerative pathway.  In general, small injuries 
remodel without the presence of scar tissue, but as the injury becomes larger the fibroblast 
infiltration increases such that there begins to be a significant amount of collagen deposition, 
ultimately impeding the functional regeneration of skeletal muscle tissue. 
In injuries resulting from VML, there are no regenerative cues present due to the 
complete destruction, or removal, of the basal lamina and surrounding connective tissue (Figure 
2.3).  This results in a loss of traditional signaling that indicates the need for SCs to migrate into 
the injury site; therefore, there does not appear to be a large influx of myoblasts into these 
injuries.13,74  Because of the lack of SC infiltration into the injury site, the infiltrating fibroblasts 
dominate this stage of regeneration, resulting in large amounts of collagen deposition.75,76  
Ultimately, the deposition of collagen I into the wound site results in the formation of scar tissue, 
limiting the ability of the muscle to uniformly contract, which results in a loss of function as 
observed from the patient.10,73,77  In addition to the loss of mechanical function observed in 
patients with VML injuries, these injuries also result in significant losses in muscle volume, 
which can generate physical deformities that may impact the psychological health of the patient. 
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2.3.4 Cell Types Involved in Skeletal Muscle Regeneration 
Concurrent with the repair phase of skeletal muscle regeneration, blood vessels, nerves, 
and fibroblasts are infiltrating the injury site.1,10,29  Skeletal muscle is a highly vascularized 
tissue, and as such its revascularization is vital for successful regeneration.78,79  The close 
proximity of SCs and endothelial cells in skeletal muscle facilitates paracrine signaling between 
these cell types to support both angiogenesis and myogenesis.80,81  Muscle is not only highly 
vascularized, but also heavily innervated to facilitate the cooperative contraction of myofibers to 
conduct uniaxial force.29  Factors such as IGF1 have been shown to induce nerve sprouting, and 
Figure 2.3. Schematic representation of repair of VML injuries.  The basal lamina is typically destroyed or 
removed in large muscle injuries, eliminating important signaling cues that recruit SCs to the injury (A).  
Instead, fibroblasts migrate into the injury site and deposit collagen (B), ultimately leading to massive scar tissue 
formation (C).  Image courtesy of M Zayas. 
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HGF and FGF2 have been shown to be potent angiogenic factors, suggesting that the growth 
factor cascade in skeletal muscle regeneration affects a variety of cell types in addition to 
myoblasts.82-87  The infiltration of fibroblasts coincides with SC infiltration to support 
regeneration by repairing and replacing connective tissue that was damaged by the injury.13  
However, as stated earlier, the deposition of connective tissue often leads to scar tissue formation 
as well as functionally impaired regeneration.12,13,30,88 
 
2.4 CURRENT TISSUE ENGINEERING STRATEGIES AND LIMITATIONS 
There are two main approaches to develop materials for skeletal muscle regeneration: the 
development of in vitro skeletal muscle constructs to augment, and the development of scaffolds 
to regenerate, damaged skeletal muscle tissue in vivo.89-92  Materials designed to guide 
regeneration of skeletal muscle can be further defined as either acellular or cellular; 
incorporating myoblasts or stem cells into their matrix.  The utilization of the scaffolding 
material as a delivery vehicle of progenitor cells attempts to address the limitation of needing 
sufficient numbers of cells to regenerate large scale injures, while acellular strategies attempt to 
address this same limitation by delivering sustained amounts of growth factors to stimulate local 
progenitor cells into the injury site.  To direct skeletal muscle growth, biomimetic scaffolds must 
facilitate cell alignment, promote skeletal muscle formation, and stimulate vascularization and 
innervation.  Cell alignment is one of the most critical factors in skeletal muscle regeneration due 
to the unique geometric organization of muscle fibers.21,93-96  Fibrous elements within scaffolding 
materials have been shown to direct cell alignment along the length of the scaffold’s surface.97-
100  Strategies to promote skeletal muscle formation and angiogenesis include the incorporation 
of growth factors and peptide sequences within the scaffolding material.78,101,102  Sustained 
delivery of growth factors improves skeletal muscle regeneration compared to single bolus 
dosing, suggesting that the controlled release of growth factors from scaffold materials is an 
efficient delivery method for these molecules.61,71,78  Finally, scaffolds need to balance 
degradation with structural and mechanical support of the injury site such that enough structural 
stability is present within the scaffold material to support mechanical loading until the 
regenerated tissue is stable enough to withstand loading independently.3,76,103 
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2.4.1 In Vitro Skeletal Muscle Development 
Engineered skeletal muscle constructs have been developed to study skeletal muscle 
formation in vitro, to develop high throughput models for drug screening applications, and 
ultimately to replace or augment damaged tissue in vivo.21,92,93  These tissues are typically 
prepared by seeding myoblasts onto a protein surface, commonly fibrin, which is remodeled into 
muscle tissue.68,104-108  Vandenburgh and colleagues developed a platform technology that could 
generate muscle constructs in the bottom of 96 well plates between two polydimethylsiloxane 
(PDMS) posts as a high throughput model for drug screening applications.  Each individual well 
was capable of being mechanically stimulated and assessed for force production.109-111  In vitro 
skeletal muscle constructs designed for implantation to replace damaged muscle tissue or to 
model skeletal muscle formation can spontaneously contract, and have been electrically 
stimulated to induce tetanic contractions, demonstrating that these constructs can accurately 
mimic skeletal muscle function.107  One of the limitations of these skeletal muscle constructs is 
the inability of nutrients to diffuse to the innermost layers of the tissue.  While this is not a 
problem for small skeletal muscle constructs used in drug screening applications, constructs 
approaching 0.4 mm in thickness result in the formation of a necrotic core, making it unsuitable 
for implantation.107,112  Recently, a study using a heterogeneous population of cells isolated from 
the muscles in mice hind limbs demonstrated that vascular networks could be formed in vitro to 
support the survival of these constructs for at least 40 days in culture.113 
Larger skeletal muscle constructs, ranging between 1 and 4 cm in length, have been 
implanted to observe engraftment, vascularization, and functional recovery of VML injuries.  
Implanting in vitro skeletal muscle constructs near existing blood vessels greatly enhances their 
vascularization.114  Successful in vivo engraftment significantly increases the force output of 
these constructs, demonstrating that these constructs are capable of integrating with the 
surrounding tissue to remain viable and enhance their force production.115  Finally, in vitro 
skeletal muscle constructs approximately 4 cm in length, termed “skeletal muscle units” (SMUs), 
were implanted into a rat VML model where 33% of the tibialis anterior (TA) muscle was 
removed.  While these SMU constructs supported some vascular and nervous tissue integration 
as well as a significant increase in TA force production after 28 days, the forces generated in 
these muscles remained significantly below baseline force values.116 
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The major limitation of these methods is the lack of vascularization of in vitro skeletal 
muscle constructs.  Dennis and Kosnik showed that myoblasts need to be within 150 µm of a 
source of oxygen to proliferate or differentiate, limiting the size of viable constructs without a 
functional vascular network.112  Further, these constructs are generated by seeding myoblasts and 
fibroblasts on protein surfaces and then they are differentiated into functional tissue.  This 
requires 3-4 weeks of culture time for the formation of a robust ECM to support construct 
contractility.92  The ability to generate contractile constructs from a patient’s own cells is an 
attractive possibility;92,111 however, nearly a month would pass between obtaining the biopsy and 
implantation.  Therefore, these constructs might be better suited for chronic reconstruction rather 
than the repair of traumatic VML injuries. 
 
2.4.2 Biomaterials for Skeletal Muscle Regeneration 
Scaffolds for skeletal muscle regeneration have been made from a variety of materials, 
ranging from synthetic polymers such as poly(glycolic acid) (PGA)117 and poly-ε-caprolactone 
(PCL);94 to natural polymers such as alginate,78 collagen,98 and fibrin;76 to decellularized ECM 
materials.118  In addition to the use of a variety of materials as acellular scaffolds, strategies for 
skeletal muscle regeneration have utilized a variety of cell sources.90,93  The incorporation of 
cells into scaffolds has significantly increased the survival of implanted cells in the injury site, 
which has previously been below 5%.119,120  While the source of these cells can vary with 
different scaffolds, in general, SCs, or myoblasts derived from satellite cells in culture, have been 
investigated to regenerate skeletal muscle injuries.90,121  The sections below discuss recent 
advances in the design of scaffolds for the regeneration of VML injuries, and are organized 
based on the composition of their scaffolding materials. 
 
2.4.2.1 Synthetic Polymers 
A variety of synthetic materials have been used as scaffolds for skeletal muscle 
regeneration such as PGA,117,122 poly(lactic acid) (PLA),123 their copolymers (PLLA/PLGA),124 
and PCL.94,125  Synthetic materials offer several advantages to natural polymers, such as their 
ability to have precisely tuned mechanical and structural properties that can be tailored to each 
tissue engineering application.100,126,127  Synthetic polymers can be fabricated into a variety of 
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geometries such as individual fibers or electrospun meshes with aligned, or random, nanofiber 
orientation.128-130  Myoblasts seeded on electrospun meshes with aligned nanofiber orientation 
generate highly aligned cultures that, when cultured in differentiation medium, readily fuse into 
aligned myotubes.94,131  Incorporating electrically conductive materials within synthetic 
scaffolding materials facilitated more efficient electrical stimulation of myoblast cultures, further 
improving myoblast differentiation compared to aligned fibers without stimulation.132-134  
Synthetic scaffolds can easily be fabricated with multiple growth factors incorporated into their 
bulk structure to facilitate the controlled release of these factors into a potential injury site.135 
The mechanical stability of synthetic polymer scaffolds that have been used for skeletal 
muscle applications,136-138 have previously demonstrated successful outcomes as structural 
support in the abdomen to repair hernias.139,140  In these applications, several studies noted the 
beginning of a vascular network forming in as little as 6 weeks after implantation of PGA 
meshes, suggesting that these scaffold materials have a modest ability to stimulate 
angiogenesis.122,141  However, a common criticism of synthetic materials is that their surfaces do 
not always readily support cell attachment.142  Due to their inherent suboptimal bioactivity, many 
strategies exist to functionalize the surfaces of synthetic polymer scaffolds, such as the addition 
of collagen or decellularized ECM, to modulate tissue responses.94,136  The limited bioactivity of 
scaffolds made from synthetic polymers limit their utility for treating VML injuries because of 
the need for the scaffolds to guide functional tissue regeneration. 
 
2.4.2.2 Natural Polymers 
Naturally occurring polymers, such as alginate,78,83,143 collagen,98,144,145 and fibrin20,76,124 
have been used extensively in skeletal muscle engineering.  Unlike synthetic polymers, natural 
polymers possess intrinsic bioactive signaling cues, and can form complexes with proteins, such 
as heparan sulfate, and growth factors to enhance cell migration, proliferation, or 
differentiation.146-149  Alginate is derived from seaweed and was originally used as an 
encapsulation agent for a variety of cell types,150 but due to its amenability to chemical 
alterations to promote cell adhesion,151 as well as its tunable mechanical and structural 
properties,152-154 it has become increasingly used as a scaffold for skeletal muscle regeneration.  
Alginate gels with stiffnesses between 13 and 45 kPa were found to maximize myoblast 
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proliferation and differentiation.155  Additionally, alginate facilitates the controlled release of a 
variety of growth factors important to skeletal muscle regeneration, such as HGF,120,143 
FGF2,120,143 IGF1,78,156 and vascular endothelial growth factor (VEGF).78,156-158  Alginate gels 
loaded with HGF and FGF2 significantly increased myoblast viability within, as well as the 
migration of myoblasts out of, these scaffolds, demonstrating that alginate can deliver myoblasts 
to skeletal muscle.120  When translated to a mouse TA laceration model, myoblast-seeded gels 
loaded with HGF and FGF2 almost completely resolved the muscular injury.  It was found that 
the combination of growth factors and the myoblasts produced this effect, as each condition 
individually only elicited a modest regenerative response.143  More recently, alginate gels 
incorporating VEGF and IGF1 have been implanted into ischemia-induced skeletal muscle 
injuries to address skeletal muscle regeneration by improving the early vascularization and 
myoblast survival within the injury sites.78,157  While this model of injury is not as severe as 
VML injuries, bulk alginate scaffolds loaded with multiple growth factors can dramatically 
improve the regeneration of skeletal muscle injuries by improving the overall vascularization and 
myoblast differentiation in situ.  However, these alginate gels have only been implanted on the 
surface of the injury site,159 and therefore their ability to direct skeletal muscle regeneration 
without the presence of the existing skeletal muscle ECM is not known. 
Collagen, particularly type I, belongs to a family of ECM proteins found in connective 
tissue, particularly in the dermis, tendons, and blood vessels.160  Scaffolds made from type I 
collagen have been used in a wide variety of tissue engineering applications including skin, 
cartilage, bone, tendon, skeletal muscle, and nerve.148,161  Collagen gels have been frequently 
used in skeletal muscle regeneration as a cell delivery vehicle, as intramuscular injections of 
myoblasts results in the rapid death of these injected cells.119  Myoblasts implanted within a 
collagen gel have been shown to migrate out of the scaffold and fuse with the existing myofibers 
present at the periphery of the injury site.162,163  Disorganized myofibers form as a result of the 
amorphous polymerization process of the collagen lattices, resulting in less optimal healing of 
muscle injuries.164  Acellular collagen sponges also supported disorganized repair of large 
muscle defects; however, a large amount of adipose tissue was observed 12 to 24 weeks post-
injury, which further limited the amount of organized, functional recovery.165  To improve the 
alignment of regenerating myofibers, collagen gels can be fabricated with aligned pore structures 
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through controlled freeze-drying processes.  These modified scaffolds facilitated aligned 
myotubes along the direction of the pores, which, when integrated into a large muscle defect, 
were capable of producing force upon electrical stimulation.98  However, because of the lack of a 
robust regenerative response observed with implanted collagen scaffolds, collagen materials 
were customized with molecules such as heparin to achieve controlled release of growth factors 
into the injury site.166,167  In fact, the functional recovery of muscles damaged by acute ischemia 
was significantly increased by adding a VEGF-loaded collagen scaffold, demonstrating that 
scaffolds can contribute to regeneration by supplying necessary growth factors to the wound 
site.168  Other growth factors, such as HGF, IGF1, and FGF2 have been added to denatured 
collagen gels to increase SC recruitment into the  injury site;169 however, no functional 
measurements were performed on these regenerating muscles and data was obtained only at early 
time points. 
Fibrin has been used extensively as a scaffold material in tissue engineering because of 
its intrinsic bioactivity and role as a provisional matrix during the initial stages of wound 
healing.149,170  Fibrin is a branched, microfibrillar polymer, formed when activated thrombin 
cleaves two small peptides from fibrinogen, allowing fibrinogen to self-assemble into a complex 
fibrillar network.  Fibrin gels have been used as the provisional seeding matrix for many in vitro 
skeletal muscle constructs, as described above in section 2.4.1.171-173  Despite completely 
degrading within 3 weeks post-injury, fibrin gels promote myoblast survival and differentiation 
into myofibers that can integrate with uninjured tissue.20,174,175  Implanting a myoblast populated 
fibrin gel near an existing blood vessel greatly enhances the vascular perfusion of these 
constructs.  These primary myoblasts formed vascularized functional mature skeletal muscle 
tissue three weeks after implantation.114  In a different approach to vascularization of skeletal 
muscle constructs, endothelial cells were seeded into fibrin-PLLA/PLGA constructs in addition 
to fibroblasts and myoblasts.  This tri-culture supported a complex vascular network, suggesting 
the need for multiple cell types to be present in cell constructs for skeletal muscle 
regeneration.124  The addition of PLLA/PLGA to these tri-culture scaffolds was done in part to 
augment the stability of fibrin constructs, as uncrosslinked fibrin is rapidly remodeled.  Another 
strategy to decrease the rate of proteolytic degradation of fibrin has been to add polyethylene 
glycol (PEG) groups to the bulk structure of fibrin.  In addition to modulating the structural 
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properties of the material, PEGylation can also be a loading mechanism for a variety of growth 
factors, such as IGF1, to facilitate a controlled release of the factor to enhance skeletal muscle 
regeneration.176 
 
2.4.2.3 Decellularized ECM 
Decellularized ECM has been harvested from a variety of tissues such as the small 
intestine, urinary bladder, dermis, and pericardium.177-179  This scaffolding material serves as an 
excellent “top-down” approach to biomaterial construction, meaning that the entire regenerative 
environment is provided at the start of regeneration, as it contains many matrix proteins and 
growth factors in their native configuration.  In contrast, a “bottom-up” approach combines 
discrete functional units with tissue-specific properties designed for specific functions, and will 
be further described in section 2.5.  While ECM-derived scaffolds are thought to contain all of 
the proteins and growth factors necessary to direct tissue regeneration, care needs to be taken 
with the decellularization process, as the types of detergents used could have a dramatic effect on 
the protein and growth factor content within the scaffold.180  Interestingly, there does not appear 
to be site-specific advantages between the decellularized ECM source site and the site of 
implantation in skeletal muscle applications.  The regenerative response in a rodent partial 
thickness abdominal wall defect due to skeletal muscle derived ECM (M-ECM) was equivalent 
to the regenerative response using a small intestine submucosa (SIS) scaffold.181  One advantage 
of using ECM derived scaffolds is that they are angiogenic and serve to promote vascularization 
of skeletal muscle injury sites.17,182  However, there are conflicting reports regarding the efficacy 
of a variety of acellular ECM scaffolds, including M-ECM, dermal ECM, and SIS, to enhance 
the functional recovery of a large muscle defect.  Investigations looking at remodeling events 1-2 
months post-injury reported modest myoblast infiltration into the injury site, although it appears 
to be somewhat disorganized.183-186  There is no consensus whether these additional myofibers 
contribute to the functional recovery of the muscle 2 months post-injury, as some studies report 
no improvements in force generation,187 while other studies report a significant improvement in 
functional recovery.188  The addition of bone-marrow derived mesenchymal stem cells (MSCs) 
to ECM scaffolds significantly improved functional recovery and blood vessel formation.  
However, MSCs have not been shown to engraft into skeletal muscle tissue, so the exact 
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mechanism of MSC-mediated increases in recovery are not clear.189  M-ECM scaffolds seeded 
with muscle derived cells that were differentiated prior to implantation also significantly 
increased the functional recovery of VML injuries 2 months post-injury by engrafting into the 
uninjured tissue.74,190  Long term remodeling, between 3-6 months post-injury, is required for 
acellular urinary bladder matrix (UBM) and SIS scaffold mediated functional recovery.191,192  
Interestingly, Corona et al. observed an increase in the force production of their negative control 
groups (i.e. the creation of a VML injury with no treatment) over time, suggesting that the scar 
tissue deposited in the injury site may be reorganizing over time to facilitate some amount of 
contractility.75,192  In human clinical trials, there have been several accounts of successful partial 
restoration of mechanical function using SIS and UBM ECM scaffolds to treat VML 
defects.15,118  While ECM scaffolds have been shown to significantly enhance skeletal muscle 
repair in VML defects, there remains a significant reduction in mechanical function compared to 
uninjured muscle.  As ECM based scaffolds are derived from complex tissue environments, the 
exact composition of these materials is not known, and while they have the ability to direct a 
regenerative response after longer time points, how these materials do so remains an active area 
of research. 
 
2.4.3 Limitations 
There have been many significant successes in developing materials to guide skeletal 
muscle regeneration.  One of the strengths of synthetic materials is the ease in which they are 
fabricated, as well as the flexibility to construct scaffolds in a variety of controlled geometries to 
control myoblast growth and differentiation,94 despite needing functionalization with natural 
materials to improve myoblast attachment or tissue outcomes.136  While natural scaffolds are 
typically more bioactive than unmodified synthetic materials, bulk scaffolds that form through 
random protein polymerization do not generate uniform cell alignment.  Applying static axial 
stretching techniques to natural polymers may facilitate the alignment of protein fibrils within 
the bulk scaffold, which will direct uniaxial alignment of cells; however, these materials have not 
yet been applied to VML injuries.193,194 
Further, many of the models of skeletal muscle injury utilize ischemia,78,176 toxin,156 or 
crush induced195 injuries.  These methods of muscle injury leave the basal lamina intact, which 
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allows SC recruitment to the injury site due to chemotactic factors being released by the basal 
lamina.9,42,76  The combination of the early recruitment of SCs to the injury sure, as well as the 
persistence of the regenerative template of the basal lamina, allows these injuries to quickly, and 
completely regenerate in 3-4 weeks.1,13,21,23  VML injuries, on the other hand, result in the 
complete destruction or removal of the basal lamina, providing no regenerative template for SCs 
to facilitate regeneration.9,76  By definition, these massive injuries do not spontaneously 
regenerate, and are instead characterized by a loss of muscle tissue and function, as well as an 
increase in the amount of scar tissue within the skeletal muscle ECM.9,183,196  Decellularized 
ECM materials have been shown to significantly improve functional outcomes in VML defects; 
however, despite their similarities to native tissue, they also do not appear to achieve complete 
alignment between healthy and regenerating tissue, likely due to the sheer volume of defect 
space.  Future scaffolds must be able to direct cell alignment within the defect sites to facilitate 
seamless integration between healthy and regenerating tissue, and likely will be required to 
enhance SC recruitment to the defect site, as the matrix cues present in injured muscle are 
destroyed in VML injuries.  Additionally, care must be taken to select a clinically relevant 
animal model to appropriately draw conclusions on effects of a given treatment on VML injuries. 
 
2.5 MICROTHREADS FOR USE IN SKELETAL MUSCLE REGENERATION 
Integration of the engineered tissue with the wound site can be mediated by creating a 
scaffold that is morphologically similar to the tissue itself, thereby controlling the scaffold-tissue 
interface to facilitate a robust integration of surrounding progenitor cells onto, or into, the 
scaffold.197  This approach of starting with a similar macroscopic structure as native tissue can be 
thought of as a “bottom-up” approach to tissue engineering, where scientists begin with basic, 
bioactive materials and subsequently modify these materials to enhance the regenerative 
response of the host tissue.  We, and others, have exploited the native properties of several 
proteins, including silk fibroin (SF), collagen, and fibrin, to polymerize into discrete biopolymer 
microthreads.198-200  SF fibers are isolated by reeling and collecting the individual fibers found in 
domesticated silkworm (Bombyx mori) cocoons or spider draglines (Nephila clavipes or Araneus 
diadematus).200-202  Silk fibers typically are fabricated in this way with a gumming protein called 
sericin, which serves to strengthen and bundle the individual fibers.203,204  These microthreads 
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can be organized as series of fiber-like cables in increasingly complex hierarchal structures 
mimicking the organization of a variety of functional tissue systems such as muscle, tendon, or 
ligament.21,205  Further, these scaffolds can be tailored to meet specific tissue engineering 
applications through changes in the manufacturing processes.  By creating scaffolds from the 
bottom-up, there is more flexibility and control in creating a tunable, biomimetic scaffold that is 
instructive in facilitating and directing tissue regeneration. 
Recently, our lab developed a method to control the polymerization process of fibrin to 
create microthreads, which have been shown to facilitate cell alignment along the longitudinal 
axis of the material.198  These fibrin microthreads have been implanted into a mouse model of 
VML injury seeded with human myoblasts, and the combination of a morphologically relevant 
scaffold material and highly myogenic cell line allowed for more complete endogenous muscle 
regeneration.76  While we observed a reduction in the deposition of scar tissue 3-4 months post-
injury, histological analyses of tissue harvested at early time points suggested that the 
microthreads were largely degraded within 2 weeks of implantation and many of the regenerated 
myofibers in the wound site at later time points exhibited some degree of misalignment with 
respect to the native muscle tissue.76  Fibrin is rapidly degraded by proteinases, such as plasmin, 
within the wound site,206,207 which suggests that the rate of proteolytic degradation of fibrin 
microthreads needs to be decreased to be used as a scaffold for skeletal muscle regeneration. 
 
2.5.1 Tuning Mechanical Cues 
While the goal of a scaffold is not to replace the intended function of a tissue, it must be 
mechanically stable in its intended environment to successfully direct regeneration and degrade 
at an appropriate, tissue-specific rate.197,208  The mechanical properties of biopolymer 
microthreads vary significantly depending on the protein being considered.  SF is one of the 
strongest protein structures that has been described, and often the mechanical and structural 
properties of SF are regulated at the scaffold fabrication level, such as by changing the 
concentration of SF within a scaffold, rather than the post-processing level, such as through 
chemical crosslinking, to tune the mechanical properties to that of the tissue of interest.  One 
such modification is the removal of the gumming protein sericin through incubations in salt 
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and/or detergent solutions, which lowers the tensile strength as well as improves the 
immunologic response in vivo.203,204 
On the other hand, biopolymer microthreads constructed of proteins commonly found in 
vivo, such as collagen or fibrin, are not as mechanically robust as SF.  To this end, various 
crosslinking methods have been described for biopolymer microthreads.198,209-211  These methods 
span a variety of methodologies of crosslinking, such as physical (dehydrothermal (DHT)),209,211 
irradiative (ultraviolet (UV) light exposure),198,211 chemical (carbodiimide or glutaraldehyde 
incubation),209-212 or biochemical (transglutaminase).211  As expected, these methods increase the 
ultimate tensile strength (UTS), as well as the stiffness of biopolymer microthreads.  
Interestingly, discrete mechanical properties were developed by modifying the pH environment 
of the carbodiimide crosslinking reaction for fibrin microthreads.210  This suggests that, similar 
to saturation of transglutaminase crosslinking,213 the efficiency of carbodiimide crosslinking can 
be regulated both through controlling the pH environment of the crosslinking reaction as well as 
the total crosslinking time.  These crosslinking procedures were also found to significantly 
increase the stiffness of biopolymer microthreads.210  Substrate stiffness is known to have a 
significant effect on cell behavior.214  In the case of skeletal muscle, softer substrates trigger a 
proliferative phenotype in myoblasts, while stiffer substrates trigger the differentiation and 
subsequent maturation of new myofibers.155  Such cell-specific responses to varying substrate 
stiffnesses highlight the need to closely match both the mechanical and biochemical environment 
of the scaffold with native muscle tissue to promote tissue regeneration. 
 
2.5.2 Tuning Biochemical Cues 
Biochemical cues and receptors are the primary way that cells communicate with each 
other and their surroundings.  Altering the ECM ligands present on a material modulates the 
cellular response to the material.  Matrix cues are known to elicit very specific cellular responses 
and changing the availability of different matrix molecules will alter the cell phenotype.215,216  
Additionally, growth factors or cytokines can also be incorporated into scaffolds to enhance cell 
responses.  For example, FGF2 was incorporated into fibrin microthreads to significantly 
increase fibroblast migration and proliferation, while the initial attachment of the fibroblasts was 
not affected by FGF2 incorporation.217  An advantage to using fibrin as a scaffolding material is 
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that this fibrin-FGF2 system did not require any intermediate molecules, such as heparin, to 
facilitate growth factor binding, rather, fibrin itself has an affinity for a large array of growth 
factors.218  Further, a variety of peptide sequences have been identified that can be crosslinked 
into the fibrin matrix with Factor XIII and will serve as tethering agents to facilitate the 
controlled release of a specific growth factor as the fibrin scaffold is degraded.102,219-221  Other 
molecules such as heparin sulfate and heparin are commonly used as intermediate molecules for 
materials such as collagen, SF, or synthetic polymers due to their high binding efficiency to a 
large number of growth factors.222  These intermediaries are often tethered using common 
crosslinking methods such as 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC), a 
chemical crosslinking agent that joins primary amine groups to free carboxylic acid groups, to 
increase bioactivity by conjugating different growth factors or peptides to scaffolds.167,223-225 
 
2.5.3. Tuning Cellular Microniches 
Biopolymer fibers made from materials such as collagen, fibrin, or silk have inherent 
biochemical properties that support cell growth.  In particular, fibrin is an essential part of the 
native provisional matrix that modulates the wound healing response and directs tissue 
regeneration.170,206  Unmodified biopolymer microthreads have been shown to support cell 
growth and outgrowth along the length of these fibers through a combination of factors including 
the radius of curvature of the microthreads, biochemical signaling, and integrin receptors present 
on the surface of the biopolymer microthreads.97,198  Additionally, MSCs maintain their 
multipotency while being cultured on fibrin microthreads, demonstrating that the cell microniche 
on fibrin microthreads is capable of supporting cells in a more plastic state.226  By altering the 
surface chemistry of fibrin microthreads with chemical or irradiative crosslinking, the 
microniche of the microthreads can be modified to direct cells to proliferate in greater number 
than without these surface modifications.210,217  Further, chemical crosslinking can also be used 
to alter the biochemical environment to induce enhanced fibroblast proliferation on braided 
collagen microthreads.167  By altering the structural organization of the microthreads with static 
axial stretching, the surface fibrillar structure of fibrin microthreads is modified to incorporate 
aligned topographic grooves, which direct increased cell alignment along the longitudinal axis of 
the microthread.194  Combined, these findings suggest that the microniche of fibrin microthreads 
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is itself able to support a variety of cell functions including growth, differentiation, and higher-
order functions such as complete tissue regeneration.76  Further, these scaffolds represent a 
dynamic platform technology that can be tuned both mechanically and biochemically to elicit 
specific, controlled cell functions to further guide tissue regeneration. 
 
2.6 CONCLUSIONS AND FUTURE DIRECTIONS 
Tissue engineering scaffolds for VML injuries have advanced from passive materials 
implanted that provide structural support to inductive scaffolds that direct endogenous tissue 
regeneration.  In addition to developing SMUs designed to directly replace lost skeletal muscle 
tissue, in vitro skeletal muscle constructs are a powerful model system to investigate biological 
questions regarding skeletal muscle formation and regeneration ex vivo.  Novel strategies have 
been developed to incorporate essential growth factors, and sophisticated materials have been 
created to direct skeletal muscle regeneration, and these materials have expanded our knowledge 
on how VML injuries repair in situ.  However, scaffolds could support more efficient 
regeneration by enhancing SC recruitment (i.e. migration) to the defect site to recruit more 
progenitor cells, as the matrix cues present in traditional muscle regeneration are destroyed or 
missing in VML injuries.  These recruited SCs must be aligned in the direction of the native 
muscle, so that nascent myofibers can fuse with existing healthy tissue at the wound margin. 
Finally, controlled structural and mechanical properties are necessary to ensure that scaffolds 
persist long enough to support organized, functional skeletal muscle regeneration. 
In this thesis, we propose to address the limitation of organizing tissue ingrowth to 
facilitate aligned muscle regeneration by implanting discrete fibrin microthreads into the void 
created by VML injuries (Figure 2.4 A-B).  The resistance to proteolytic degradation of fibrin 
microthreads will be increased through post–production crosslinking methods to ensure that the 
microthreads persist long enough to guide functional regeneration in vivo.  We will load fibrin 
microthreads with HGF to increase the recruitment of SCs onto fibrin microthreads and into the 
void space created by VML injuries (Figure 2.4C).  We hypothesize that fibrin microthreads with 
an increased resistance to proteolytic degradation and loaded with HGF will enhance the 
functional, regeneration of skeletal muscle tissue (Figure 2.5 D-E). 
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Figure 2.4. Our approach to skeletal muscle regeneration.  To regenerate muscle tissue from VML defects (A), 
fibrin microthreads will be implanted in plane with undamaged muscle (B).  Microthreads will be loaded with HGF 
to recruit SCs to the wound site and begin to proliferate (C) and fuse (D) to regenerate large volumes of muscle 
tissue (D).  Image courtesy of M Zayas. 
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Structural Properties of Fibrin Microthreads1 
 
 
 
3.1 INTRODUCTION 
Scaffolds that direct skeletal muscle regeneration must facilitate alignment and 
organization of newly forming muscle fibers parallel to the uniaxial force conduction pathway.2,3  
To best promote de novo muscle regeneration in a large defect, the scaffold must also be 
biocompatible, support cell ingrowth from the surrounding musculature, and ultimately degrade 
as new tissue forms.2,4  Several studies have investigated synthetic materials and natural 
polymers, such as a copolymer of poly(L-Lactic acid) and poly(L-glycolic 
acid)polyglycolic/polylactic acid (PLLA/PLGA),5 poly(ε-caprolactone) (PCL),6,7 alginate,8,9 
Matrigel,10 decellularized muscle tissue,11-13 collagen,14-17 and fibrin,4,5,18,19 as scaffolds to 
facilitate muscle regeneration.  While synthetic scaffolds are advantageous for generating 
materials with aligned fibrillar morphology, they are commonly modified with bioactive 
signaling molecules, such as collagen, to direct cell-mediated tissue regeneration.6  Biopolymer 
scaffolds that are fabricated from extracellular matrix molecules such as collagen or fibrin 
possess intrinsic bioactive signaling cues, however, it can be challenging to engineer biopolymer 
scaffolds with precisely designed biochemical and biophysical surface cues to guide specific cell 
functions.15,20  Previous studies have primarily focused on the effects of scaffold compositions 
on cell and tissue responses such as myoblast proliferation, differentiation, and tissue 
regeneration. In contrast, few studies have systematically characterized the roles of scaffold 
degradation or growth factor elution on skeletal muscle regeneration. 
Several studies have investigated the use of fibrin-based scaffolds to facilitate skeletal 
muscle regeneration.  While its role as a provisional matrix makes fibrin an appealing material 
for tissue regeneration due to its ability to direct wound healing, it is highly susceptible to 
proteolytic degradation and remodeling in the presence of myoblasts.19,21  Various materials 
processing strategies have been investigated to increase the structural stability and the 
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persistence of fibrin-based scaffolds including chemical and physical crosslinking with agents 
such as transglutaminase/Factor XIII,22,23 ruthenium sodium persulfate,24,25 and ultraviolet (UV) 
light.26  These crosslinking strategies demonstrated enhanced fibrin scaffold stiffness without 
affecting cell viability, but they did not show correlations between increases in stiffness with 
resistance to proteolytic degradation.  One alternate approach to increasing the structural and 
mechanical stability of fibrin scaffolds has been to mix PLLA/PLGA into the fibrin scaffold.5  
However, this method does not improve the intrinsic structural stability of fibrin, but it replaces 
it with a porous PLLA/PLGA scaffold.  As such, there remains a need to develop fibrin based 
materials with increased resistance to proteolytic degradation for long term cell culture or 
implantation studies. 
Our laboratory developed novel biomaterial constructs termed fibrin microthreads, which 
integrate the bioactivity of fibrin gel scaffolds with an aligned fiber matrix that directs cell 
alignment.  We showed that the mechanical properties of these microthreads can be modulated 
by crosslinking with UV energy,26 and that we could incorporate growth factors into these 
microthreads to direct cell proliferation and outgrowth on the surfaces of the scaffolds in a dose 
and time dependent manner.27  When uncrosslinked fibrin microthreads were implanted in large 
muscle defects in a mouse model, we found that cell-populated microthreads enhanced the 
regenerative response of the host tissue, allowing for more complete endogenous muscle repair.4  
While we observed a reduction in scar tissue deposition at later time points of the study (3-4 
months), histological analyses of tissue harvested at early time points suggested that the 
microthreads were largely degraded within 2 weeks of implantation and many of the regenerated 
myofibers in the wound site at later time points exhibited misalignment with respect to the native 
muscle tissue.  Other studies indicate that skeletal muscle tissue regeneration peaks 2 to 3 
weeks post injury, suggesting that scaffold persistence in the wound site is critical for facilitating 
the regeneration of functional, organized skeletal muscle tissue.28  From these findings, we 
hypothesize that myofiber formation and alignment as well as functional skeletal muscle 
regeneration will be enhanced by the persistence of fibrin microthreads that facilitate organized 
tissue deposition in the wound site. 
This chapter reports on the results of the first study to investigate the use of 
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) as a crosslinking strategy for fibrin 
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microthreads.  While carbodiimide crosslinking is a robust approach to modulate the 
mechanical properties of collagen scaffolds,29,30 and to tether growth factors to the surface of 
scaffolds,31,32 it has not previously been used on fibrin-based materials.  Previous studies 
showed that optimal carbodiimide-mediated crosslinking occurs in an acidic environment,33 but 
previous unpublished studies from our lab suggest that this environment adversely affects the 
ultimate tensile strength (UTS) of fibrin microthreads during scaffold production.  Here, we 
examined the effects of EDC crosslinking time and buffer pH on the structural and biochemical 
properties of fibrin microthreads.  We hypothesized that the use of different buffer pH levels for 
the EDC crosslinking reaction would permit control of the degree of crosslinking and result in 
the ability to generate microthreads with tunable mechanical properties and plasmin degradation 
rates that might be more suitable for use as a scaffold to promote skeletal muscle regeneration. 
 
3.2 MATERIALS and METHODS 
3.2.1 Fibrin Microthread Preparation 
3.2.1.1 Microthread Extrusion 
Fibrin microthreads were co-extruded from solutions of fibrinogen and thrombin using 
extrusion techniques described previously.26  Briefly, fibrinogen from bovine plasma (Sigma, 
St. Louis, MO; F8630) was dissolved in HEPES 
(N-[2-Hydroxyethyl]piperazine-N'-[2-ethanesulfonic acid]) buffered saline (HBS, 20 mM 
HEPES, 0.9% NaCl; pH 7.4) at 70 mg/mL and stored at -20 °C until use.  Thrombin from 
bovine plasma (Sigma; T4648) was dissolved in HBS at 40 U/mL and stored at -20 °C until use. 
To fabricate microthreads, fibrinogen and thrombin solutions were warmed to room 
temperature, and thrombin was mixed with a 40 mM CaCl2 (Sigma) solution to form a working 
solution of 6 U/mL.  Fibrinogen and thrombin/CaCl2 solutions were loaded into 1 mL syringes 
which were inserted into a blending applicator tip (Micromedics Inc., St. Paul, MN; SA-3670).  
The solutions were combined in the blending applicator and extruded through polyethylene 
tubing (BD, Sparks, MD) with an inner diameter of 0.86 mm into a bath of 10 mM HEPES (pH 
7.4) in a Teflon coated pan at a rate of 0.225 mL/min using a dual syringe pump.  After 8-15 
minutes, 25.4 cm, amorphous fibrin microthreads were removed from the buffer solution and 
stretched to form three-19-cm microthreads; these were air dried under the tension of their own 
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weight.  Dry microthreads were placed in aluminum foil and stored in a desiccator until use. 
 
3.2.1.2 EDC Crosslinking Procedure 
Fibrin microthreads were affixed to vellum frames with a window size of 4 cm using 
medical-grade silicone adhesive (Factor II, Lakeside, AZ).  Once the glue was cured, 
microthreads were hydrated in either acidic buffer (50 mM 2-(N-morpholino)ethanesulfonic acid 
(MES), Sigma, pH 5.0) or neutral buffer (100 mM NaH2PO4, Sigma, pH 7.4) for 30 minutes at 
room temperature.  Hydrated fibrin microthreads were crosslinked at room temperature with 
either acidic (EDCa) or neutral (EDCn) buffer containing 16 mM N-hydroxysuccinimide (NHS, 
Sigma) and 28 mM EDC (Sigma) for 1, 2, 3, 4, 12, or 24 hours.  Control microthreads were 
either not rehydrated (UNX), or hydrated with distilled water (UNXdi), acidic buffer (UNXa), or 
neutral buffer (UNXn) in the absence of EDC/NHS for two hours.  After crosslinking, the 
buffered EDC/NHS solution was aspirated and the microthreads were rinsed three times in a DI 
(de-ionized) water bath for 5 minutes each rinse, air dried, and stored in a desiccator until use. 
 
3.2.2 Mechanical Characterization of Crosslinked Microthreads 
To facilitate uniaxial testing, individual microthreads were affixed with medical grade 
silicone adhesive to vellum paper frames with precut windows that defined the region of loading.  
An initial gage length of 2.0 cm was defined as the distance between adhesive spots at the edges 
of the precut window in the vellum frame.  The microthreads on the vellum frames were 
hydrated in phosphate buffered saline (PBS) for at least 60 minutes prior to testing.  Hydrated 
microthread diameters were measured using a calibrated reticule with a 10X objective, coupled 
to a Nikon Eclipse E600 upright microscope (Melville, NY).  Microthreads were assumed to be 
cylindrical, and the average diameter calculated from 3 measurements taken along the length of 
each microthread defined the cross-sectional area.  After hydration, microthreads were mounted 
in the grips of a uniaxial testing machine (ElectroPuls E1000; Instron, Norwood, MA) and a 1 N 
load cell, the edges of each vellum frame were cut, and the microthreads were uniaxially loaded 
until failure at a 50% strain rate (10 mm/min) relative to the initial gage length.  Force and 
displacement were recorded continuously throughout each test at a frequency of 10 Hz.  The 
mechanical failure load of each microthread was recorded as the point where a rapid (80%) drop 
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from the maximum load occurred.  Engineering stress was calculated as the amount of force 
detected by the load cell divided by the initial cross-sectional area.  Strain was calculated as the 
increased extension from the gage-length. 
A MATLAB (MathWorks, Natick, MA) script was written to analyze the UTS, strain at 
failure (SAF), and load at failure for each sample.  A script was created in Excel (Microsoft, 
Redmond, WA) to characterize the maximum tangent modulus (MTM), which was assessed by 
identifying the highest linear region of the stress-strain curve for each sample (over a range of 
time corresponding to 20% of the length of each test) and fitting it to a linear region of the 
stress-strain curve.  Statistical analysis was used to identify and remove outliers as defined by 
microthreads whose wet diameters were 1.5 times greater than the inner quartile range (IQR) for 
each sample set (average wet diameter ± 1.5 *IQR).  To ensure this method was robust, we 
determined that the distribution of wet diameter measurements was normal using SigmaPlot 11.0 
software (Systat Software, Inc., San Jose, CA) to validate our definition, and exclusion, of 
outliers. Data points falling outside of this range were excluded from later statistical analysis. 
 
3.2.3 Structural Characterization of Crosslinked Microthreads 
3.2.3.1 Microthread Swelling 
Prior to mechanical testing, the diameters of dry crosslinked microthreads were recorded 
using a calibrated reticule with a 10X objective.  The average diameter for each microthread 
was calculated from three measurements taken along the length.  The wet diameter 
measurements taken during the mechanical testing procedure were also used to calculate the 
swelling ratio which was defined as the ratio of the wet diameter of a microthread to its dry 
diameter (wet/dry diameter). 
 
3.2.3.2 Degradation Assay 
Single crosslinked microthreads were cut into 0.8 cm fragments and secured to the 
bottom of 48-well plates using medical grade silicone adhesive (Figure 3.1A).  Stock solutions 
of human plasmin (EMD Biosciences, San Diego, CA; 527621) were aliquoted and stored 
according to the manufacturer’s instructions.  Each experimental condition was run in triplicate.  
Microthreads were hydrated in 500 µL of tris buffered saline (TBS; 25 mM Tris-HCl (Sigma), 
 Chapter 3
Crosslinking Strategies Facilitate Tunable Structural Properties of Fibrin Microthreads 46 
 
Figure 3.1. Experimental configuration of the degradation 
assay.  Macroscopic view of degradation assay in a 48 well 
plate (A).  Microthreads 0.8 cm in length were glued to the 
bottom of individual wells with medical grade silicone adhesive 
(inset).  After initial hydration, the microthreads were 
visualized and the diameter measurements across three different 
areas of the microthread were averaged together to calculate the 
initial microthread diameter, d0 (B). Images were periodically 
taken of each microthread to measure the diameter and quantify 
the amount of degradation as a function of time (C). 
0.9% NaCl, pH 7.5) for 1 hour, and images were taken with a 10X objective on a Leica inverted 
microscope (Leica, Wetzlar, Germany) coupled with Leica imaging software to record diameter 
values at time 0 (d0, Figure 3.1B).  The TBS was aspirated and replaced with 500 µL of 0.1 
U/mL of plasmin in TBS and samples 
were incubated at 37 °C until analysis 
for degradation by imaging.  
Microthreads were imaged every two 
hours for the first 6 hours, and 
subsequently every 12 hours, or until 
they were completely degraded 
(Figure 3.1C).  Each image was 
processed with ImageJ (NIH) to 
measure the microthreads’ diameter at 
three different positions along the 
length and plotted as a ratio to the 
initial diameter value (d/d0). 
 
3.2.4 Cell Culture 
Immortalized mouse myoblasts (ATCC, Manassas, VA; C2C12) were cultured in a 1:1 
(v/v) ratio of high glucose Dulbecco’s modified Eagle Medium (DMEM, Gibco BRL, 
Gaithersburg, MD) supplemented with 4 mM L-glutamine and Ham’s F12 (Gibco) with 10% 
fetal bovine serum (FBS, HyClone, Logan, UT).  Cells were incubated at 37 °C with 5% CO2 
and maintained at a density below 70% confluence using standard cell culture techniques.  
Routine cell passage was conducted using 0.25% trypsin-EDTA (CellGro, Manassas, VA). 
 
3.2.5 Cell Attachment Assay 
3.2.5.1 Microthread Bundling and Seeding 
To facilitate cell seeding for cell attachment assays, microthreads were bundled together 
in groups of 10 and adhered to stainless steel rings (Seastrom Manufacturing, Twin Falls, ID; 
inner diameter, 0.750 inches; outer diameter, 1.188 inches; thickness, 0.005 inches) with medical 
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grade silicone adhesive.  Individual washers were placed in wells of a standard six-well plate 
over an elevated 13 mm diameter circular ThermanoxTM coverslip (Nalge Nunc International, 
Rochester, NY), as described previously.34  Prior to cell seeding, microthread bundles were 
sterilized in 70% ethanol for 1 hour, rinsed in deionized (DI) water 3 times, air dried in a laminar 
flow hood, and stored in a desiccator until use. 
Immediately prior to seeding, 150 µL of sterile PBS was added to the coverslip to hydrate 
the microthreads for at least 1 hour.  To attach C2C12 cells to the microthread bundles, the PBS 
was aspirated and replaced with 100 µL of cell suspension (100,000 cells/mL) in complete 
culture medium.  After a 4 hr incubation at 37 °C, cell-seeded microthread bundles were 
transferred into a new six-well plate with 2 mL of fresh medium and returned to the incubator.  
Each experimental treatment was run in duplicate and medium was changed every 2 days. 
 
3.2.5.2 Analysis of Cell Viability 
To characterize cell morphology and viability a viability assay was conducted after either 
3 or 7 days of culture using a Live/Dead Stain Kit (Molecular Probes, Eugene, OR; L3224) 
according to the manufacturer’s instructions.  At each time point, the medium was aspirated and 
replaced with 2 mL of sterile PBS with 4 µM ethidium homodimer-1 and 2 µM calcein AM and 
plates were incubated at room temperature for 30 minutes.  Calcein (green, Ex/em 495 nm/515 
nm) is retained in the cytoplasm of living cells while ethidium (red, Ex/em 495 nm/635 nm) is 
excluded by intact cell membranes and enters damaged membranes where it binds nuclear DNA.  
Microthread bundles were visualized on a Leica inverted microscope using a 10X objective and 
dye-appropriate filter sets and photomicrographs were collected and processed using Leica 
imaging software. 
 
3.2.5.3 Analysis of Cell Number 
Quantification of the cell density of C2C12 cells on microthread bundles was 
determined after 1 or 3 days of culture.  At each time point, cell-seeded microthread bundles 
were fixed in 10% neutral buffered formalin for 15 minutes and rinsed 3 times in DI water.  
Constructs were stained with Hoechst (1:6000, Molecular Probes) for 6 minutes and rinsed 3 
times with DI water.  Three regions of the cell-seeding area were visualized on a Leica inverted 
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microscope using a 10X objective and photomicrographs taken using Leica imaging software 
and images of nuclei were counted using ImageJ.  To calculate cell density on the surface of the 
microthread bundles, it was assumed that images corresponded to one half of the surface area of 
the microthread bundle.  Approximating a cylindrical geometry for each bundle, length (l) and 
diameter (d) measurements enabled calculation of the total surface area (SA) as: SA ൌ 0.5 ∗ π ∗
l ∗ d.  Total cell number was divided by the SA of each image to calculate the cell surface 
density. 
 
3.2.6 Statistical Analyses 
Statistical analyses were performed using a one-way analysis of variance (ANOVA) with 
p < 0.05 indicating significant differences between groups using SigmaPlot 11.0 software.  For 
post hoc analysis, a Holm-Sidak pairwise multiple comparison test was performed to determine 
significance between experimental groups using an overall significance level of p < 0.05.  
Where indicated, a paired Student’s t-test was performed with p < 0.05 indicating significant 
differences between groups.  The data are reported as means ± standard deviation for the 
mechanical and structural characterization and as means ± standard error for the cell density 
values (3 measurements were obtained per microthread bundle). 
 
3.3 RESULTS 
3.3.1 Crosslinking Enhances the Ultimate Tensile Strength of Fibrin Microthreads 
Biopolymer microthreads designed as tissue engineering scaffolds are required to have 
mechanical properties comparable to the native tissues they are replacing.  Fibrin microthreads 
were crosslinked in an acidic or a neutral pH buffer, mounted onto vellum test frames, and 
uniaxially loaded until failure to determine the mechanical properties of crosslinked 
microthreads.  Characteristic stress-strain curves of uncrosslinked and EDC crosslinked 
microthreads showed initial toe regions of increasing elongation with little increase in stress 
(Figure 3.2A).  However, the crosslinked microthreads displayed a much shorter toe region than 
uncrosslinked microthreads, followed by a much more rapid increase in stress until failure 
(Figure 3.2A).  UTS values of microthreads crosslinked for 4 and 12 hours were significantly 
greater than UNX microthreads (Figure 3.2B).  There were no significant differences between 
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the UTS values of crosslinked microthreads as a function of buffer pH or time, and the UTS 
values of EDCa 24hr microthreads were not significantly greater than UNX microthreads.  
Control microthreads incubated in acidic buffer without EDC for 24 hours were completely 
degraded (data not shown).  To further characterize the effects of EDC crosslinking time and 
buffer pH on the mechanical properties of fibrin microthreads, we conducted an additional series 
of experiments that examined shorter crosslinking time points.  The results of this study showed 
that all EDC crosslinked microthreads were significantly stronger than UNX microthreads 
(Figure 3.2C), independent of the crosslinking buffer. 
 
 
Figure 3.2. Mechanical properties of microthreads as a function of crosslinking time and buffer.  
Characteristic stress-strain curves for fibrin microthreads (A).  Fibrin microthreads exhibited an initial toe region 
and in the case of the crosslinked microthreads, were followed by a rapid increase in stress until failure.  
Uncrosslinked microthreads displayed low stiffness and highly elastic toe regions, regardless of buffer treatment.  
UTS of fibrin microthreads crosslinked for 4, 12, or 24 hours (B; n≥18).  UTS of fibrin microthreads crosslinked 
for 1, 2, 3 or 4 hours (C; n≥30).  * indicates significant differences with respect to UNX microthreads by one-way 
ANOVA with Holm-Sidak post hoc analysis (p < 0.05). 
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Table 3.1. The mechanical and structural properties of EDC crosslinked fibrin microthreads. 
To evaluate the effects of buffer pH conditions on the mechanical properties of fibrin 
microthreads, microthreads were incubated in crosslinking buffer solutions with or without EDC 
for 2 hours.  The mean diameters, peak loads, UTS, SAF, and MTM of these microthreads are 
summarized in Table 3.1.  The UTS of microthreads crosslinked for two hours were found to be 
dependent on crosslinking buffer pH, and all crosslinked microthreads (EDCn and EDCa) were 
significantly stronger than microthreads incubated in buffer conditions without the addition of 
EDC (Figure 3.3A).  EDCa microthreads failed at significantly lower strains than UNXa and 
UNX microthreads (Figure 3.3B).  EDCa microthreads had significantly higher moduli than 
EDCn, and all crosslinked microthreads were significantly stiffer than uncrosslinked controls 
(Figure 3.3C). 
 
 
 
 
Figure 3.3. Mechanical properties of microthreads crosslinked for 2 hours. The UTS (A), SAF (B), and MTM 
(C) values of uncrosslinked and crosslinked microthreads.  Crosslinking microthreads in either buffer exhibited 
significantly higher UTS values, including a difference between the two crosslinking buffers.  EDCa microthreads 
failed at significantly lower strains than UNX or UNXa microthreads.  † and ‡ indicate statistical significance with 
respect to all other conditions and * indicates statistical differences between indicated groups by one-way ANOVA 
with Holm-Sidak post hoc analysis (p < 0.05, n≥23 for all conditions).
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3.3.2 Crosslinking Decreases the Swelling Ratio of Fibrin Microthreads 
To predict the effect of the degree of crosslinking on the structural properties of fibrin 
microthreads, dried microthreads were rehydrated in PBS for at least 1 hour.  Diameter 
measurements were taken before and after hydration of microthreads to calculate the swelling 
ratio as an approximation of crosslinking density within the microthreads.35,36  Swelling ratios 
for crosslinked microthreads (EDCa and EDCn) were significantly less than that for UNX 
microthreads and were independent of crosslinking time (Figure 3.4A).  The swelling ratio was 
higher for EDCn microthreads than for EDCa microthreads, demonstrating a dependence of pH 
on the degree of crosslinking.  UNXn and UNXdi microthreads were found to have 
significantly lower swelling ratios than UNX microthreads, which was still significantly higher 
than the swelling ratio of EDCa or EDCn microthreads (Figure 3.4B).  
 
 
 
 
 
 
Figure 3.4. Swelling ratio of microthreads crosslinked as a function of time and buffer pH.  Swelling ratio is 
significantly changed by the pH of the crosslinking buffer independent of crosslinking time (A).  The swelling 
ratios of microthreads treated for 2 hours were statistically different between all experimental groups except for 
UNXa microthreads when compared to UNX microthreads (B).  * indicates statistical significance with respect to 
UNX microthreads; † indicates significance with respect to all EDCa microthreads; and ‡, #, °, § indicates 
significance to all other groups by one-way ANOVA with Holm-Sidak post hoc analysis (p < 0.05, n≥26). 
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3.3.3 Crosslinking Increases Fibrin Microthread Resistance to Proteolytic Degradation 
In vivo, fibrin is gradually degraded by tissue proteases, namely plasmin.23  To evaluate 
whether the method or duration of crosslinking would enhance the structural integrity of fibrin 
microthreads and increase their persistence as a provisional scaffold, the sensitivity of 
microthreads to plasmin digestion was evaluated in vitro.  No significant differences in the 
temporal degradation profile were noted with respect to crosslinking time for microthreads 
crosslinked for 1, 2, 3, or 4 hours (data not shown). 
Representative phase contrast images of microthreads incubated in plasmin are shown at 
0 and 12 hours of plasmin treatment (Figure 3.5).  All uncrosslinked microthreads (UNX, 
UNXdi, UNXa, UNXn) were completely degraded at 12 hours (Figure 3.5 B, D, F, and J).  
EDCn microthreads showed extensive degradation (Figure 3.5L) at this time point, while EDCa 
and microthreads incubated without plasmin (negative control) showed no noticeable 
degradation (Figure 3.5 H and N).  Uncrosslinked microthread controls completely degraded 
within four hours of plasmin incubation (Figure 3.6).  EDCn microthreads persisted for 
approximately 24 hours, significantly slower than UNX microthreads.  EDCa microthreads and 
microthreads incubated in TBS alone (no plasmin) showed no evidence of degradation 
throughout the duration of the assay (1 week) and, while not significantly different from each 
other, were significant with respect to EDCn and UNX microthreads, demonstrating three unique 
degradation profiles with our crosslinking treatments and uncrosslinked microthreads. 
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Figure 3.5. Representative images of microthreads in a degradation assay at 0 hours (A, C, E, G, I, K, and 
M) and at 12 hours (B, D, F, H, J, L, and N).  Microthreads were incubated in 0.1 U/mL of plasmin in TBS (pH 
7.5) and the diameter at each time point was measured.  Uncrosslinked controls (UNX: A and B; UNXdi: C and 
D; UNXa: E and F; UNXn: I and J) all completely degraded before 12 hours, leaving no microthread at the glue 
interface (white arrow head).  EDCn microthreads (K and L) persisted at 12 hours with approximately 50% of 
their initial diameter.  Neither the EDCa microthreads (G and H) nor the no plasmin control (M and N) 
exhibited any degradation at 12 hours.  Scale bar = 200 µm.
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Figure 3.6. Degradation profiles of 
microthreads treated with plasmin.  All 
control microthreads completely degraded 
within 4 hours, while EDCn microthreads 
persisted until 24 hours, after which only 
residual debris remained.  Neither EDCa 
microthreads nor the no plasmin control 
exhibited any degradation within the assay 
period.  EDCa and EDCn were statistically 
different than all controls and each other at 
all time points by one-way ANOVA with 
Holm-Sidak post hoc analysis (p < 0.05, 
n=6). 
 
 
3.3.4 EDC Crosslinking Enhances Cell Attachment to Fibrin Microthreads 
To determine whether our crosslinking strategy would alter cell functions such as cell 
adhesion and viability, EDC crosslinked and uncrosslinked microthreads were bundled in groups 
of ten, seeded with C2C12 cells and analyzed at 1 and 3 day time points following incubation.  
Cell attachment was measured, and quantified by measuring the cell density along the surface of 
the microthreads using Hoechst 33342 nuclear dye.  When microthread bundles were hydrated 
for seeding, all of the constructs except for the EDCa microthread bundles compacted into a 
structure that exhibited a morphology approximating a large, single thread with the topography 
of each single microthread visible in its substructure; whereas EDCa microthread bundles 
remained discrete, individual microthreads.  One day after seeding, cells readily attached to 
each bundle as visualized with Hoechst (Figure 3.7 A, C, E, G, I, and K).  Significantly higher 
cell densities were observed on EDCa microthreads (Figure 3.7G) than UNX microthreads 
(Figure 3.7A and Figure 3.8).  After 3 days of culture, the microthreads exhibited a significant 
increase in the number of C2C12 cells on the surface where the microthread surfaces appeared to 
be confluent at this time point (Figure 3.7 B, D, F, H, J, and L).  All groups except for UNXdi 
microthreads had significantly higher cell densities at day 3 than that determined immediately 
after seeding (Figure 3.8).  Interestingly, on EDCa crosslinked microthreads, which displayed 
discrete microthread structures, the cells created web-like structures between adjacent 
microthreads (Figure 3.7H, arrows).  The cell densities of UNXn microthreads were 
significantly higher than UNX microthreads at 3 days of culture (Figure 3.8). 
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Figure 3.7. Representative images 
of microthreads seeded with 
10,000 C2C12 cells for 1 day (A, 
C, E, G, I, and K) or for 3 days (B, 
D, F, H, J, and L).  Microthreads 
were stained with 33342 Hoechst 
(blue) to quantify the cell 
attachment and density on each 
microthread.  The density of cells 
on the microthreads appeared to 
increase with time, suggesting that 
the cells were proliferating.  
Uncrosslinked controls (UNX: A 
and B; UNXdi: C and D; UNXa: E 
and F; UNXn: I and J) showed 
moderate cell densities at day 1, 
while crosslinked microthreads 
(EDCn: K and L; EDCa: G and H) 
showed higher numbers of cells in 
similar regions of analysis.  Cell 
densities appear to increase on the 
crosslinked microthreads compared 
to the uncrosslinked controls, and 
web-like structures of cells can be 
seen between different EDCa 
microthreads at 3 days (H, arrows).  
Scale bar = 200 µm. 
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Figure 3.8.  Density of C2C12 cells 
seeded on fibrin microthreads for 1 or 3 
days.  With the exception of UNXdi, all 
groups showed a significant increase in cell 
density from 1 to 3 days.  At 1 day, EDCa 
microthreads had significantly higher cell 
densities than UNX microthreads. At 3 
days, UNXn microthreads had significantly 
higher cell densities than UNX 
microthreads.  Brackets indicate 
significance with indicated groups by 
one-way ANOVA with Holm-Sidak post 
hoc analysis (p < 0.05) * represent 
statistical significance between 1 and 3 days 
by a paired Student’s t-test (p < 0.05, n≥3).  
 
The increase in cell density that was observed with crosslinking did not correspond to an 
increase in cell death.  Viability stains were performed at day 3 for all groups (Figure 3.9 A, C, 
E, G, I, and K).  While there appeared to be differences in the number of live cells (green), the 
cells completely covered the microthreads and the number of dead cells (red) did not appear to 
increase.  In all experimental cases, C2C12 cells tended to align along the longitudinal axis of 
the microthreads as well as within the grooves between the microthreads in the compacted 
bundles.  Background autofluorescence in the red spectrum was observed for each treatment 
group which limited the ability to visually identify all of the nonviable cells on the microthreads 
(Figure 3.9 B, D, F, H, J, and L). 
With increasing culture duration, cell-seeded microthreads became less morphologically 
distinct, possibly due to the activity of proteases secreted by the cells.  By day 7, discrete 
microthread structure was observed only for EDCa microthreads.  On these scaffolds, there was 
extensive cell growth on the surface and no indication of microthread degradation (Figure 3.9G, 
insert).  EDCn microthreads persisted for 5 days, while UNX microthreads degraded between 3 
and 4 days (data not shown). 
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Figure 3.9. Representative 
images of C2C12 cell viability on 
crosslinked microthreads at 3 
days (A, C, E, G, I, and K) and 
negative controls (B, D, F, H, J, 
and L).  Microthreads were 
initially seeded with 10,000 C2C12 
cells, cultured for 3 days, and 
stained with calcein (green, 
localized in cytoplasm of live 
cells), and ethidium homodimer-1 
(EthD-1, red, binds to DNA of 
dead cells).  Uncrosslinked 
controls (UNX: A; UNXdi: C; 
UNXa: E; UNXn: I) showed nearly 
complete cell coverage on all 
scaffolds, with few dead cells 
detected (white arrow heads).  
Crosslinked microthreads (EDCn: 
K; EDCa: G) showed higher 
density of live stained cells with 
similar numbers of dead cells, 
despite the increase in total cell 
number.  In all cases, the negative 
acellular controls autofluoresced, 
limiting our ability to visually 
quantify the dead cells (B, D, F, H, 
J, and L).  When C2C12 cells 
were cultured on microthreads for 
7 days, all scaffolds except EDCa 
microthreads (G, insert) were 
completely degraded.  Scale bar = 
200 µm. 
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3.4 DISCUSSION 
The goal of this study was to investigate the effect varying crosslinking times and pH on 
EDC crosslinking of fibrin microthreads to develop microthread scaffolds with tunable 
mechanical and structural properties to enhance skeletal muscle regeneration.  Skeletal muscle 
is a load bearing tissue, so microthreads must be able to withstand considerable uniaxial loading 
to avoid mechanical failure in the injury site.  Our early implantation studies demonstrated that 
UNX microthreads withstand sufficient loading in situ to persist in an injury site and facilitate 
tissue ingrowth.4  Interestingly, the stiffness of fibrin microthreads is in the MPa range, while 
skeletal muscle is reported to have a static stiffness of 12 kPa,37 which can increase to 11.2 MPa 
in contracting muscle.38  Mooney and colleagues have reported that softer substrates trigger a 
proliferative phenotype in myoblasts, while stiffer substrates trigger myoblast differentiation.8,37  
Our uncrosslinked microthreads are stiffer than static muscle tissue, but more compliant than 
contracting muscle tissue, while EDCn microthreads are as stiff as contracting muscle, and 
EDCa microthreads are twice as stiff as contracting muscle.  Despite being stiffer than static 
skeletal muscle, we observed healthy myoblasts that readily proliferated with limited cell death 
on all of our scaffolds.  While it can be argued that a softer substrate would increase cell 
proliferation and better populate a wound site, evidence suggests that inhibiting early 
differentiation of myoblasts with growth factors will significantly impede muscle regeneration.39  
Downstream signaling induced by either growth factors or mechanical stimulation does not 
necessarily follow the same molecular pathways, however, these findings highlight the need to 
closely match both the mechanical and biochemical environment of the scaffold with native 
muscle tissue to promote tissue regeneration.  While we have not investigated the 
differentiation capacity of myoblasts on our microthread scaffolds, studies suggest that scaffolds 
that are degradable will readily facilitate differentiation.8  In this study, we demonstrated that 
degradable, EDC-crosslinked scaffolds qualitatively improve cell attachment and therefore hold 
substantial promise for use in skeletal muscle regeneration. 
The difference in swelling ratio observed with the crosslinking conditions indicates that 
acidic and neutral crosslinking environments greatly affect the internal structure of the fibrin 
microthreads.  Water binding efficiency, or swelling ratio, has been used as a tool to estimate 
the degree of crosslinking in fiber-based biopolymer scaffolds.26,29,36  Acidic buffer facilitates 
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the higher availability of deprotonated carboxylic groups through the hydrolysis of amino acids 
asparagine or glutamine to their acidic counterparts aspartate and glutamate respectively,40,41 
which are required to form EDC/NHS reactive intermediaries and, ultimately, the amide bonds 
that create the interfibrillar crosslinks within the microthreads.  In our study, we hypothesize 
that the depletion of free carboxylic groups may alter the surface charge of the microfibrils 
within the microthreads, facilitating interfibrillar interactions, or crosslinks, which may explain 
the reduction in swelling ratio.36  The differences in swelling ratios suggest that each condition 
differentially affects the crosslinking density within the microthreads.  That is, the acidic buffer 
facilitated the formation of more interfibrillar crosslinks within the microthreads than the neutral 
buffer.  In future studies, we will conduct a systematic series of experiments to validate these 
findings by detecting free amine groups as well as measuring the efficiency of biochemical 
interactions associated with the crosslinking reaction. 
The hypothesis that EDCa and EDCn microthreads were crosslinked differentially was 
further supported by the results of our in vitro degradation assay.  Uncrosslinked microthreads 
incubated in the presence of plasmin degraded within 4 hours, EDCn microthreads degraded 
within 24-48 hours, and EDCa microthreads did not show any degradation in our studies.  
These observations support the hypothesis that the decrease in swelling ratio is consistent with an 
increase in interfibrillar crosslinks within discrete microthreads.  One possible explanation for 
the decreased degradation rate of the crosslinked microthreads is that these crosslinks inhibit 
enzyme access to cleavage sites.  In studies evaluating the effects of Factor XIII crosslinking on 
fibrinolysis, it was found that increasing concentrations of Factor XIII decreased the rate of 
degradation, supporting the hypothesis that carbodiimide crosslinking may function similarly by 
hindering the access of plasmin to its cleavage sites and therefore increasing the persistence of 
fibrin in a proteolytic environment.22  Interestingly, when the culture time of C2C12 cells 
seeded on the microthreads was extended to 7 days, the cell-mediated temporal degradation trend 
was comparable to the plasmin degradation trend.  The results of our recent implantation study 
suggest that the regenerative response of a large volume skeletal muscle defect might be 
enhanced with the inclusion of a scaffold with an increased persistence in the wound site.4  
Together, these findings suggest that we would anticipate a more robust skeletal muscle 
regeneration response in a large muscle defect if our scaffolds were fabricated with EDCn or 
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EDCa crosslinked microthreads, since our in vitro studies demonstrate that these scaffold persist 
longer than the UNX microthreads that were used for our initial studies.  We plan to pursue the 
effects of increased fibrin microthread degradation time due to controlled chemical crosslinking 
on skeletal muscle regeneration in future studies. 
The initial increase in cell density observed on the surfaces of the EDCa microthreads 
may correlate to the increase in microthread stiffness observed from the tensile tests.  Previous 
studies showed that the stiffness of a substrate may affect the presentation of specific integrin 
binding sites such as the RGD motif or the development of focal adhesion complexes, increasing 
the initial attachment of C2C12 cells onto stiffer substrates.42  Fibrin is known to interact with 
many integrins, including αv and α5, which contribute to skeletal muscle precursor cell adhesion 
and maturation.42,43  We hypothesize that the interactions between these integrins and fibrin 
microthreads may be responsible for the initial, significant differences in cell density on EDCa 
crosslinked microthreads, relative to UNX microthreads after 1 day of culture.  Further, the lack 
of a reduction in cell adhesion indeed suggests the binding sites remained intact through the 
crosslinking procedure.  These findings suggest that this crosslinking strategy could enable the 
use of EDC as a conjugation agent to tether therapeutic molecules to the surface of the 
microthreads, increasing their bioactivity and regenerative potential without negatively 
impacting cell attachment.  While the strategic conjugation of peptides, growth factors, or 
therapeutic agents to the surface of fibrin microthreads is not the goal of this dissertation, this 
ability could be used in future studies to further direct cell and tissue responses to fibrin 
microthreads in a precise manner. 
 
3.5 CONCLUSIONS 
In this study, we demonstrated that the mechanical and structural properties of fibrin 
microthreads can be modulated by varying the pH in the EDC crosslinking procedure.  We 
showed that a physiological crosslinking pH resulted in the production of microthreads that are 
significantly stronger and stiffer as well as significantly more resistant to proteolytic degradation 
than UNX microthreads.  We also showed that acidic crosslinking buffer further increases the 
strength and stiffness of microthreads as well as their resistance to proteolytic degradation 
compared to EDCn crosslinked microthreads.  Further, these results suggest that cell adhesion 
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and proliferation on the surface of microthreads are not compromised by carbodiimide 
crosslinking.  The ability to generate scaffolds with tunable mechanical and structural 
properties is essential to strategically develop scaffolds that match the mechanical and 
biochemical requirements of regenerating tissue.  The tunable properties of EDC crosslinked 
microthreads in this study may be ideal to stimulate muscle regeneration due to their controllable 
resistance to proteolytic degradation, however, the biochemical properties of these microthreads 
may need to be tailored to facilitate the recruitment of myoblasts to a skeletal muscle injury site. 
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Chapter 4: Static Axial Stretching Enhances 
the Mechanical Properties and Cellular 
Responses of Fibrin Microthreads1 
 
 
 
4.1 INTRODUCTION 
Biopolymer microthreads are a platform technology that can be used for several 
applications including scaffolds for tissue engineering, delivery vehicles for growth factors or 
cells, or as suture materials.  These microthreads can be composed of a variety of materials, 
including collagen,2-4 silk,5-7 or fibrin.8,9  The structural requirements of these microthreads vary 
for each tissue or device application.  For example, scaffolds implanted into load-bearing tissues 
such as skeletal muscle require that the constructs provide provisional mechanical stability to the 
tissue in the wound site until native tissue is regenerated.10  Conversely, a delivery vehicle for 
growth factors or cells may require relatively large initial mechanical loads to implant into the 
wound site, but require rapid degradation to facilitate controlled release of the specific growth 
factor or cell type.  Skeletal muscle regeneration requires scaffolds that are capable of 
withstanding physiologic loading and can persist in situ for several weeks to guide the formation 
of nascent myofibers.  Therefore, there is a significant need to tune or modulate the mechanical 
properties of these materials during the microthread fabrication process to enable the design of 
function-specific microthread scaffolds. 
Fibrin has been used extensively as a scaffold material in tissue engineering because of 
its intrinsic bioactivity and its role as a provisional matrix during the initial stage of wound 
healing.11,12  Fibrin is a branched, microfibrillar polymer, formed when activated thrombin 
cleaves two small peptides from fibrinogen, allowing fibrinogen to self-assemble into a complex 
fibrillar network.  Fibrin gels have been shown to increase cell production of extracellular matrix 
proteins when compared to extracellular matrix protein production in cell-seeded collagen gels.13  
The molecular structure of fibrin enables individual microfibrils within the microfibrillar 
networks to undergo reorganization under tension, with strain at failure values in excess of 
200%.14  Another study demonstrated that the increase in tensile strength of stretched bulk fibrin 
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scaffolds increased the alignment of the fibrin polymer network within the matrix.15  Together 
these findings support the hypothesis that stretching of microfibrillar fibrin networks during 
scaffold fabrication will increase the organization and alignment of the polymer-like network and 
enhance the mechanical strength of the scaffold. 
Our laboratory developed a novel technique to extrude dense fibrin scaffolds into 
microthreads with average diameters between 100 and 150 µm.16  One advantage of these 
biopolymer microthreads is that their cylindrical shape facilitates cell alignment and new tissue 
deposition along the longitudinal axis of the microthread, enabling the guided regeneration of 
tissues with aligned fibrous tissue organization such as skeletal muscle, tendon, or ligament.  
Another advantage of creating microthreads from a dense fibrin matrix is to increase the 
mechanical strength of the overall fibrin scaffold.16  To further augment the mechanical 
properties of fibrin microthreads, we have investigated ultraviolet (UV),16 and carbodiimide,17 
crosslinking methods to enhance the tensile strength of fibrin microthreads, and showed that 
carbodiimide crosslinking increased the tensile strength of microthreads as well as their 
resistance to proteolytic degradation in vitro.  The current fibrin microthread fabrication process 
involves stretching microthreads immediately after fibrin polymerization, which generates 
uniform scaffolds with reproducible structural properties; however, we are not aware of any 
systematic studies that analyze the effects of static axial stretching on the structural or functional 
properties of fibrin scaffolds, including fibrin microthreads. 
The goal of this chapter was to quantitatively characterize the effect of static axial 
stretching on the mechanical, structural, and biochemical properties of fibrin microthreads.  We 
stretched fibrin microthreads 0-200% of their original lengths and evaluated their uniaxial 
strengths, rates of proteolytic degradation, and the degree with which C2C12 myoblasts aligned 
along the longitudinal axes of the microthreads.  The results show that while stretching decreases 
the diameters of fibrin microthreads, it significantly increases the tensile strength and stiffness of 
the microthreads without affecting their rate of proteolytic degradation.  The ability to tune the 
mechanical properties of fibrin microthreads without the use of crosslinking agents will create a 
more robust scaffold material that can be strategically employed as a regenerative matrix for 
tissues with varying mechanical and structural properties. 
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4.2 MATERIALS and METHODS 
4.2.1 Fibrin Microthread Preparation 
4.2.1.1 Microthread Extrusion 
Fibrin microthreads were co-extruded from solutions of fibrinogen and thrombin using 
extrusion techniques described previously in section 3.2.1.1.16,17  Briefly, fibrinogen from bovine 
plasma (Sigma, St. Louis, MO; F8630) was dissolved in HEPES (N-[2-Hydroxyethyl]piperazine-
N'-[2-ethanesulfonic acid]) buffered saline (HBS, 20 mM HEPES, 0.9% NaCl; pH 7.4) at 70 
mg/mL and stored at -20 °C until use.  Thrombin from bovine plasma (Sigma; T4648) was 
dissolved in HBS at 40 U/mL and stored at -20 °C until use. 
To fabricate microthreads, fibrinogen and thrombin solutions were thawed and warmed to 
room temperature, and thrombin was mixed with a 40 mM CaCl2 (Sigma) solution to form a 
working solution of 6 U/mL.  Equal volumes of fibrinogen and thrombin/CaCl2 solutions were 
loaded into separate 1 mL syringes which were inserted into a blending applicator tip 
(Micromedics Inc., St. Paul, MN; SA-3670).  The solutions were combined in the blending 
applicator and extruded through polyethylene tubing (BD, Sparks, MD) with an inner diameter 
of 0.86 mm into a bath of 10 mM HEPES (pH 7.4) in a Teflon coated pan at a rate of 0.225 
mL/min using a dual syringe pump. 
 
4.2.1.2 Static Axial Stretching with and without a Drying Phase 
Microthreads were incubated in 10 mM HEPES buffer for 10 minutes to facilitate fibrin 
polymerization, then the scaffolds were carefully removed from the bath solution without 
additional deformation and dried on a custom-made stretching device overnight (Figure 4.1A).  
After drying, microthreads were rehydrated in deionized (DI) water for one hour and static 
axially stretched to either 0, 50, 75, 100, 125, 150, 175 or 200 % of their initial length.  To 
analyze the contribution of the drying phase on the mechanical properties of stretched 
microthreads, batches of microthreads were also stretched immediately after polymerization to 
the desired percentage (Figure 4.1B).  After stretching, all microthreads were hung to dry under 
the tension of their own weight.  Percent yield of microthreads was determined as the ratio of the 
number of stretched microthreads and the original number of microthreads mounted on the 
stretching device.  Stretch percentages were reported as the ratio between the deformation (ΔL) 
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of the microthread and the starting length (L0) of the microthread (stretch % = ΔL/L0 *100%).  
Microthreads were fabricated using previously reported methods, which included static axial 
stretching of approximately 150% immediately after polymerization to form three 19 cm 
microthreads.17  Hence these microthreads were designated as control microthreads.  Dry, 
stretched microthreads were placed in aluminum foil and stored in a desiccator at room 
temperature until use. 
Figure 4.1. Flow-chart of the experimental setup for microthread fabrication with and without a drying 
phase.  Microthreads were extruded into a pH controlled bath solution and incubated for 10 minutes at room 
temperature for microthread polymerization.  After polymerization, microthreads were removed from the bath and 
dried overnight on a custom-made stretching device.  The next day microthreads were rehydrated, static axially 
stretched to the desired percentage, and dried for immediate testing or storage (A).  Control microthreads were 
stretched immediately after fibrin polymerization and dried overnight (B). 
 
4.2.2 Mechanical Characterization of Stretched Fibrin Microthreads 
Mechanical characterization of stretched fibrin microthreads was performed using 
techniques described previously in section 3.2.2.17  Briefly, individual microthreads were affixed 
with medical grade silicone adhesive to vellum paper frames with precut windows that defined 
the region of loading.  An initial gage length of 2.0 cm was defined as the distance between 
adhesive spots at the edges of the precut window in the vellum frame.  The microthreads on the 
vellum frames were hydrated in phosphate buffered saline (PBS) for at least 60 minutes prior to 
testing.  Hydrated microthread diameters were measured using a calibrated reticule with a 10X 
objective, coupled to a Nikon Eclipse E600 upright microscope (Melville, NY).  Microthreads 
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Figure 4.2. A representative stress-strain curve 
showing how each mechanical parameter was 
calculated in our MATLAB script. 
were assumed to be cylindrical, and the diameter was determined by averaging 3 measurements 
taken along the length of each microthread to define the cross-sectional area.  After hydration, 
microthreads were securely mounted in the grips of a uniaxial testing machine (ElectroPuls 
E1000; Instron, Norwood, MA) and a 1 N load cell, the edges of each vellum frame were cut, 
and the microthreads were uniaxially loaded until failure at a 50% strain rate (10 mm/min) 
relative to the initial gage length.  Force and displacement were recorded continuously 
throughout each test at a frequency of 10 Hz.  The mechanical failure load of each microthread 
was recorded as the point where a rapid (80%) drop from the maximum load occurred.  The grip-
vellum paper interface was visually inspected during each test to ensure that no slippage 
occurred.  Microthreads that slipped in the grips during testing were excluded from further 
analysis.  Engineering stress was calculated as the amount of force detected by the load cell 
divided by the initial cross-sectional area.  Strain was calculated as the increased extension from 
the gage-length. 
A MATLAB (MathWorks, Natick, MA) script was written to analyze the ultimate tensile 
strength (UTS), initial microthread modulus, maximum tangent modulus (MTM), strain at failure 
(SAF), and load at failure for each sample (Figure 4.2).  The initial modulus was defined as the 
initial linear region of the stress-strain curve, 
typically within the toe region.  The MTM was 
defined as the highest linear region in the stress-
strain curve for each sample over a moving 
window length corresponding to 20% of the total 
length of each test) and fitted to a linear region 
of the stress-strain curve.  The strain hardening 
ratio was defined as the ratio between the MTM 
and the initial modulus.  In the event that there 
was no change in the slope of the stress-strain curve (i.e. no visible toe region), the initial 
modulus was equal to the MTM and these values were not used to calculate strain hardening.  
Statistical analysis was used to identify and remove outliers as defined by microthreads whose 
wet diameters were 1.5 times greater than the inner quartile range (IQR) for each sample set 
(average wet diameter ± 1.5 *IQR).  To ensure this method was robust, we determined that the 
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distribution of wet diameter measurements was normal using SigmaPlot 11.0 software (Systat 
Software, Inc., San Jose, CA) to validate our definition, and exclusion, of outliers. Data points 
falling outside of this range were excluded from later statistical analysis. 
 
4.2.3 Structural Characterization of Stretched Fibrin Microthreads 
4.2.3.1 Scanning Electron Microscopy 
Fibrin microthreads were imaged with a scanning electron microscope (SEM) to 
characterize microthread morphology and surface topography.  Air-dried fibrin microthreads 
were mounted on aluminum stubs (Ted Pella, Redding, CA) coated with double-sided carbon 
tape and sputter coated with a thin layer of gold-palladium for 30 seconds at 45 mA using an 
EMS 550 (Electron Microscopy Sciences, Hatfield, PA).  Images were acquired at 5 kV with a 
JSM-KLG SEM. 
 
4.2.3.2 Microthread Swelling 
Prior to mechanical testing, the diameters of dry crosslinked microthreads were recorded 
using a calibrated reticule with a 10X objective.  In each case, the diameter for each microthread 
was averaged from three measurements taken along the length.  The wet diameter measurements 
taken during the mechanical testing procedure were also used to calculate the swelling ratio 
which was defined as the ratio of the wet diameter of a microthread to its dry diameter (wet/dry 
diameter). 
 
4.2.3.3 Transverse Strain and Poisson Ratio Calculations 
Transverse strain (diameter strain) was calculated as the change in the mean wet diameter 
of each stretched microthread with respect to the mean diameter of the unstretched microthreads.  
Poisson’s ratio was determined to be the negative of the ratio between the transverse strain and 
the axial strain of microthreads after stretching (Poisson = - transverse strain / axial strain). 
 
4.2.3.4 Degradation Assay 
Microthread degradation was performed on single fibers on the bottom of 48 well plates 
as previously described in Section 3.2.3.2.17  Briefly, stretched microthreads were cut into 0.8 cm 
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fragments and secured to the bottom of 48 well plates using medical grade silicone adhesive.  
Stock solutions of human plasmin (EMD Biosciences, San Diego, CA; 527621) were aliquoted 
and stored according to the manufacturer’s instructions.  Each experimental condition was run in 
triplicate.  Microthreads were hydrated in 500 µL of tris buffered saline (TBS, 25 mM Tris-HCl 
(Sigma), 0.9% NaCl, pH 7.5) for 1 hour, and images were taken with a 10X objective on a Leica 
inverted microscope (Leica, Wetzlar, Germany) coupled with Leica imaging software to record 
diameter values at time 0 (d0).  The TBS was aspirated and replaced with 500 µL of 0.1 U/mL of 
plasmin in TBS and samples were incubated at room temperature.  Microthreads were imaged 
every 30 minutes or until they were completely degraded.  Each image was processed with 
ImageJ (NIH) to measure the microthreads’ diameter at three different positions along the length 
and plotted as a ratio to the initial diameter value (d/d0). 
 
4.2.4 Cell Culture 
Immortalized mouse myoblasts (CRL-1772, ATCC, Manassas, VA; C2C12) were 
cultured in a 1:1 (v/v) ratio of high glucose Dulbecco’s modified Eagle Medium (DMEM, Gibco 
BRL, Gaithersburg, MD) and Ham’s F12 (Gibco), supplemented with 4 mM L-glutamine and 
10% fetal bovine serum (FBS, HyClone, Logan, UT).  Cells were incubated at 37 °C with 5% 
CO2 and maintained at a density below 70% confluence using standard cell culture techniques.  
Routine cell passage was conducted using 0.25% trypsin-EDTA (CellGro, Manassas, VA). 
 
4.2.5 Cell Attachment and Alignment Assay 
Two single microthreads from the same stretch group were adhered to stainless steel 
rings (Seastrom Manufacturing, Twin Falls ID; inner diameter 0.750 in.; outer diameter 1.188 
in.; thickness 0.005 in.) with medical grade silicone adhesive.  Each experimental condition was 
performed in duplicate.  Individual rings were placed in wells of a standard six-well plate over an 
elevated 13 mm diameter circular ThermanoxTM coverslip (Nalge Nunc International, Rochester, 
NY), as described previously in section 3.2.5.1.17,18  Prior to cell seeding, microthreads were 
sterilized in 70% ethanol for 1 hour, rinsed in DI water 3 times, air dried in a laminar flow hood, 
and stored in a desiccator until use. 
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Figure 4.3. Method to determine nuclear alignment on fibrin microthreads.  Grey scale images of nuclei on 
microthreads (A), were thresholded to remove background fluorescence and to visualize nuclei in ImageJ (B), and 
the ImageJ function analyze particles was used to identify individual nuclei and their orientation with respect to the 
long axis of the microthread (C). 
Immediately prior to seeding, 150 µL of sterile PBS was added to the coverslip to hydrate 
the microthreads for at least 1 hour.  To attach C2C12 cells to the microthread, the PBS was 
aspirated and replaced with 100 µL of cell suspension (100,000 cells/mL) in complete culture 
medium.  After a 4 hour incubation, cell-seeded microthreads were transferred to a clean six-well 
plate with 2 mL of fresh medium and returned to the incubator.  After 24 hours, microthreads 
were fixed in 4% paraformaldehyde and stained with Hoechst 33342 to visualize myoblast nuclei 
(Figure 4.3A).  Fluorescent images were analyzed by thresholding the grey scale image in 
ImageJ (NIH) (Figure 4.3B), and performing the particle analysis function within the ImageJ 
software to obtain the orientation of the long axis of the nucleus with respect to the microthread 
(Figure 4.3C).  Nuclei that were on the edge of the microthread, or in contact with another 
nucleus (cell-cell contact) were excluded from analysis, and the others were either binned in 15° 
increments and plotted into a histogram presenting the average frequency of each bin size, or 
averaged together to obtain total cell angle measurements. 
 
4.2.6 Statistical Analyses 
Statistical analyses were performed using a one-way analysis of variance (ANOVA) with 
p < 0.05 indicating significant differences between groups, using SigmaPlot 11.0 software.  For 
post hoc analyses, Holm-Sidak pairwise multiple comparison tests were performed to determine 
significant differences between experimental groups using an overall significance level of p < 
0.05.  Where indicated, a Student’s t-test was performed with p < 0.05 indicating significant 
differences between groups.  The data are reported as means ± standard deviation for the 
mechanical and structural characterization and as means ± standard error for the degradation (3 
discrete microthreads were analyzed for each of six experimental runs) and cell alignment 
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studies (4 discrete microthreads were analyzed for each condition for each of two experimental 
runs). 
 
4.3 RESULTS 
4.3.1 Stretching Increases the Ultimate Tensile Strength of Fibrin Microthreads 
The mechanical properties of static axially stretched microthreads 
were investigated for the design of tissue-specific microthread 
scaffolds.  Interestingly, while most static axially stretched 
microthreads were fabricated with similar percent yields, there was a 
reduction in the percent yield of microthreads stretched 200% of 
their initial length (Table 4.1).  Characteristic stress-strain curves for 
stretched microthreads show that the 0, 50, and 75% stretch groups 
have an initial toe region of increasing elongation with little change 
in stress (Figure 4.4A).  Interestingly, higher stretch percentages 
decreased this toe region, becoming undetectable in microthreads stretched 100% of their initial 
length, and also decreased the SAF of the material twofold.  Based on these mechanical results 
Table 4.1. Percent yield for 
fabrication of static axially 
stretched microthreads. 
 
Figure 4.4. Characteristic stress-strain curves for fibrin microthreads fabricated with a drying phase.  
Microthreads were produced, dried, rehydrated in DI water, and stretched to the indicated percentage.  
Representative stress-strain curves showed three distinct stretch regimes: low stretch microthreads (stretched 0, 50, 
or 75% of their initial lengths), moderate stretch microthreads (stretched 100 or 125% of their initial lengths), and 
high stretch microthreads (stretched 150, 175, 200% of their initial lengths) (A).  Low stretch microthreads 
displayed elastic toe regions and low stiffness.  Middle and high stretch microthreads did not always have 
characteristic toe-regions, but they appeared to deform linearly until failure at higher stresses and at lower strain 
values (B). 
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Figure 4.5. Mechanical properties of fibrin microthreads as a function of stretch percentage.  Microthreads 
were fabricated, dried, rehydrated in DI water, stretched to the indicated percentage and dried in their stretched 
state.  Microthreads were subsequently pulled to failure under uniaxial tension and the UTS (A), MTM (B), and 
SAF (C) were calculated.  Low stretch microthreads failed at significantly lower UTS values, and were less stiff 
than high stretch microthreads.  Low stretch microthreads also failed at significantly higher SAF values than high 
stretch microthreads.  * indicates statistical significance between corresponding groups using one-way ANOVA 
with Holm-Sidak post hoc analysis (p < 0.05, n≥41). 
we observed that the microthreads appear to exhibit 3  
distinct structural morphologies that we are classifying 
as low stretch microthreads (microthreads stretched to 
0, 50, or 75% of their initial length), moderate stretch 
microthreads (threads stretched to 100 or 125% of their 
initial length), or high stretch microthreads 
(microthreads stretched to 150, 175, or 200% of their 
initial length).  Characteristic stress-strain curves of 
each of the low, moderate, and high stretch groups 
show the loss of the toe-region with the moderate and 
high stretch microthreads, as well as the increase in the 
MTM with increasing stretch (Figure 4.4B).  The mean 
diameters, peak loads, UTS, MTM, and SAF of all 
microthreads loaded to failure in uniaxial tension are 
summarized in Table 4.2.  UTS of high stretch 
microthreads were significantly higher than those of 
low stretch microthreads (Figure 4.5A).  Additionally, 
moderate stretch microthreads displayed significantly 
lower UTS values than high stretch microthreads.  The 
MTM values showed a similar trend where the high 
stretch microthreads were found to be stiffer than the 
low stretch microthreads (Figure 4.5B).  High stretch 
microthreads also failed at significantly lower SAF 
values than low stretch microthreads (Figure 4.5C). 
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To characterize the relationship between static axial stretching and the stiffness of the 
fibrin microthreads, we analyzed the strain hardening behavior of the stretched microthreads.  
Strain hardening refers to an increase in the tangent modulus with increasing strain (compare 
initial and maximum tangent modulus in Figure 4.2).  Interestingly, static axial stretch was not 
found to affect the strain hardening ratio of fibrin microthreads (Table 4.3).  Most stretching 
conditions demonstrated significantly higher MTM than the initial moduli in the toe regions of 
the stress-strain curves, showing that these fibrin microthreads are undergoing strain hardening.  
Additionally, the initial modulus of the high stretch microthreads was significantly greater than 
the initial modulus of low stretch microthreads.  Combined with earlier observations about the 
effects of stretch on MTM values, these data suggest that high stretch microthreads are stiffer 
than the low stretch microthreads at all strain values during uniaxial loading.  Taken together, 
these data support the observation that there are three discrete ranges of mechanical strength that 
correspond to the amount of stretching of fibrin microthreads. 
 
Table 4.2. The mechanical and structural properties of fibrin microthreads stretched after a drying phase.
 
Table 4.3. Strain hardening behavior of static uniaxially stretched fibrin microthreads. 
* indicates significance with the 0% stretch group 
and † indicates significance with the 200% 
stretch group as determined by one-way ANOVA 
with Holm-Sidak post hoc analysis, and ‡ 
indicates significance between initial modulus 
and MTM within a single percentage group as 
determined by Student’s t-test (p < 0.05, n≥41). 
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Figure 4.6. Scanning electron micrographs of stretched fibrin 
microthreads.  Low (inset) and high magnification micrographs of fibrin 
microthreads stretched 0%, 75%, 150%, and 175% of their original lengths.  
As microthreads are stretched, their diameters decrease, and the topography 
changes from a smooth surface (0% and 75% stretch microthreads) to a 
surface with aligned grooves present at the 150% and 175% stretch groups 
(white arrows).  Scale = 25 µm and inset image scale = 400 µm. 
4.3.2 Stretching Decreases the Diameters and Swelling Ratios of Fibrin Microthreads, but 
does not Affect Poisson’s Ratio 
To begin to understand the structural organization of fibrin fibrils within the 
microthreads, dried microthreads were imaged with a SEM and swelling ratios were calculated to 
estimate interfibrillar interactions, fibrillar packing and orientation, as well as crosslinking 
density.  Scanning electron micrographs of the microthreads show an apparent decrease in 
diameter of the 
microthreads with increased 
stretch (Figure 4.6).  Low 
stretch microthreads 
(Figure 4.6, 0% and 75%) 
exhibited a smooth, 
rounded morphology with 
no evidence of surface 
topography.  With 
increasing stretch, the 
microthread surfaces 
exhibit a more complex 
topography.  There is 
evidence of longitudinal 
grooves present on high 
stretch microthreads 
(Figure 4.6, 150% and 175%), suggesting that the uniaxial deformation generated by stretching 
of the microthreads may impart fibrillar reorganization on the surface of the microthreads 
(Figure 4.6, white arrows).  Both the dry and wet diameters of microthreads were significantly 
higher in the low stretch microthread groups compared to the high stretch groups (Figure 4.7A).  
The swelling ratios of low stretch microthreads were also significantly higher than high stretch 
groups (Figure 4.7B), suggesting that stretching microthreads decreases both their mean 
diameters and their swelling ratio.  The transverse strain increased with increasing stretch (Figure 
4.7C).  High stretch microthreads had the highest transverse strain, and the low stretch 
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microthreads had the lowest.  Interestingly, Poisson’s ratio was constant regardless of the amount 
of axial stretch applied to the microthreads (Figure 4.7D), suggesting that this material property 
is conserved through the stretch regimen applied in this study. 
 
 
 
Figure 4.7. Structural properties of fibrin microthreads as a function of stretch.  Plots showing 
changes of wet and dry diameters (A), changes in swelling ratio (B), transverse strain along the diameter 
of the stretched microthreads (C), and Poisson’s ratio (D) as a function of static axial stretch.  Low stretch 
microthreads had significantly larger diameters and higher swelling ratios than high stretch microthreads.  
Low stretch microthreads had transverse strain measurements that were significantly lower than all other 
microthreads.  Poisson’s ratio was found to be constant regardless of the amount of axial stretch applied 
to the microthreads.  * and brackets indicates statistical significance between corresponding similar 
groups using one-way ANOVA with Holm-Sidak post hoc analysis (p < 0.05, n≥41). 
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Figure 4.8. Comparison of the UTS of fibrin 
microthreads stretched with or without a drying 
phase.  The UTS values of microthreads stretched with a 
drying phase were significantly higher than microthreads 
that were immediately stretched after polymerization.  
Additionally, microthreads stretched 150% with a drying 
phase had significantly higher UTS values than any other 
group, including the control. * and brackets indicates 
significance between corresponding groups as determined 
by one-way ANOVA with Holm-Sidak post hoc analysis 
and † indicates significance between immediate stretch 
and drying phase treatments within a single percentage 
group as determined by Student’s t-test (p < 0.05, n≥25). 
4.3.3 A Drying Phase is Necessary for the Increase in Ultimate Tensile Strength of Stretched 
Fibrin Microthreads 
To investigate whether the microthread drying phase affected the stretching-mediated 
changes in the mechanical and structural properties of fibrin microthreads, we stretched 
microthreads immediately after extrusion and 
polymerization in the HEPES bath (Figure 
4.1B).  These microthreads were compared to 
those used in the previous experiment, where a 
drying step was included after polymerization, 
but prior to the stretching of the fibrin 
microthreads (Figure 4.1A).  When the UTS 
values of microthreads stretched immediately 
after polymerization were compared to 
corresponding microthreads that had 
undergone a drying phase prior to 
stretching, the groups with a drying phase 
had significantly higher UTS values (Figure 
4.8).  Additionally, microthreads stretched 
with a drying phase had smaller diameters 
than microthreads stretched immediately 
after polymerization, while 0% stretch 
microthreads had larger diameters than 
control microthreads (Table 4.4).  Microthreads stretched immediately after polymerization also 
had comparable UTS values to the control microthreads.  However, microthreads that were 
processed with a drying phase exhibited a fourfold increase in UTS with respect to control 
microthreads, demonstrating that the combination of a drying phase and stretching are necessary 
to enhance the mechanical strength of microthreads.  
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Figure 4.9. Degradation profiles of microthreads static 
axially stretched with a drying phase.  Plots show changes 
in microthread diameter as a function of time and stretching 
regime.  While 0% stretch microthreads exhibited a lag in 
the initial rate of degradation with respect to 100% and 
150% stretch microthreads as indicated by a smaller 
negative slope of d/d0 versus time, none of these degradation 
profiles are significantly different from one another or from 
control microthreads that were made with the current 
fabrication process (n=6). 
Table 4.4. The mechanical properties of fibrin microthreads stretched with and without a 
drying phase. 
† indicates statistical significance from microthreads stretched with a drying phase determined 
with a Student’s t-test (p < 0.05) and * indicates statistical significance from control microthreads 
using one-way ANOVA with Holm-Sidak post hoc analysis (p < 0.05). 
 
4.3.4 Stretch Does Not Affect the Proteolytic Degradation of Fibrin Microthreads 
To evaluate whether static axial stretching affects the rate of proteolytic degradation of 
fibrin microthreads, microthreads were incubated with plasmin and the degradation of the 
microthreads was observed over time as a 
function of the change in microthread 
diameter.  Since results from Chapter 3 
showed a rapid rate of degradation of 
uncrosslinked fibrin microthreads,17 the 
kinetics of proteolytic degradation were 
slowed by performing the assay at room 
temperature.  There was a trend for 
moderate and high stretch microthreads to 
have smaller d/d0 ratios than low stretch 
microthreads at any point in time (Figure 
4.9), however, no significant differences 
were observed in the degradation rate of 
low, moderate, or high stretch fibrin 
microthreads, based on d/d0 measurements. 
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Figure 4.10. C2C12 myoblast alignment on static axially stretched fibrin microthreads.  Results of the 
nuclear alignment analysis are presented as histograms of the average percentage of nuclei oriented along the 
long axis of the microthread in 15⁰ increments (A).  In all cases, most nuclei were aligned with the long axis of 
the microthread (0-15⁰ orientation).  There was no change in the amount of cells aligned with the long axis of the 
microthread between low and moderate stretch microthread groups; however, there was almost a twofold 
increase with high stretch microthreads.  The average alignment angle of all nuclei along the microthreads shows 
that the average nuclear angle decreased twofold when cultured on high stretch microthreads (B).  
Representative fluorescent images of Hoechst stained nuclei on stretched microthreads show similar levels of 
attachment on microthreads regardless of their stretch regime (C-E).  * indicates significance with all other 
groups as determined by one-way ANOVA with Holm-Sidak post hoc analysis (p < 0.05, n≥150 cells analyzed 
for each group, n≥2 experimental duplicates, scale = 100 µm). 
4.3.5 Stretch Enhances Cell Alignment along the Longitudinal Axis of Fibrin Microthreads 
We investigated how stretching fibrin microthreads affected cell alignment of C2C12 
myoblasts after seeding.  All stretch percentages facilitated a range of cell alignment with respect 
to the long axis of the microthread (Figure 4.10A).  Cells tended to align more closely with the 
longitudinal axis of the microthreads with increasing levels of stretch, resulting in a 30% 
increase in myoblast nuclei oriented relative to low stretch microthreads (0-15° cell angle).  The 
percentage of cells that showed no preferential orientation to the long axis of microthreads      
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(45-90° cell angle) also decreased with increased stretch regimes (22%, 18%, and 4% for low, 
moderate, and high stretch microthreads, respectively).  When the alignment angles of all of the 
cells were averaged together, there was almost a twofold, statistically significant decrease in cell 
orientation with respect to the long axis of the microthread (Figure 4.10B).  Taken together, these 
data show that the surfaces of moderate and high stretch microthreads direct increased alignment 
of myoblast nuclei along the long axis of microthreads.  This trend was most evident with 
myoblasts analyzed in the high stretch group, where a majority of cells were aligned within 15 
degrees of the microthread axis, and had the least amount of cells aligned towards the 
circumferential axis of the microthreads. 
 
4.4 DISCUSSION 
The goal of the present study was to characterize fibrin microthreads with tunable 
structural properties in the absence of exogenous crosslinking agents.  Fibrin microthreads are a 
platform technology that can be used as scaffolds for tissue regeneration in a variety of tissue 
systems such as skeletal muscle, skin, tendon, ligament, or myocardium.  Each of these tissue 
systems has distinct mechanical and structural requirements, suggesting that there is a significant 
need to create fibrin microthreads with tunable mechanical properties.  In this study, we 
demonstrated that microthreads dried after polymerization, rehydrated, and then stretched to 
specific percentages produced three distinct stretch regimes (low, moderate or high stretch) that 
produce microthreads with specific mechanical properties.  The tensile properties reported in this 
study for moderate and high stretch microthreads are comparable to those previously reported for 
carbodiimide crosslinked fibrin microthreads in Chapter 3.17  High stretch fibrin microthreads 
have tensile strengths comparable to carbodiimide crosslinked microthreads in an acidic buffer 
(EDCa), and moderate stretch microthreads are comparable to carbodiimide crosslinked 
microthreads in a neutral buffer (EDCn).  While UTS values of stretched microthreads were 
comparable to carbodiimide crosslinked microthreads, the stiffness of these microthreads 
increased three to fourfold in comparison to carbodiimide crosslinked microthreads. 
Our observations that the tensile strength of fibrin microthreads increased with the 
magnitude of microthread stretching are consistent with previous observations with collagen 
microthreads, where UTS and stiffness values of uncrosslinked collagen microthreads increased 
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with static axial stretching.19  Furthermore, when fibrin gels were stretched and imaged with 
atomic force microscopy, a significant increase in the interfibrillar alignment of fibrin fibrils was 
observed.15  Interestingly, we did not observe any changes in Poisson’s ratio with increasing 
stretch, suggesting that these microthreads, composed of a dense fibrin matrix, demonstrated a 
consistent level of hydration within their fibrillar network, as was previously suggested with low 
concentration fibrin gels.20  Together with the swelling ratio observations, we hypothesize that 
the combination of static axial stretching and drying are affecting the ability of the microthreads 
to swell independent of Poisson’s ratio, resulting in decreased water content and subsequently 
increased packing density within the microthreads.  These combined findings suggest that the 
increased tensile strength and stiffness of stretched microthreads is due to an increase in the 
interfibrillar orientation and interaction of fibrin fibrils within the microthread.  An increase in 
the interfibrillar alignment could explain why no significant decreases in the load at failure were 
observed for stretched microthreads even when we observed decreases in the diameter of 
stretched fibrin microthreads. 
When C2C12 myoblasts were seeded on the surfaces of stretched fibrin microthreads, we 
observed that cell orientation appeared to sense changes in the topography on the surfaces of the 
scaffold.  Small cylindrical substrates, such as fibrin microthreads, have been previously shown 
to facilitate longitudinal alignment of cells.9,21  This phenomenon may explain why 
approximately 40% of the myoblast nuclei were oriented with the longitudinal axis of low stretch 
microthreads (0-15⁰ orientation).  In this study, we observed that there was a shift in the overall 
distribution of cell alignment towards the long axis of the scaffold when we applied a high 
stretch regimen to the microthreads and further, that the mean alignment angle of cells seeded on 
stretched microthreads significantly decreased twofold.  Additionally, it has been shown that 
increasing the alignment of fibers on the surface of a scaffold will enhance myoblast alignment 
along the scaffold.22  Our SEM micrographs provide evidence of longitudinal topography on 
high stretch microthreads, further suggesting an alignment of the fibrils on the surface of the 
microthreads, similar to previous observations for stretched fibrin gels.15,23  Together, these 
findings support our hypothesis that static axial stretching of fibrin microthreads facilitates the 
reorganization and alignment of fibrin fibrils on the surfaces of scaffolds.  To our knowledge, 
there has been little work on the design of scaffolds that concurrently mimic a tissue-like fibrous 
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architecture and also provide topographic instructive cues that direct cell function and 
orientation.  In future studies, we will combine the findings presented here with an analysis on 
the topography of fibrin microthreads to assess the contribution of microthread topography to 
cell alignment, based on the hypothesis that the internal reorganization of fibrin fibrils within the 
microthread produces an aligned surface topography that facilitates enhanced cell alignment. 
It is interesting to note that static axially stretched fibrin microthreads show strain 
hardening ratios of 2-4, similar to previously reported values for uncrosslinked, single fibrin 
fibers.14  Regardless of the amount of strain on the microthreads during uniaxial loading, there is 
a tenfold increase in stiffness between low and high stretch microthreads.  Previous studies have 
shown that stiffer substrates stimulate myoblast proliferation, which may be important for 
delivering enough myoblasts to repair large muscle defects in vivo for skeletal muscle 
regeneration.24,25  In addition to increased alignment of fibrils on the surface of the scaffold, 
substrate stiffness has been suggested to enhance cell alignment, a critical step towards myoblast 
fusion.26  While we have not characterized alignment-guided myoblast differentiation on static 
axially stretched fibrin microthreads as a function of scaffold rigidity, we hypothesize that there 
would be an increased ability of stretched microthreads to support myoblast differentiation.   
Previous studies showed that fibrin clots stretched 200-300% of their original length 
degraded at a slower rate, suggesting that stretching fibrin fibrils somehow blocked access of 
proteases to their target sites in fibrin.27  In this study, we showed that fibrin microthreads, 
stretched 0-200% of their original length, generated scaffolds with tunable mechanical and 
morphologic properties without significantly changing the rate of proteolytic degradation of the 
materials.  In previous studies, the density of fibrin fibrils has also been found to influence 
fibrinolysis, where densely packed, larger fibrin fibrils were found to degrade at slower rates 
than less densely packed, or thinner, fibrin fibrils.28,29  It is important to note that in these 
previous studies, researchers examined physiologic concentrations of fibrinogen.  In our study, 
fibrin microthreads are extruded with a fibrinogen concentration that is almost tenfold higher 
than physiologic levels.  We hypothesize that stretching these fibrin microthreads plastically 
deforms the fibrin fibril network within the microthread rather than protect discrete degradation 
sites.  This mechanism may explain why we did not observe a significant change in the 
degradation rate of stretched microthreads. 
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When uncrosslinked microthreads were implanted in a large skeletal muscle defect, 
microthreads were shown to degrade within 1-2 weeks.30  It was hypothesized that microthreads 
would have to persist for a longer duration of time for use as a scaffold in a large muscle defect.  
Static axial stretching of fibrin microthreads has not been found to significantly affect proteolytic 
degradation, so in vivo applications for these microthreads may be limited to implantation times 
of 1-2 weeks.  Another application for fibrin microthreads has been to use microthreads as suture 
material, as well as a cell delivery vehicle.31  We report here an efficient, and reproductive, 
method for increasing the mechanical strength of fibrin microthreads, which may aid in the use 
of these microthreads as a suture material due to their enhanced tensile strengths.  The ability to 
stretch fibrin microthreads is also favorable from a manufacturing standpoint, as this method 
would increase the yield of usable microthreads per batch as well as standardize the microthread 
production process to reduce batch-to-batch variability.  Further modifications of stretched 
microthreads, such as carbodiimide crosslinking, could generate microthreads with additional 
resistance to degradation as well as increased strength for use as a long-term scaffold for a 
variety of tissue regeneration applications.  However, because of a lack of an increased resistance 
to proteolytic degradation, static axially stretched microthreads are not recommended for 
implantation into large muscle defects for skeletal muscle regeneration. 
 
4.5 CONCLUSIONS 
In this study, we present fibrin microthreads that are dried, rehydrated, and then static 
axially stretched with low (0-75%), moderate (100-125%), or high (150-200%) stretch regimes 
to generate tunable mechanical properties such as UTS and stiffness.  The increase in UTS was 
attributed to the drying phase as well as the decrease in microthread diameter, as failure loads did 
not change.  Increased strengths were comparable to those of carbodiimide crosslinked 
microthreads,17 demonstrating that crosslinking is not necessary to increase the mechanical 
strength of microthreads. 
The fact that high stretch microthreads failed at the same load as low-stretch 
microthreads suggests that static axial stretching is reorganizing the fibrillar structure of fibrin 
fibrils within the microthreads.  This hypothesis was supported by SEM micrographs and 
increased cell alignment on high-stretch microthreads.  Interestingly, stretched microthreads with 
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increased mechanical strength did not have enhanced resistance to proteolytic degradation.  
Taken together, these findings suggest that we have developed a mechanism by which we can 
tune microthread structural properties without affecting their proteolytic degradation.  
Additionally, combining this process with crosslinking, or the incorporation of bioactive 
molecules, will significantly enhance the functional utility of these materials for the design of 
therapeutic delivery systems and scaffolds to promote functional tissue regeneration. 
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5.1 INTRODUCTION 
There are almost 100,000 reconstructive maxillofacial surgical procedures performed 
annually as a result of traumatic injury, cancer ablation, or cosmetic procedures, profoundly 
impacting the quality of life of patients.1,2  The excision or removal of muscle tissue may occur 
during these procedures, resulting in large scale muscle injuries termed volumetric muscle loss 
(VML) injuries, which cannot be repaired by skeletal muscle’s innate repair mechanism.3  In 
small muscle wounds such as those from exercise, the basal lamina rapidly releases hepatocyte 
growth factor (HGF) upon injury to stimulate the activation, and recruitment, of satellite cells 
(SCs) to the wound site.4-7  These local progenitor cells reside between the sarcolemma and basal 
lamina of muscle fibers, and are responsible for the regeneration of skeletal muscle tissue.8,9  In 
VML injuries, this basal lamina has been completely destroyed or removed, and it is unclear 
what growth factors are present to promote SC migration (i.e. recruitment) into the injury site.  
The rapid release of HGF occurs in the first 48-72 hours of injury, as prolonged HGF signaling 
inhibits skeletal muscle regeneration,7,10 highlighting the importance of the temporal expression 
of growth factors in skeletal muscle regeneration.  Thus, there is a need for biomimetic scaffolds 
to recapitulate early regenerative cues, such as HGF signaling, missing in VML injuries to 
stimulate the recruitment of SCs to the injury site. 
To efficiently assess SC recruitment, a variety of in vitro chemotactic assays have been 
described to rapidly measure SC migration assays.  Many chemotactic assays such as migration 
across membranes in Boyden chambers,11 or over defined two-dimensional (2D) substrates,12 do 
not accurately mimic the complex three-dimensional (3D) environment present in wound 
healing.  To improve upon 2D migration studies, sophisticated cell tracking algorithms have 
been developed to track cell movement in 3D gel matrices.13,14  While the analysis of migration 
through gels remains a significant improvement to 2D migration, these models still do not mimic 
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the highly organized structure present in fibrillar tissues such as skeletal muscle, tendon, or 
ligament.  Our laboratory developed a cell outgrowth assay designed to measure the importance 
of topographic cues in a model of 3D cell outgrowth along biopolymer microthread 
materials.15,16  Here, cells were seeded into type I collagen gels that mimic the provisional matrix 
at the wound margins.  These collagen gels are cast around 3D biopolymer microthreads, and the 
rate of cell outgrowth on the microthreads was measured.15  This method of cell outgrowth, 
which is a combination of migration and proliferation, occurs in skeletal muscle regeneration, 
where minor wounds do not result in rupture of the basal lamina, resulting in the longitudinal 
recruitment of SCs along myofibers to the injury site.9,17  In skeletal muscle fibers, the basal 
lamina is composed of a combination of extracellular proteins such as type IV collagen and 
laminin-2, but not type I collagen.18  Furthermore, fibrin is rapidly deposited as a provisional 
matrix following injury in skeletal muscle as a provisional matrix to support wound healing.19  
Therefore, we aim to modify this assay to generate a model system to predict SC recruitment for 
skeletal muscle regeneration in skeletal muscle injuries. 
In this chapter, we describe an in vitro assay that can rapidly assess myoblast outgrowth 
onto fibrin microthreads as a predictor of in vivo recruitment to the injury site by adsorbing HGF 
to fibrin microthreads.  Because HGF is present in the injury site for the first 3 days, our goal 
was to develop an HGF loading strategy to facilitate the rapid release of HGF.  We hypothesized 
that passive adsorption could be employed as an HGF delivery mechanism to rapidly release 
HGF, and that HGF-adsorbed fibrin microthreads would enhance the rate of myoblast outgrowth.  
We demonstrate that HGF can be adsorbed to carbodiimide crosslinked fibrin microthreads in an 
active form to support 2D myoblast proliferation and migration, and cell outgrowth in a 3D 
environment.  The release of adsorbed HGF from crosslinked microthreads corresponded to the 
time frame of HGF expression in skeletal muscle injuries.20  HGF incorporation onto crosslinked 
microthreads could be essential for modulating skeletal muscle progenitor cell recruitment to 
wound sites such as those in VML, and could amplify the regenerative response of damaged 
tissues to scaffolds. 
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5.2 MATERIALS and METHODS 
5.2.1 Fibrin Microthread Preparation 
5.2.1.1 Microthread Extrusion 
Fibrin microthreads were co-extruded from solutions of fibrinogen and thrombin using 
extrusion techniques described in section 3.2.1.1.21,22  Briefly, fibrinogen from bovine plasma 
(Sigma, St. Louis, MO; F8630) was dissolved in HEPES (N-[2-Hydroxyethyl]piperazine-N'-[2-
ethanesulfonic acid]) buffered saline (HBS, 20 mM HEPES, 0.9% NaCl; pH 7.4) at 70 mg/mL 
and stored at -20 °C until use.  Thrombin from bovine plasma (Sigma; T4648) was dissolved in 
HBS at 40 U/mL and stored at -20 °C until use. 
To fabricate microthreads, fibrinogen and thrombin solutions were thawed and warmed to 
room temperature, and thrombin was mixed with a 40 mM CaCl2 (Sigma) solution to form a 
working solution of 6 U/mL.  Fibrinogen and thrombin/CaCl2 solutions were loaded into 1 mL 
syringes which were inserted into a blending applicator tip (Micromedics Inc., St. Paul, MN; SA-
3670).  The solutions were combined in the blending applicator and extruded through 
polyethylene tubing (BD, Sparks, MD) with an inner diameter of 0.86 mm into a bath of 10 mM 
HEPES (pH 7.4) in a Teflon coated pan at a rate of 0.225 mL/min using a dual syringe pump.  
After 10 minutes, 25.4 cm, amorphous fibrin microthreads were removed from the buffer 
solution and stretched to form three-19-cm microthreads; these were air dried under the tension 
of their own weight.  Dry microthreads were placed in aluminum foil and stored in a desiccator 
until use. 
 
5.2.1.2 Fibrin Microthread Crosslinking 
Fibrin microthreads were crosslinked using techniques described previously in section 
3.2.1.2.22  Briefly, microthreads were hydrated in an acidic buffer of 50 mM 2-(N-
morpholino)ethanesulfonic acid (MES, Sigma, pH 5.2) or a neutral buffer of 100 mM 
monosodium phosphate (NaH2PO4, Sigma, pH 7.4) for 30 minutes and then crosslinked in either 
acidic (EDCa) or neutral (EDCn) buffer containing 16 mM N-hydroxysuccinimide (NHS, 
Sigma) and 28 mM 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC, Sigma) for 2 hours 
at room temperature.  After crosslinking, the buffered EDC/NHS solution was aspirated and the 
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microthreads were rinsed three times in deionized (DI) water, air dried, and stored in a desiccator 
until use. 
 
5.2.2 Adsorption of HGF to Microthreads 
Three similarly treated microthreads (uncrosslinked (UNX), EDCn, or EDCa) 1.8 cm in 
length were attached onto polydimethylsiloxane (PDMS, 0.75 in. inner diameter, Dow Corning, 
Midland, MI) rings, sterilized with 70% ethanol for 90 minutes, rinsed in DI water 3 times, and 
air dried in a laminar flow hood overnight.  Sterile microthread-PDMS constructs were hydrated 
in Dulbecco’s phosphate buffered saline (DPBS) and the PDMS surfaces were blocked with 
0.25% bovine serum albumin (BSA, Sigma) for 1 hour.  These solutions were aspirated and 
replaced with 1 mL of varied concentrations of HGF (0, 5, 10, 20, 40 or 100 ng/mL, Peprotech, 
Rocky Hill, NJ) in DPBS and incubated at room temperature for 2 hours.  The microthreads were 
rinsed five times in DPBS and immediately used for experiments.  To estimate the amount of 
HGF adsorption, we loaded microthreads with 100 ng/mL fluorescein isothiocyanate (FITC)-
labeled BSA (Sigma), rinsed the microthreads five times in DPBS, and imaged the microthreads 
with a Zeiss inverted microscope (Zeiss, Thornwood, NY). 
 
5.2.3 Cell Culture 
Immortalized mouse myoblasts (C2C12, ATCC, Manassas, VA) were cultured in a 1:1 
(v/v) ratio of high glucose Dulbecco’s modified Eagle Medium (DMEM, Gibco BRL, 
Gaithersburg, MD) supplemented with 4 mM L-glutamine and Ham’s F12 (Gibco) with 10% 
fetal bovine serum (FBS, HyClone, Logan, UT).  Cells were incubated at 37 °C with 5% CO2 
and maintained at a density below 70% confluence using standard cell culture techniques.  
Routine cell passage was conducted using 0.25% trypsin-EDTA (CellGro, Manassas, VA). 
 
5.2.4 Quantifying Release of HGF from Microthreads 
To quantify the active release of HGF, three HGF-loaded (0, 40, or 100 ng/mL HGF) 
microthreads attached to PDMS rings were incubated in 1 mL of serum-free medium (SFM, 1:1 
v/v high glucose DMEM/F-12).  At 24 hour increments, two 0.5 mL aliquots of conditioned-
SFM (C-SFM) were replaced and incubated on C2C12 myoblasts to determine the ability of the 
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C-SFM to induce myoblast proliferation.  Myoblasts were seeded in 24 well plates at a density of 
10,000 cell/well and incubated in SFM for 4 hours prior to incubation with C-SFM to maintain a 
uniform cell population for each experiment.  As a negative or positive control, myoblasts were 
cultured in SFM containing either 0 or 5 ng/mL of soluble HGF, respectively.  Each 
experimental condition was run in triplicate.  After an incubation time of 4 hours in C-SFM, cells 
were fixed with ice cold methanol, permeabilized with 0.1% Triton X-100 (Sigma), 
immunostained with a primary antibody against Ki67 (1:400, D3B5; Cell Signaling 
Technologies, Danvers, MA) and an Alexafluor 568 secondary (1:200, Life Technologies, 
Carlsbad, CA), then counterstained with Hoechst 33342 (1:6000, Molecular Probes).  To 
determine the percentage of proliferating cells, five images were taken of each well with a Zeiss 
inverted microscope and the number of Ki67 positive nuclei were normalized to the total number 
of nuclei counted in each image. 
 
5.2.5 Two-dimensional Motogenic Response from HGF-loaded Microthreads 
To confirm that released HGF could stimulate myoblast migration, a dual-well PDMS 
device 5 mm thick was fabricated with two 1.9 cm diameter chambers and a 1 cm long, 3 mm 
wide, cell migration channel between the two chambers, which was initially sealed with a PDMS 
plug (Figure 5.1A).  PDMS constructs were autoclave sterilized and secured to the bottom of P60 
dishes (BD Falcon, Franklin Lakes, NJ) with sterile vacuum grease (Dow Corning).  Three HGF-
loaded microthreads were placed in the first chamber to serve as an HGF reservoir with 1 mL of 
medium, and the second chamber was seeded with 80,000 myoblasts in 1 mL of medium.  As a 
negative or positive control, the first chamber was loaded with 0 or 100 ng/mL of soluble HGF, 
respectively.  The cell seeding chamber was rinsed 4 hours after seeding to remove any non-
adherent cells from the well, and then the plug separating the two chambers was removed (Figure 
5.1B).  Both chambers received equal volumes of medium to limit fluid flow after the removal of 
the plug.  The cell front was immediately imaged and reimaged every 6 hours for 24 hours on a 
Leica inverted microscope (Leica, Wetzlar, Germany) coupled with Leica imaging software 
(Figure 5.1C).  Each experimental condition was run in duplicate.  To calculate migration rates, 
the position of the cells was determined at each time based on their distance from their starting 
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location in ImageJ (NIH), and a line of linear regression was fitted for each sample using Excel 
(Redmond, WA), where the slope is the migration rate (µm/hr) (Figure 5.1D). 
 
5.2.6 Three-dimensional Motogenic Outgrowth from HGF-loaded Microthreads 
To measure cell outgrowth in a 3D model, we developed an outgrowth assay based upon 
a previously described outgrowth system.15  Here, the outgrowth assay was miniaturized to 
reduce medium volumes, and to isolate different microthread conditions from each other.  Raised 
rectangular platforms of Thermanox® tissue culture plastic (3 x 13 mm) (Nalge Nunc, Rochester, 
NY) were elevated 2-3 mm above the surface of 6 well tissue culture dishes using molded PDMS 
plugs, and secured in place with medical-grade silicone adhesive (Factor II, Lakeside, AZ) 
(Figure 5.2A).  The outgrowth assays were sterilized in 70% ethanol for at least 2 hours, rinsed 
in DI water 3 times, and then air dried in a laminar flow hood. 
After 0, 5, 10, 20, or 40 ng/mL of HGF was adsorbed to fibrin microthreads, the PDMS 
rings were affixed to the outgrowth assay with four dots of sterile vacuum grease so that the 
microthreads were in contact with the central region of the raised platforms (Figure 5.2A).  Each 
platform system had 6 microthread/platform interfaces, and each condition was done in 
duplicate. 
Figure 5.1. Two dimensional assay developed to quantify the migration of myoblasts towards HGF-loaded 
microthreads.  Schematic of 2D migration assay.  Three similarly crosslinked microthreads loaded with 0, 40, or 
100 ng/mL of HGF were placed in one chamber, and C2C12 myoblasts were seeded into the second chamber (A).  
The two chambers were isolated with a PDMS block, which was removed to establish an HGF gradient at the start 
of the experiment (B).  Brightfield images were taken where the cell front was present in the cell-seeded chamber 
every 6 hours (C), and the distance from their starting position (gray dashed line) was measured over time.  The 
distance traveled at each time point was plotted in Excel, and was fit to a line of linear regression, where the slope of 
the regression line was the migration rate (D).  Scale = 50 µm. 
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To create cell 
outgrowth assays, 40 µL of 
myoblast-populated fibrin 
gels were placed on each 
platform.  These fibrin gels 
were produced by generating 
a 1 mL aliquot of sterile 
fibrinogen (5.22 mg/mL), 
thrombin (2.35 U/mL), 
calcium chloride (31.25 
mM), and cell solution 
(909,000 cell/mL) in a 
8:1:1:2 ratio to produce a 
fibrin gel with a final 
fibrinogen concentration of 
3.5 mg/mL and a final cell 
concentration of 150,000 cell/mL.  Prior to mixing into the fibrin gel solution, myoblasts were 
loaded with DiO (Life Technologies) for twenty minutes, following the manufacturer’s 
instructions.  Myoblast-populated fibrin gels were incubated at 37 °C for 1 hour to facilitate 
complete gel formation, after which the wells were flooded with 4 mL of medium to completely 
cover the top of the gel. 
To study cell outgrowth on the fibrin microthreads, the microthread-coverslip interfaces 
were imaged daily to measure outgrowth, and the position of the leading cell was determined 
based on its distance from the edge of the coverslip (Figure 5.2B).  To measure the effect of HGF 
on myoblast outgrowth, the outgrowth rate was determined as the slope of the line of linear 
regression from the first two days.  After two days, the amount of dye present in migration cells 
was diminished due to cell division, so cells were redosed with DiO by adding 1 mL of medium 
supplemented with 5 µL of DiO solution.  Microthreads were incubated in DiO-supplemented 
medium for 20 minutes, and then 3 mL of medium was removed from the wells and replaced 
Figure 5.2. Myoblast outgrowth assay schematic.  A top, isometric, and 
side projection of the outgrowth assay (A).  Microthreads were suspended 
over an elevated Thermanox coverslip, upon which a myoblast populated 
fibrin gel was seeded.  Representative images from the outgrowth assay (B).  
Dashed white lines highlight the thread edges, and the Thermanox coverslip 
is visible as the autofluorescent green rectangle on the left side of the images.  
Arrowheads indicated the furthest cell along the microthread, and the 
outgrowth distance at each time point was determined to be the distance to 
the leading cell (arrowhead) from the edge of the coverslip.  Scale = 100 µm. 
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with 2 mL of fresh medium.  The wells were gently agitated to mix the medium, and then an 
additional 2 mL was removed from each well and replaced with 2 mL of fresh medium. 
After four days of culture, outgrowth assays were fixed in 4% paraformaldehyde and two 
microthreads per treatment group were permeabilized with 0.1% Triton X-100 and stained for 
Ki67, as described above in section 5.2.4.  A single image from each microthread, focusing on 
the leading cell as well as the following confluent layer of cells, was imaged using a 20X long 
distance objective on an inverted Zeiss microscope, and the percentage of Ki67 positive nuclei 
were normalized to the total number of nuclei present the image. 
 
5.2.7 Statistical Analyses 
Statistical analyses were performed using a one-way analysis of variance (ANOVA) with 
p < 0.05 indicating significant differences between groups using SigmaPlot 11.0 software (Systat 
Software, Inc., San Jose, CA).  For post hoc analysis, a Holm-Sidak pairwise multiple 
comparison test was performed to determine significance between experimental groups using an 
overall significance level of p < 0.05.  The data are reported as means ± standard error, where the 
sample size indicates the number of experimental replicates performed. 
 
5.3 RESULTS 
5.3.1 Adsorbed HGF is Rapidly Released from Fibrin Microthreads 
To characterize the mechanism by which passively adsorbed HGF is released from fibrin 
microthreads, we developed several assays to study the release, and activity, of HGF.  FITC-
labeled BSA was used as a model molecule to confirm protein adsorption on UNX and 
crosslinked microthreads, based on its similar molecular weight to HGF.  For UNX and EDCn 
microthreads, no FITC signal was detected with un-labeled BSA (Figure 5.3 A-B).  When FITC-
labeled BSA was adsorbed to UNX and EDCn microthreads, there was an increase in detectable 
FITC signal, with qualitatively more BSA adsorption observed on EDCn microthreads than on 
UNX microthreads (Figure 5.3 D-E).  Interestingly, there was no notable evidence of BSA 
adsorption onto EDCa microthreads, relative to control samples (Figure 5.3 C and F).  Together, 
these findings suggest that crosslinking the fibrin microthreads in a neutral environment affects 
the ability of molecules to bind to the surface of the microthreads. 
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To quantitatively evaluate the temporal release activity of HGF from microthreads, 
myoblasts were incubated in medium conditioned by HGF-adsorbed microthreads and cells were 
assayed for increases in Ki67 expression.  The percent of Ki67 positive myoblasts significantly 
increased with SFM conditioned with HGF coated EDCn microthreads at day one (Figure 5.4A).  
This level of stimulation was equivalent to that of 5 ng/mL of soluble HGF, which is in the range 
of HGF concentrations found in the literature to maximally stimulate proliferation in myoblast 
populations.23  Active HGF was detected from UNX microthread C-SFM at day one, and no 
HGF-response was detected from EDCa microthreads (Figure 5.4A).  Interestingly, EDCa 
microthread C-SFM stimulated myoblast proliferation regardless of the concentration of HGF 
adsorbed at one day.  HGF coated, EDCn microthread C-SFM from day two also stimulated 
myoblast proliferation to values comparable to 5 ng/mL of soluble HGF (Figure 5.4B); however, 
by day four C-SFM was not found to have any effect on myoblast proliferation (Figure 5.4C). 
 
Figure 5.3. Representative images of microthreads loaded with FITC-labeled BSA.  UNX (A, D), EDCn (B, 
E), or EDCa (C, F) microthreads were loaded with 0 ng/mL (A-C) or 100 ng/mL (D-F) FITC-BSA.  UNX and 
EDCn microthread controls did not show evidence of fluorescence (A, B), and adsorbed FITC-BSA increased the 
detectable fluorescence of these microthreads (D, E).  EDCa microthreads did not show any evidence of BSA 
adsorption (F), relative to controls (C).  Scale = 100 µm. 
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Figure 5.4. Percentage of C2C12 myoblasts expressing Ki67 stimulated from fibrin microthread C-SFM.  
Microthreads had increasing amounts of HGF adsorbed to their surfaces, and the ability of microthread C-SFM was 
compared to SFM with no exogenous HGF (negative control, black control bar) and SFM supplemented with 5 
ng/mL HGF (positive control, white control bar).  C-SFM from 24hrs (A), 48 hrs (B), and 96 hrs (C) were analyzed.  
EDCn microthread C-SFM from the first and second days were able to stimulate significantly higher amounts of 
myoblasts to express Ki67 compared to negative controls while releasate from the fourth day showed no increases in 
proliferation, suggesting that active HGF is released within the first two days of culture. † indicate statistical 
significance with the negative control, ‡ indicate statistical significance with the 0 ng/mL of the same microthread 
treatment group, and * represent statistical significance with the indicated groups as determined by one-way 
ANOVA with Holm-Sidak post hoc analysis (p > 0.05, n≥2). 
 
5.3.2 HGF Released from Fibrin Microthreads is a Motogenic Factor for Myoblasts 
To confirm that released HGF could stimulate myoblast migration, a dual-well PDMS 
device was fabricated where one reservoir had three HGF-loaded microthreads and the second 
chamber was seeded with C2C12 myoblasts (Fig 5.1A).  The PDMS block separating the two 
channels was removed after 4 hours to allow for myoblast attachment (Fig 5.1B) to measure 
myoblast migration towards HGF-adsorbed microthreads in a 2D system.  Migration was 
observed for 24 hours to limit the amount of proliferation in this system because the doubling 
time of C2C12 myoblasts is between 15-18 hours.24-26  There was a two-fold increase in the rate 
of myoblast migration stimulated by HGF-adsorbed EDCn microthreads independent of the 
amount of HGF adsorbed, suggesting that incubating microthreads with 40 ng/mL of HGF either 
saturates the surface of the microthreads, or that 40 ng/mL of HGF generates a similar cell 
response to the amount of HGF released from microthreads adsorbed with 100 ng/mL of HGF 
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(Figure 5.5).  The migration rates stimulated by both HGF loading concentrations on EDCn 
microthreads were significantly higher than empty control reservoirs and they were comparable 
to experimental conditions that contained 100 ng/mL of soluble HGF; which was found to 
maximally stimulate migration of SCs along muscle fibers.27  Despite measuring an increase in 
expression of Ki67 from myoblasts incubated in HGF-loaded UNX microthread C-SFM, we did 
not observe a motogenic response from UNX microthread C-SFM.  There was no motogenic 
response towards EDCa microthreads regardless of the amount of HGF adsorbed. 
 
Figure 5.5. Two-dimensional myoblast 
migration towards HGF-loaded 
microthreads.  Migration towards EDCn 
microthreads doubled between unloaded and 
HGF-loaded treatment groups.  There was no 
significant increase in migration towards 
UNX or EDCa microthreads with increasing 
amounts of adsorbed HGF.  As a control, 0 
ng/mL of soluble HGF (HGF, black) or 100 
ng/mL of soluble HGF (HGF, white) was 
added to microthread chambers.  * indicate 
significant differences with migration rates 
from HGF-loaded microthreads of similar 
crosslinking type as determined by one-way 
ANOVA with Holm-Sidak post hoc analysis 
(p < 0.05, n≥2). 
 
5.3.3 HGF Adsorbed onto Fibrin Microthreads Enhances Myoblast Outgrowth 
To determine the effects of HGF-loading onto cell outgrowth along fibrin microthreads, 
we developed a miniature assay to quantify the rate of cell outgrowth onto fibrin microthreads in 
a 3D system.  Because there were no detectable differences in 2D migration between 40 and 100 
ng/mL of HGF, we adsorbed 0, 5, 10, 20, or 40 ng/mL of HGF to the surface of microthreads to 
evaluate the effect of lower concentrations of HGF on the 3D outgrowth of myoblasts.  The 
HGF-loaded microthreads were positioned over raised Thermanox coverslips (Figure 5.2A), and 
C2C12 myoblasts were preloaded with the membrane dye tracker DiO to acquire daily images to 
visualize cell outgrowth (Figure 5.2B).  The myoblast outgrowth rate was significantly higher on 
EDCn microthreads adsorbed with 40 ng/mL of HGF compared to untreated controls (Figure 
5.6A).  Interestingly, while there was no HGF-mediated outgrowth response on EDCa 
microthreads, myoblasts migrated along these microthreads at similar rates as UNX 
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microthreads.  However, the total distance myoblasts traveled along EDCn microthreads after 4 
days also significantly increased two- to three-fold with 10, 20, and 40 ng/mL of HGF compared 
to 0 ng/mL of HGF (Figure 5.6B).  These elevated distances are similar to the distances traveled 
by myoblasts along UNX microthreads, again suggesting that adsorbing HGF to EDCn 
microthreads restores the bioactivity lost during crosslinking.  These data suggest that 
preadsorption of 20 or 40 ng/mL of HGF to the surface of EDCn microthreads will maximize the 
outgrowth rate and distance these myoblasts will travel within 4 days. 
 
 
5.3.4 Fibrin Microthreads Enhance Myoblast Proliferation 
Cell outgrowth is a phenomenon that incorporates both cell migration as well as cell 
proliferation.  To understand what aspect of the measured outgrowth rates are due to 
proliferation, we quantified the amount of Ki67 positive cells present on the microthreads at day 
4.  In most cases, the cells were observed to be a confluent layer with several cells ahead of the 
migration front (Figure 5.7).  Interestingly, Ki67 positive cells were evenly distributed among the 
Figure 5.6. Cell outgrowth of C2C12 myoblasts from fibrin gels along fibrin microthreads with increasing 
concentrations of HGF preadsorbed to their surfaces.  Outgrowth rate of myoblasts along microthreads during the 
first two days of HGF release (A).  Cell outgrowth doubled on EDCn microthreads loaded with 40 ng/mL of HGF 
compared to unloaded EDCn microthreads.  There was no observable effect of loading HGF to either UNX or EDCa 
microthreads.  A graph displaying the total distance traveled in four days by myoblasts (B).  The raw distance 
traveled on EDCn microthreads increased with larger amounts of preadsorbed HGF.  * and brackets indicate 
statistical significance with indicated groups as determined by ANOVA with Holm-Sidak post hoc analysis (p < 
0.05, n=6). 
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leading cells as well as within the layer of cells behind the migration front.  There was a 
significant increase in the percentage of proliferating cells with EDCn and EDCa microthreads 
(Figure 5.8).  There appeared to be qualitative increases in the number of Ki67 positive cells on 
crosslinked microthreads that had 20 ng/mL of HGF adsorbed to their surfaces; however, there 
were no significant increases in the percent of proliferating cells on microthreads with respect to 
HGF concentration, likely due to the absence of released HGF at this time point. 
 
 
 
 
 
Figure 5.7. Representative images of the outgrowth assay at day 4 with Ki67 staining.  In all cases, the 
myoblasts are migrating from the left of the image to the right.  Single cells not surrounded by other cells are 
referred to as leading cells, while the subconfluent layer of cells behind the leading cell are the migration front.  
Proliferating cells, shown here as Ki67 positive nuclei, appear to be evenly distributed throughout the leading cells 
as well as within the layers of cells behind the migration front.  Arrowheads indicate representative Ki67 positive 
cells and grey dotted lines indicate microthread edges.  Scale = 100 µm.
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Figure 5.8. Percentage of Ki67 
positive myoblasts in the 
migration front of the 
outgrowth assay at day 4.  
EDCn and EDCa microthreads 
consistently had an increased 
percentage of Ki67 positive cells, 
although there was no increase in 
proliferating cells with respect to 
HGF concentration.  * indicate 
statistical significance with other 
microthread groups in the same 
HGF concentration as determined 
by ANOVA with Holm-Sidak 
post hoc analysis (p < 0.05, n=4). 
 
5.4 DISCUSSION 
Treatment of VML injuries remains a significant healthcare concern due to the inability 
of skeletal muscle to functionally regenerate these critically sized injuries.  One reason that VML 
defects are difficult to regenerate via the endogenous skeletal muscle regenerative pathway is 
that the ECM is completely removed from these injury sites, eliminating essential cues that 
typically initiate regeneration.  One of the first signals that is released from damaged skeletal 
muscle is HGF, which functions to activate, and recruit satellite cells to the wound site.28,29  We 
showed that HGF can adsorb to the surface of EDCn fibrin microthreads and rapidly release 
from the microthreads within 2-4 days, and that this release will facilitate enhanced myoblast 
outgrowth along fibrin microthreads in a 3D outgrowth assay.  We hypothesize that HGF-loaded 
EDCn microthreads will enhance skeletal muscle regeneration due to this increased ability to 
recruit myoblasts. 
To support the findings that cell outgrowth was only enhanced on HGF-loaded EDCn 
microthreads, results from our FITC-labeled BSA study indicated that a large increase in 
fluorescence was observed on EDCn microthreads, while no adsorption was detected on EDCa 
microthreads and small amounts of BSA-FITC were detected on UNX microthreads.  
Carbodiimide crosslinked surfaces have an increased amount of amide bonds due to the coupling 
of free amino and carboxyl groups, which may decrease the surface charge of the microthreads.  
In Chapter 3, we hypothesized that EDCa microthreads were composed of additional aspartate 
and glutamate amino acid residues due to the hydrolysis of the amine containing residues 
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asparagine and glutamine, respectively.22  The changes in the amino acid composition of EDCa 
microthreads compared to EDCn microthreads suggest that the surface chemistry of EDCa 
microthreads may be significantly altered, although further studies using Fourier transform 
infrared spectroscopy (FTIR) analysis are required to confirm these changes.  Ultimately, these 
data suggest that because EDCa microthreads are not able to adsorb bioactive molecules such as 
BSA-FITC or HGF, they may not be able to direct SC recruitment to VML injuries. 
It is interesting to note that while HGF adsorbed to EDCn microthreads stimulated 
proliferation and migration, HGF adsorbed to UNX microthreads only stimulated proliferation.  
HGF is a pleiotropic growth factor that stimulates a variety of cell functions including 
proliferation,30 migration,31,32 and survival.33  Regardless of which downstream pathway is 
activated, HGF signaling begins with its association with its tyrosine kinase receptor, c-met.34,35  
Studies assessing the motogenic effects of HGF have found its effect to be maximized with 
concentrations at or below 100 ng/mL, and in general, higher concentrations elicit increased 
motility,27,36,37 while concentrations between 2 and 10 ng/mL have been found to stimulate 
myoblast proliferation.4,23,38  The ability of a growth factor to have several different functions 
based on its relative concentration to its receptor has been previously documented.23,39  Based on 
the size of HGF (100kDa), if we assume that the shape of HGF molecules is spherical, we can 
estimate the minimum size of the radius to be 3.06 nm, with a minimum surface area of 59 
nm2.40  From Chapter 3, if we assume microthreads are approximately 130 µm in diameter, the 
surface area of each microthread is 4.08 mm2 per cm of microthread.  From these calculations, 
we can estimate the theoretical adsorption limit of HGF to microthreads, which is 11.5 ng of 
HGF per 1 cm of microthread.  Since we adsorbed 1.8 cm lengths of microthreads, this yields an 
adsorption limit of 20.7 ng of HGF per microthread.  Given that we are adsorbing HGF to three 
microthreads at a time, the maximum amount of HGF that could be adsorbed, and then released, 
would be 62.1 ng.  If we continue to adsorb HGF onto microthreads in a volume of 1 mL and 
assume that all of the HGF adsorbed to the microthreads, this would require a loading 
concentration of at least 62.1 ng/mL to reach the adsorption limit.  Because we did not observe 
any significant differences in myoblast proliferation or migration between adsorbing EDCn 
microthreads with a loading concentration of 40 ng/mL or 100 ng/mL, we assume that we did not 
reach this theoretical maximum.  However, the minimum concentration of HGF that has been 
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reported to induce a chemotactic response on myoblasts is 10 ng/mL.31  Combined with previous 
literature, our data suggest that we are releasing at least 10 ng/mL of HGF per day from EDCn 
microthreads to enhance 2D and 3D migration.  While we were unable to directly quantify the 
amount of HGF released to verify these calculations, we did make qualitative observations 
regarding BSA adsorption, which is approximately the same molecular weight as HGF, on the 
two different microthread scaffolds.  We observed an increase in adsorption of FITC-labeled 
BSA on EDCn microthreads, further supporting the hypothesis that EDCn microthreads are 
facilitating the adsorption of more HGF than UNX microthreads. 
In a similar system with collagen microthreads, fibroblasts were observed to migrate 
along EDC crosslinked materials at slower rates than uncrosslinked collagen microthreads.41  
Interestingly, we did not observe a significant reduction in myoblast outgrowth on crosslinked 
fibrin microthreads.  However, by adsorbing EDCn fibrin microthreads with 40 ng/mL of HGF, 
we have increased the outgrowth rate on EDCn microthreads twofold, slightly higher than the 
outgrowth rate on unloaded, control UNX microthreads.  The total distance traveled along the 
microthreads followed the same trend: HGF loading increased the distance to the leading cell 
along EDCn microthreads to be comparable to the distances of myoblasts growing along UNX 
microthreads.  For a scaffold to successfully regenerate skeletal muscle in VML defects, the 
material must recruit myoblasts to the wound site and persist for 2-4 weeks, long enough for the 
entire wound to regenerate.42  We hypothesize that the increased ability of EDCn microthreads to 
stimulate myoblast migration by the incorporation of HGF, combined with their increased 
resistance to proteolytic degradation,22 will enhance skeletal muscle regeneration. 
While we did not observe any evidence of HGF adsorption to EDCa microthreads, it is 
interesting to note that SFM conditioned for 24 hours by EDCa microthreads stimulated an 
increase in myoblast proliferation, regardless of the concentration of HGF present for the 
adsorption process (0, 40, or 100 ng/mL).  This effect was observed only when medium was 
conditioned by EDCa microthreads in the first 24 hours, and could be further evidence that the 
acidic conditions are supporting both the crosslinking, and degradation of fibrin microthreads.  
Fibrin degradation products have been shown in a variety of systems to direct cell functions such 
as proliferation and migration.43-46  In Chapter 3, we observed that prolonged incubation in the 
acidic buffer degraded the microthreads.  These degradation products would have formed during 
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the hydration step, where microthreads were incubated in acidic buffer prior to crosslinking, and 
were loosely retained in the matrix of EDCa microthreads during the crosslinking reaction.  
These degradation products would then be released within a 24 hour period with the capacity to 
stimulate myoblast proliferation, but not migration.  Future studies will analyze C-SFM from 
EDCa microthreads to identify the presence of any mitogens, specifically looking for fibrin 
degradation products.44 
We consistently observed several cells migrating ahead of what appeared to be a 
confluent cell layer along microthreads throughout the cell outgrowth study.  This suggests that 
the migration of several cells along the microthread substrate precedes the proliferation of these 
cells to achieve a confluent layer.  This phenomenon was observed each day that the 
microthreads were imaged (Fig 5.2B for a representative data set), suggesting that this is a 
continuous process, where several motile cells migrate ahead of a more confluent layer of cells 
that results from proliferation of other cells.  This effect has been observed with endothelial cells, 
and migration was found to be diminished when cells were treated with mitomycin C, suggesting 
that both proliferation and migration are necessary for outgrowth.36  Interestingly, when the 
percentage of Ki67 positive cells was quantified along microthreads at 4 days of culture, a 
substrate-dependent increase in proliferation was observed.  Substrate stiffness has been reported 
to increase myoblast proliferation in other 2D studies,47 and we have previously reported in 
Chapter 3 that EDCn and EDCa microthreads are significantly stiffer than UNX microthreads.22  
Together, these observations suggest that while it is being released, HGF likely plays a role in 
enhancing the migration of motile cells along EDCn microthreads, while the cells are also 
proliferating to form confluent layers of cells behind these leading cells. 
 
5.5 CONCLUSIONS 
In this study, we passively adsorbed increasing amounts of HGF to the surface of 
crosslinked fibrin microthreads to ultimately enhance myoblast recruitment to skeletal muscle 
defects.  Our immunofluorescence analyses suggest that the surface of EDCn microthreads 
facilitate the most HGF adsorption.  We also showed that these substrates are capable of 
stimulating both myoblast proliferation and migration.  These effects plateaued when 40 ng/mL 
of HGF were adsorbed to the surface.  UNX microthreads supported some HGF adsorption, 
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which supported myoblast proliferation but not migration, possibly due to low concentrations of 
adsorbed HGF.  We hypothesize that changes in the surface chemistry between UNX and EDCn 
microthreads are responsible for this difference in adsorption capacity for HGF.  While EDCa 
microthreads did not facilitate the adsorption of HGF, medium conditioned from these 
microthreads stimulated myoblast proliferation, possibly due to the release of fibrin degradation 
products that resulted from the crosslinking procedure.  Regardless of the adsorption of HGF, the 
proliferation of myoblasts 4 days after cells migrated along the microthreads was increased on 
crosslinked microthreads.  The ability of EDCn microthreads to adsorb HGF in a way that 
facilitates its rapid, active release is ideal for VML injuries, and we hypothesize that these HGF-
loaded EDCn microthreads will enhance skeletal muscle regeneration in these defects. 
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6.1 INTRODUCTION 
Volumetric muscle loss (VML) typically results from traumatic incidents; such as those 
presented from combat missions, where soft tissue extremity injuries account for approximately 
63% of diagnoses.1,2  These injuries not only cause cosmetic deformities, which may lead to the 
development of psychological conditions, but also lead to a devastating loss of function due to 
the complete removal of large amounts of tissue and its native basement membrane.3  While 
skeletal muscle has an innate repair mechanism that is largely directed by this native tissue 
architecture, it is unable to compensate for large-scale injuries due to the destruction of this 
regenerative template and growth factor reservoir.  The current standard of care for large-scale 
skeletal muscle injury is an autologous tissue transfer from an uninjured site.4  This complicated 
surgical procedure yields limited restoration of muscle function and can result in complications 
such as donor site morbidity, infection, and graft failure due to necrosis.4,5  While muscle flaps 
may be a suitable treatment, as many as 10% of muscle flap surgeries develop complete graft 
failure, demonstrating the need for an alternative treatment.5,6  Thus, there is a need to develop 
an off-the-shelf, biomimetic scaffold that directs functional skeletal muscle tissue regeneration 
within large defect sites. 
Skeletal muscle regeneration is mediated by local progenitor cells known as satellite cells 
(SCs), which reside between the sarcolemma and basal lamina of muscle fibers.7,8  In small 
muscle wounds such as those from exercise, the basal lamina rapidly releases hepatocyte growth 
factor (HGF) to stimulate the activation, and recruitment, of SCs to the wound site.9-12  This 
immediate rapid release is important to gather enough progenitor cells to repair large defects.12,13  
Importantly, reentry into the cell cycle has been found to be solely mediated by HGF.14,15  
Because it inhibits SC differentiation, HGF will inhibit muscle regeneration if present for a 
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prolonged period, demonstrating that careful attention must be paid to the time scale that HGF is 
supplemented to a VML defect.12,16 
Acellular scaffolds engineered to direct the regeneration of VML injuries can be tuned 
via multiple design criteria to facilitate the recruitment of SCs to the injury site and create 
organized nascent myofibers.  A simple method to increase the number of SCs at the injury site 
is to incorporate relevant growth factors within the scaffolding material such that they would be 
released upon implantation.  Surprisingly, recent studies ignore the necessary goal of recruiting 
SCs to the defect, and rather focus on the revascularization of the tissue,17 or rely on the growth 
factors present in decellularized extracellular matrix (ECM) materials to direct regeneration.18,19  
While some of these studies report improvements in mechanical function,20 many studies using 
acellular ECM materials report that long term remodeling, between 3-6 months, is necessary for 
ECM scaffold mediated functional recovery.21,22  These data suggest that the addition of an 
exogenous factor capable of stimulating rapid SC recruitment may facilitate functional recovery 
at earlier time points, as this would recapitulate regenerative cues missing in VML injuries and 
expedite the remodeling of the defect site. 
An additional limitation of previous acellular strategies is that regenerating myofibers are 
often not parallel to the remaining myofibers, limiting the functional efficiency of the newly 
formed tissue.23-25  This disorganized regeneration may be a result of the random protein network 
present in both decellularized ECM and the polymerization process involved in the formation of 
alginate or gelatin materials.  To assist in the organized creation of myofibers within an injury 
site, we have developed biomimetic biopolymer microthreads that have a similar morphology to 
native tissue.  By geometrically guiding the directional organization of the polymerization 
process of fibrinogen and thrombin, we developed an aligned fibrin microthread scaffold that is 
capable of directing cell alignment along the longitudinal axis of the microthread structure.26  
Results from early implantation studies investigating the use of fibrin microthreads in a mouse 
model of VML suggest that fibrin microthreads stimulate skeletal muscle regeneration; however, 
it was noted that a decreased rate of degradation of the microthreads could enhance the 
microthread-mediated regenerative response.27  In Chapter 3, we showed that the mechanical and 
structural properties of carbodiimide crosslinked fibrin microthreads can be tuned by altering the 
buffer conditions of the crosslinking reaction without adversely affecting cell attachment, 
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proliferation, or viability.28  When incubated in plasmin, the primary agent of fibrinolysis, these 
differentially crosslinked microthreads showed varying increases in resistance to proteolytic 
degradation, suggesting that these crosslinked materials might be ideal for skeletal muscle 
regeneration.  In Chapter 5, we adsorbed HGF to uncrosslinked (UNX) microthreads and 
microthreads crosslinked with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) in neutral 
(EDCn), or acidic (EDCa) buffers, and found that EDCn microthreads were able to adsorb HGF.  
Over the period of 2-4 days, HGF was released in an active form and was capable of stimulating 
myoblast proliferation and migration in two- and three-dimensions. 
In this Chapter, we investigate the ability of HGF loaded EDCn (EDCn-HGF) 
microthreads to enhance regeneration of functional tissue in a mouse VML model.  We 
hypothesize that EDCn-HGF microthreads will increase the functional recovery of VML injuries 
in the tibialis anterior (TA) muscle by increasing the number of SCs within the injury site.  
Interestingly, while there was not a significant increase in Pax7 positive SCs compared to injured 
controls two weeks post-injury, there was a significant increase in myogenin positive nuclei, 
suggesting that the recruitment of the majority of the SCs occurred before the two week time 
point.  This increase in differentiating myoblasts led to a significant increase in mechanical 
function of the TA eight weeks post-injury; however, the EDCn microthreads were still present 
in the wound site.  Together, these data suggest that by adsorbing HGF onto EDCn microthreads, 
we are recapitulating regenerative cues lost in VML injuries to ultimately enhance skeletal 
muscle regeneration. 
 
6.2 MATERIALS and METHODS 
6.2.1 Fibrin Microthread Preparation 
6.2.1.1 Microthread Extrusion 
Fibrin microthreads were co-extruded from solutions of fibrinogen and thrombin using 
extrusion techniques described previously in section 3.2.1.1.26,28  Briefly, fibrinogen from bovine 
plasma (MP Biomedical, Irvine, CA; Cat No. 08820224) was dissolved in HEPES (N-[2-
Hydroxyethyl]piperazine-N'-[2-ethanesulfonic acid]) buffered saline (HBS, 20 mM HEPES, 
0.9% NaCl; pH 7.4) at 70 mg/mL and stored at -20 °C until use.  Thrombin from bovine plasma 
(Sigma; T4648) was dissolved in HBS at 40 U/mL and stored at -20 °C until use. 
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To fabricate microthreads, fibrinogen and thrombin solutions were thawed and warmed to 
room temperature, and thrombin was mixed with a 40 mM CaCl2 (Sigma) solution to form a 
working solution of 6 U/mL.  Fibrinogen and thrombin/CaCl2 solutions were loaded into 1 mL 
syringes which were inserted into a blending applicator tip (Micromedics Inc., St. Paul, MN; SA-
3670).  The solutions were combined in the blending applicator and extruded through 
polyethylene tubing (BD, Sparks, MD) with an inner diameter of 0.86 mm into a bath of 10 mM 
HEPES (pH 7.4) in a Teflon coated pan at a rate of 0.225 mL/min using a dual syringe pump.  
After 10 minutes, 25.4 cm, amorphous fibrin microthreads were removed from the buffer 
solution and stretched to form three-19-cm microthreads; these were air dried under the tension 
of their own weight.  Dry microthreads were placed in aluminum foil and stored in a desiccator 
until use. 
 
6.2.1.2 Fibrin Microthread Crosslinking 
Fibrin microthreads were crosslinked using techniques described in section 3.2.1.2.28  
Briefly, to create EDCn microthreads, microthreads were hydrated in monosodium phosphate 
buffer (100 mM NaH2PO4, Sigma, pH 7.4) for 30 minutes and then crosslinked in monosodium 
phosphate buffer containing 16 mM N-hydroxysuccinimide (NHS, Sigma) and 28 mM EDC 
(Sigma) for 2 hours at room temperature.  After crosslinking, the buffered EDC/NHS solution 
was aspirated and the microthreads were rinsed three times in a deionized (DI) water bath, air 
dried, sterilized with ethylene oxide, and stored in a desiccator until use. 
 
6.2.1.3 Adsorption of HGF to Microthreads 
Three unsterilized EDCn microthreads were attached onto polydimethylsiloxane (PDMS, 
inner diameter 0.75 in., Dow Corning, Midland, MI) rings, sterilized with 70% ethanol for 90 
minutes, rinsed with DI water three times, and air dried in a laminar flow hood overnight, as 
described in section 5.2.2.  Sterile microthread-PDMS constructs were hydrated in Dulbecco’s 
phosphate buffered saline (DPBS) and the PDMS surfaces were blocked with 0.25% bovine 
serum albumin (BSA, Sigma) for 1 hour.  These solutions were aspirated and replaced with 1 mL 
of 40 ng/mL of HGF (Peprotech, Rocky Hill, NJ) in DPBS and incubated at room temperature 
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for 2 hours.  The microthreads were rinsed three times in DPBS, twice in L-15 (Mediatech, Inc., 
Manassas, VA) and immediately used for implantation. 
 
6.2.2 Animals and Surgical Procedures 
All animal protocols were approved by the Institutional Animal Care and Use Committee 
(IACUC) at Worcester Polytechnic Institute.  Female nude SCID hairless outbred (Strain SHO; 
Charles River Laboratories, Wilmington, MA) mice between 7 and 8 weeks of age were used to 
compare results to previous experiments within our lab.27  Mice were anesthetized with an intra-
peritoneal (i.p.) injection of ketamine/xylazine (50/5 mg/kg), and all surgical procedures were 
performed under a stereo microscope as previously described.27  The skin flap and fascia 
covering the TA muscle of the right hindleg were retracted (Figure 6.1A) and a critical sized 
defect was created in the central region of the muscle by resecting approximately 30 mg (4 x 2 x 
2 mm) of tissue (Figure 6.1B).  The severity of each injury was assessed by measuring a 50% 
reduction in the force produced by single electrical impulses (twitch force) compared to pre-
injury values.  At this point, one of five treatments were implanted into the injury site: no 
intervention (untreated), fibrin gel, UNX microthreads, EDCn microthreads, or EDCn-HGF 
microthreads.  Fibrin gel implants were created by dropwise addition of sterile-filtered 
fibrinogen (70 mg/mL) into the injury site until it was full, followed by a single drop of sterile-
filtered thrombin (6 U/mL).  Fibrin microthreads were implanted in the injury site with sterile 
forceps and cut to the size of the injury, and were positioned such that the microthreads were 
parallel to the remaining myofibers.  On average, 8-15 microthreads were used to fill the injury 
site.  After implantation, microthreads were secured in the wound site using sequential drops of 
sterile fibrinogen and thrombin solutions.  The muscle was kept hydrated during the procedure 
using sterile saline.  The skin flap was replaced over the wound and secured with 8-0 SecurosOrb 
suture with TG140-8 needles (Securos, Fiskdale, MA; Cat No. 008170).  Animals were allowed 
to recover under a heat lamp and administered 0.05 mg/kg buprenorphine every 12 hours for 72 
hours for post-op care.  A total of three animals per treatment were used for analysis at 14 days 
post-injury, and six animals per treatment for analysis at 60 days post-injury. 
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Figure 6.1. Schematic representation of study performed in Chapter 6.  Healthy TA muscles were exposed and 
baseline force values were measured (A).  A VML size injury was induced by resecting 4 x 2 x 2 mm of tissue, and 
one of five treatments was implanted (B).  After 14 or 60 days, the TA was exposed, and observations were made on 
the gross morphology (C).  After fixation, TA muscles were bisected (D) and observed either in the sagittal plane 
(longitudinal cross-section) or coronal plane (lateral top-down cross-section) (E).  Images courtesy of M Zayas.
 
6.2.3 Histological and Immunohistochemical Analysis 
Animals were euthanized at either 14 or 60 days post-injury and the TA muscle was 
exposed and dissected longitudinally away from the tibia leaving both ends affixed.  The shape 
of the muscle as well as the gross morphology of the wound site was recorded, and the 
approximate wound site was marked with a histology marking pen (Figure 6.1C).  The whole 
lower leg was placed in 4% paraformaldehyde in PBS for 1 hr, after which the TA muscle was 
removed from the rest of the lower leg and fixed for an additional 2 hr at room temperature.  
Tissue was rinsed in phosphate buffered saline (PBS) three times, bisected with a razor blade 
along the center of the wound site (Figure 6.1D), and stored in 70% ethanol until processing and 
paraffin embedding.  Muscle sections were embedded in two orientations: a longitudinal cross-
section of the sagittal plane of the muscle, which reveals regeneration in the defect site as a 
function of tissue depth, and a lateral top-down view of the coronal plane of the muscle, 
revealing regeneration events as a function of tissue width (Figure 6.1E).  Serial 5 µm sections 
were cut from both tissue orientations, mounted on Superfrost Plus slides (VWR, West Chester, 
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PA), and used for histological and immunohistochemical (IHC) analyses.  Slides stained with 
Masson’s trichrome, which stains cytoplasm (muscle) and fibrin structures in red, collagen and 
connective tissue in blue, and nuclei in black, were prepared using at least two sections 50 µm 
apart per tissue orientation per animal using standard 
procedures.  In all cases, histological and IHC data will 
be presented with a cartoon inset of the appropriate 
tissue orientation, and will denote the location within 
the injury site that is being analyzed (Figure 6.2). 
Serial sagittal and coronal 5 µm sections were stained to visualize Pax7 positive nuclei 
(SCs), myogenin positive nuclei (myotubes), and platelet endothelial cell adhesion molecule 
(PECAM; CD-31; blood vessels), respectively.  For all staining, sections were deparaffinized in 
xylenes and rehydrated through a series of graded alcohols.  Antigen retrieval was conducted in a 
pressure cooker for 20 min using a citrate-based antigen retrieval solution (Vector Laboratories, 
Burlingame, CA; H-3300).  The samples were allowed to cool to room temperature and rinsed 
with PBS.  Each section was incubated for 30 min in a blocking solution of 2.5% horse serum in 
a humidified chamber.  Sections were stained separately using antibodies targeting Pax7 
(Developmental Studies Hybridoma Bank, Iowa City, IA) at a 1:15 dilution, myogenin (Abcam, 
Cambridge, MA; ab1835) at a 1:100 dilution, or PECAM (Abcam; ab28364) at a dilution of 1:50 
in PBS/0.05% Tween for 45 min at room temperature.  After 2 rinses of PBS/Tween, slides were 
incubated in 3% hydrogen peroxide for 30 min to inhibit endogenous peroxidase activity.  The 
slides were rinsed twice in PBS and incubated in the appropriate Impress horseradish peroxidase-
based secondary antibody (anti-mouse IgG (Vector, MP7402) for Pax7 and myogenin, anti-
rabbit IgG for PECAM (Vector, MP7401)) for 30 min at room temperature.  An Impact DAB kit 
(Vector, SK-4105) was used to develop positive staining due to the presence of the Impress 
secondary antibody.  Slides were counterstained with hematoxylin, dehydrated through graded 
alcohols and xylenes, and cover-slipped for analysis.  Histology and IHC images were observed 
on a Nikon Eclipse E400 microscope (Nikon, Inc., Melville, NY) coupled with a RT Color Spot 
camera (Spot Diagnostics, Sterling Heights, MI) with matching software. 
Figure 6.2. Cartoon denoting location of 
proximal and distal ends of TA muscle. 
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6.2.3.1 Estimation of Wound Size 
To approximate the 
change in the wound size over 
time, the defect width, length, and 
depth were measured from 
multiple images that were 
acquired from slides stained with 
Masson’s trichrome with a Nikon 
Eclipse E400 microscope using a 
10X objective and stitched together using Adobe Photoshop CD5.1 (Adobe, San Jose, CA).  
Images were imported into ImageJ (NIH) and the length and width (coronal sections), and the 
depth and length (sagittal sections) of the defect region were measured (Figure 6.3).  Wound 
margins were defined by identifying the implanted microthreads in UNX, EDCn, or EDCn-HGF 
microthread treatment groups, and by identifying disorganized myofibers surrounded by collagen 
fibers for untreated or fibrin gel treatment groups.  In treatment groups where adipose tissue was 
observed, this was identified as part of the wound site and included in these measurements.  
Length measurements were combined between both tissue orientations, as they represent the 
same measurement in three-dimensional (3D) space. 
 
6.2.3.2 Collagen Quantification 
Collagen quantification was performed digitally by analyzing the entire defect site of 
Masson’s trichrome stained tissue sections compiled in section 6.2.3.1 (Figure 6.4A).  Collagen 
pixel red green blue (RGB) values were recorded at 4-6 points in each of 15 images to obtain an 
average pixel RGB value (59, 93, 199) to identify collagen deposition in Masson’s trichrome 
images.  Photoshop was used to select all blue pixels using this average RGB value (i.e. collagen 
content) in each image using the SELECT > COLOR RANGE function with a “fuzziness” value of 
92 (Figure 6.4B).  The fuzziness value was empirically selected by averaging the same value for 
15 randomly selected images, and functions as a threshold value to include varying RGB values 
of collagen.  The resulting image was imported into ImageJ, thresholded with a value of 214, and 
analyzed for percent of black pixels (i.e. collagen content) (Figure 6.4C).  Parts of the image that 
Figure 6.3 Definition of VML defect dimensions.  The dimensions of 
defects stained with Masson’s trichrome 14 and 60 days post-injury 
were measured to assess the change in defect size between these time 
points. 
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did not contain muscle tissue were also selected and removed from this percent area calculation 
to ensure that the analysis of percent area only considered muscle tissue. 
Figure 6.4. Collagen quantification 
method for VML defects.  
Composite images of the entire 
muscle defect, stained with Masson’s 
trichrome, 60 days post-injury were 
prepared (A), and each blue pixel was 
selected in Photoshop (B).  The 
resulting image was imported into 
ImageJ, thresholded, and the percent 
of black pixels was determined to be 
the collagen content (C). 
 
6.2.4 Contractile Force Measurements 
To measure the muscle strength recovered by the implants, the contractile force evaluated 
for animals before injury (baseline), after injury, and at the time of sacrifice in situ, as previously 
described.27  Briefly, the right hindleg knee joint was anchored using a custom clamping system 
fixed to the base of the stereo microscope stand.  A silk ligature was secured to the cleft between 
digits 1 and 2 of the mouse paw and it was anchored to a force transducer (Harvard Apparatus, 
Holliston, MA) on the other end.  The exposed TA muscle was stimulated using 2 custom needle 
electrodes placed on the proximal surface of the muscle.  Electrical stimulation was applied at 4 
V with a 4 ms pulse duration at 500 ms intervals and the resultant twitch forces (g) were 
recorded at a rate of 200 Hz using a BioPac MP-100 (BIOPAC Systems, Inc., Goleta, CA) and 
accompanying software (AcknowledgeTM, BIOPAC Systems, Inc.).  Maximum force produced at 
tetanus was measured by reducing the pulse intervals to 20 ms.  As a control, the twitch force 
and maximum force at tetanus were measured for the contralateral leg 60 days post-injury.  At 
least fifteen contraction measurements per animal per time point were made. 
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6.2.5 Statistical Analyses 
Statistical analyses were performed using a one-way analysis of variance (ANOVA) with 
p < 0.05 indicating significant differences between groups using SigmaPlot 11.0 software (Systat 
Software, Inc., San Jose, CA).  For post hoc analysis, a Holm-Sidak pairwise multiple 
comparison test was performed to determine significance between experimental groups using an 
overall significance level of p < 0.05.  Where indicated, a paired Student’s t-test was performed 
with p < 0.05 indicating significant differences between groups.  The data are reported as means 
± standard error. 
 
6.3 RESULTS 
6.3.1 Gross Morphology of No Intervention and Fibrin Gel Implants Show Loss of Muscle 
Volume 
To characterize how acellular fibrin microthread implants affect skeletal muscle 
regeneration, we implanted UNX, EDCn, and EDCn-HGF microthreads into VML injuries 
within the TA muscle of mice.  As a material control, we implanted fibrin gels to the injury site 
to assess whether the fibrin biomaterial itself would induce muscle regeneration or whether the 
structural architecture of the microthreads was required for organized, functional regeneration.  
Throughout this study, no animals experienced any complications from the surgical procedures, 
and all survived to their designated time points.  The body weight of each animal was recorded 
before surgery and before euthanization, and no significant changes in weight were noted at any 
time point (Table 6.1).  Fourteen days post-injury, there was evidence of muscle volume loss in 
untreated and fibrin gel implant groups as shown by a loss of the convex shape of the surface of 
the muscle (black arrowheads, Figure 6.5 A-B).  There appeared to be deformities in the shape of 
the muscles that were treated with UNX microthread implants (Figure 6.5C), although the 
general shape of the muscle was consistent with healthy tissue.  EDCn and EDCn-HGF 
Table 6.1. Animal weight at time of sacrifice.
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microthreads remained visible 14 days post-injury, although the EDCn-HGF microthreads 
appeared to be covered by a layer of tissue (white arrowheads, Figure 6.5 D-E).  Sixty days post-
injury, the loss of muscle volume persisted in all animals treated with untreated control and fibrin 
gel implant groups (Figure 6.5 F-G).  The shape of muscles 60 days post-injury with microthread 
implants exhibited a smooth, convex surface, showing no evidence of muscle loss (Figure 6.5 H-
J).  While microthreads were still visible in muscles treated with EDCn and EDCn-HGF implant 
groups, the area of the defect site seemed to decrease, and there appeared to be new muscle 
growth in and around the microthreads in these implant groups (Figure 6.5 I-J).  Additionally, all 
mice that received EDCn-HGF implants 60 days post-injury were recorded to be highly active in 
their cages. 
 
 
 
Figure 6.5. Gross morphology of TA muscle defects.  VML injuries were created in each TA muscle, received no 
intervention (A,F), or fibrin gel (B,G), UNX microthread (C,H), EDCn microthread (D,I), or EDCn-HGF 
microthread (E,J) implants, and were allowed to recover to 14 days (A-E) or 60 days (F-J) post-injury.  There was a 
loss of muscle volume evident by a loss in the convex shape of the surface of the muscle in untreated control and 
fibrin gel implant groups at both time points (black arrowheads).  Additionally, some microthreads remain visible in 
EDCn (D,I) and EDCn-HGF (E,J) microthread implant groups at both time points (white arrowheads). 
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6.3.2 Fourteen Days Post-Injury, Microthread Implants Support Myoblast Infiltration 
We analyzed the amount of muscle regeneration 14 days post-injury to determine the 
early regenerative response to fibrin microthread implants.  There was a clear demarcation 
between healthy tissue, regenerating tissue, and the remaining injury site in each implant group 
in tissue sections stained with Masson’s trichrome, where blue stains for collagen and connective 
tissue, black stains cell nuclei, and red stains cytoplasm (muscle) and fibrin structures.  
Regenerating tissue was defined as multinucleated cells (myofibers) with centrally positioned 
nuclei.  With the exception of EDCn-HGF microthreads, all other treatment groups supported the 
deposition of connective tissue (Figure 6.6).  All fibrin gel and microthread implants persisted 14 
days post-injury and, interestingly, fibrin gel implants appeared to be heavily infiltrated with 
adipocytes (Figure 6.6B).  There were fewer cells in the central region of the defect site of EDCn 
and EDCn-HGF microthreads than UNX microthreads (Figure 6.6 C-E). 
The tissue morphology at the distal end of the muscle defects showed the integration of 
the host tissue with each of the implants (Figure 6.7).  Untreated controls showed the most 
collagen fiber deposition (blue arrows), with few infiltrating myoblasts (Figure 6.7 A-B).  Fibrin 
gel implants displayed poor integration with the host tissue, as evident by the lack of myoblast 
growth or myofiber formation within the implant itself.  Instead of remaining an acellular space, 
there were a large number of adipocytes (white arrows) that infiltrated within the fibrin gel 
matrix (Figure 6.7 C-D).  While there was more myoblast ingrowth (black arrows) into UNX 
microthread implants than fibrin gel implants, there was also adipocyte infiltration into the 
microthread structures, and connective tissue was deposited around the microthread implants 
(Figure 6.7 E-F).  EDCn and EDCn-HGF microthread implant groups showed good tissue 
integration, as several myofibers were observed around, and between, discrete microthreads 
(Figure 6.7 G-J).  EDCn-HGF microthread implants supported larger amounts of tissue ingrowth 
than EDCn microthread implants, and had less collagen deposition at this time point. 
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Figure 6.6. Low magnification images of entire VML defect sites 14 days post-injury.  Masson’s trichrome 
images of the coronal plane of VML defects with untreated controls (A), fibrin gel implants (B), or UNX (C), EDCn 
(D), or EDCn-HGF (E) microthread implants.  All defect sites are indicated by the black dotted line, and are 
surrounded by healthy muscle tissue.  Black arrows indicate muscle growth, blue arrows indicate connective tissue 
and collagen, white arrows indicate adipose tissue, and asterisks indicate microthreads within the defect.  Varying 
amounts of muscle ingrowth are evident between treatment groups, with a large amount of adipocyte infiltration 
visible in fibrin gel implants.  Inset shows tissue orientation and region of analysis with respect to distal and 
proximal ends of the injury site.  Scale = 500 µm.
 
 
Chapter 6
Hepatocyte Growth Factor Adsorbed onto EDC Crosslinked Microthreads Restores 
Mechanical Function in Mouse Model of VML
119 
 
 
Figure 6.7. Morphology of the distal end of VML defect sites 14 days post-injury. Masson’s trichrome images 
of the coronal plane of VML defects with untreated controls (A-B), fibrin gel implants (C-D), or UNX (E-F), EDCn 
(G-H), or EDCn-HGF (I-J) microthread implants at low (A,C,E,G,I) and high (B,D,F,H,J) magnification.  All defect 
sites are indicated by the black dotted line, and are surrounded by healthy muscle tissue.  Black arrows indicate 
muscle growth, blue arrows indicate connective tissue and collagen, white arrows indicate adipose tissue, and 
asterisks indicate microthreads within the defect.  Inset shows tissue orientation and region of analysis with respect 
to distal and proximal ends of the injury site.  Scale = 200 µm (A,C,E,G,I) and 50 µm (B,D,F,H,J). 
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6.3.3 Sixty Days Post-Injury, EDCn-HGF Microthreads Support Robust Regeneration of 
Muscular Tissue 
A previous study suggested that scar tissue contributed to functional muscle recovery 
after the sixty day post-injury time point;19 therefore, to determine the amount of skeletal muscle 
regeneration due to fibrin microthreads, we analyzed the amount of tissue regeneration that 
occurred 60 days post-injury.  While additional remodeling may occur over the next several 
months, we assumed that the majority of functional regeneration had occurred by this time point.  
There was a marked reduction in the number of mononuclear cells within the injury site 60 days 
post-injury, suggesting that the remodeling phase of skeletal muscle regeneration was complete 
(Figure 6.8).  Remodeling without an implant resulted in disorganized myofibers that were 
surrounded by scar tissue (Figure 6.8A); while fibrin gel implants were completely remodeled 
into adipose tissue (Figure 6.8B).  UNX microthread implants were mostly degraded at this time, 
although some small pieces of microthreads were observed.  These microthreads were remodeled 
into a combination of adipose tissue, dense scar tissue, and somewhat organized myofibers 
(Figure 6.8C).  EDCn microthreads persisted through 60 days post-injury (asterisks) with 
minimal adipose infiltration (Figure 6.8 D-E).  Myofibers were observed in direct contact with 
microthreads, and this new tissue seems to be organized in plane with the surrounding healthy 
tissue (Figure 6.8E).  Interestingly, the central regions of EDCn microthread implants appear to 
largely remain acellular at this time (Figure 6.8D). 
The distal end of the muscle defect revealed that at least some muscle tissue ingrowth 
occurred into each defect site (Figure 6.9).  Collagen tissue surrounded most of the regenerated 
myofibers present in the untreated control group (Figure 6.9 A-B).  While both fibrin gel and 
UNX microthread implants supported extensive adipocyte infiltration (Figure 6.9 C-F), UNX 
microthreads also facilitated muscle tissue ingrowth, with small myofibers visible within the 
fatty tissue (Figure 6.9 E-F); however, these myofibers were not aligned with the surrounding 
healthy tissue.  In contrast, myofibers completely surrounded several EDCn-HGF microthreads 
aligned with the surrounding tissue, showing a remarkable amount of tissue ingrowth (Figure 6.9 
I-J). 
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Figure 6.8 Low magnification images of entire VML defect sites 60 days post-injury.  Masson’s trichrome 
images of the coronal plane of VML defects with untreated controls (A), fibrin gel implants (B), or UNX (C), EDCn 
(D), or EDCn-HGF (E) microthread implants.  All defect sites are indicated by the black dotted line, and are 
surrounded by healthy muscle tissue.  Black arrows indicate muscle growth, blue arrows indicate connective tissue 
and collagen, white arrows indicate adipose tissue, and asterisks indicate microthreads within the defect.  Fibrin gel 
implants were replaced with adipocytes, and UNX microthread implants were remodeled with adipoctytes and 
collagen.  Crosslinked microthreads persist at this time point with little cell infiltration, however it is apparent that 
much of the defect site was remodeled into muscle tissue.  Inset shows tissue orientation and region of analysis with 
respect to distal and proximal ends of the injury site.  Scale = 500 µm.
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Figure 6.9. Morphology of the distal end of VML defect sites 60 days post-injury. Masson’s trichrome images 
of the coronal plane of VML defects with untreated controls (A-B), fibrin gel implants (C-D), or UNX (E-F), EDCn 
(G-H), or EDCn-HGF (I-J) microthread implants at low (A,C,E,G,I) and high (B,D,F,H,J) magnification.  All defect 
sites are indicated by the black dotted line, and are surrounded by healthy muscle tissue.  Black arrows indicate 
muscle growth, blue arrows indicate connective tissue and collagen, white arrows indicate adipose tissue, and 
asterisks indicate microthreads within the defect.  Inset shows tissue orientation and region of analysis with respect 
to distal and proximal ends of the injury site.  Scale = 200 µm (A,C,E,G,I) and 50 µm (B,D,F,H,J). 
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6.3.4 Microthread Implants Reduce the Size of the Defect Site, but do not Affect Collagen 
Deposition 
To quantify the observation that the defect size appeared smaller 60 days post-injury than 
14 days post-injury, the length and width of defects were measured using coronal sections 
(Figure 6.3).  The length and width of defects from untreated control and fibrin gel implant 
groups were qualitatively smaller than their 
respective measurements from microthread 
implant groups (UNX, EDCn, and EDCn-HGF 
microthreads) at 14 days post-injury; however, 
all of the measurements were similar at 60 days 
post-injury.  Both the length and width of 
defects with microthread implants significantly 
decreased from 14 to 60 days post-injury (Table 
6.2).  Measurements taken 60 days post-injury 
were normalized against the measurements 
taken 14 days post-injury to obtain percent 
decreases in each of these dimensions over 
time.  Interestingly, the percent of defect length 
from 14 days post-injury for each microthread 
implant group was significantly lower than the 
percent change for fibrin gel implants (Figure 6.10).  Similarly, the percent of defect width 
remaining from 14 days post-injury for each microthread group was significantly lower than the 
percent change for both the untreated control and fibrin gel implant groups.  These data suggest 
that microthread implant groups are facilitating an increase in tissue remodeling. 
 
Table 6.2. Length and width of VML defects 14 and 60 days post-injury.
* indicate significance with 14 day post-injury measurements as determined by Student’s t-test (p < 0.05). 
 
Figure 6.10. Change in muscle defect length and 
width from 14 to 60 days post-injury.  Microthread 
implants decrease defect size, suggesting that the 
muscle may be remodeling the defect site into 
functional tissue. * indicate significance with 
indicated groups as determined by one-way ANOVA 
with Holm-Sidak post hoc analysis (p < 0.05, n=6). 
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To determine the amount of scarring, a typical 
consequence of VML injuries, we used Photoshop to 
isolate all the blue pixels in low magnification composite 
images of the defect sites at 60 days post-injury (Figure 
6.4).  The number of pixels that were blue in the injury 
site were measured, and the total percent of the defect site 
that was comprised of these blue pixels was recorded.  
There was a qualitative increase in the percent of collagen 
tissue present in the defect site; however, there was no 
statistical significance between these measurements 
(Figure 6.11). 
 
6.3.5 Crosslinked Microthreads Enhance Recruitment of Satellite Cells 
To determine the amount of SCs in the area surrounding the VML defect, sections of 
VML defects were stained by IHC with an antibody recognizing Pax7 at 14 and 60 days post-
injury.  Positive nuclei were detected in all treatment groups 14 days post-injury, indicating that 
in all injuries SCs were being recruited to the injury site (Figure 6.12).  Few SCs were observed 
within the injury sites of untreated control groups (Figure 6.12A) or fibrin gel implants (Figure 
6.12B).  SCs were observed to be in close proximity to microthread implants (Figure 6.12 C-E), 
and in all cases seemed to be located near newly forming myofibers.  Sixty days post-injury, 
there were fewer SCs present in the defect site of all treatment groups (Figure 6.13).  SCs were 
situated on the periphery of myofibers that were located near remaining EDCn and EDCn-HGF 
microthreads (Figure 6.13 D-E).  Both EDCn and EDCn-HGF microthread implants recruited 
significantly more SCs than would typically be present in uninjured tissue, however, only EDCn 
microthread implants recruited significantly more SCs than untreated control and fibrin gel 
implant groups 14 days post-injury (Figure 6.14).  While there was a significant reduction in the 
number of SCs present 60 days post-injury with respect to 14 days post-injury, there were no 
significant differences between treatment groups or uninjured controls, suggesting that no 
additional SC recruitment is occurring at this time, implying that SC-mediated regeneration is 
complete. 
Figure 6.11. Percent collagen content 
within VML defect sites 60 days post-
injury. No significant differences 
detected by one-way ANOVA with 
Holm-Sidak post hoc analysis (p < 0.05, 
n=6). 
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Figure 6.12. IHC staining of Pax7 positive cells in VML defects 14 days post-injury. IHC staining for Pax7 with 
a hemotoxylin counterstain of VML defects with untreated controls (A), fibrin gel implants (B), or UNX (C), EDCn 
(D), or EDCn-HGF (E) microthreads, or un-injured muscle (F).  SCs (Pax7 positive) were recruited towards the 
injury site, and appear in close proximity to microthreads.  Asterisks indicate microthreads and black arrowheads 
denote representative Pax7 positive nuclei.  Inset shows tissue orientation and region of analysis with respect to 
distal and proximal ends of the injury site.  Scale = 50 µm. 
Figure 6.13. IHC staining of Pax7 positive cells in VML defects 60 days post-injury. IHC staining for Pax7 with 
a hemotoxylin counterstain of VML defects with untreated controls (A), fibrin gel implants (B), or UNX (C), EDCn 
(D), or EDCn-HGF (E) microthreads, or un-injured muscle (F).  SCs (Pax7 positive) were recruited towards the 
injury site, and appear in close proximity to microthreads.  Asterisks indicate microthreads and black arrowheads 
denote representative Pax7 positive nuclei.  Inset shows tissue orientation and region of analysis with respect to 
distal and proximal ends of the injury site.  Scale = 50 µm. 
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Figure 6.14. Number of Pax7 
positive cells in VML defects.  There 
were significantly more Pax7 positive 
SCs in crosslinked (EDCn and EDCn-
HGF) implant groups than un-injured 
controls, however only EDCn 
microthread implants had elevated 
numbers of SCs present compared to 
the untreated control group.  * and 
brackets indicate significant 
differences between indicated groups 
as determined by one-way ANOVA 
with Holm-Sidak post hoc analysis, † 
denote significance with D14 values 
as determined by Student’s t-test
(p < 0.05, n=3 for D14, n=6 for D60). 
 
6.3.6 HGF Delivery Promotes Increased Number of Myogenin Positive Nuclei 
To determine the amount of nascent myofibers forming within the VML defect, sections 
of VML defects were stained by IHC with an antibody recognizing myogenin at 14 and 60 days 
post-injury.  Myogenin is a transcription factor that promotes myoblast fusion to become 
immature myofibers, and thus is considered a differentiation marker for myoblasts.  Myogenin 
positive nuclei were found in all implant groups 14 days post-injury, however, the number of 
multinucleated myofibers increased with the presence of microthread implants (Figure 6.15).  
Myofibers were located immediately adjacent to several crosslinked microthreads, indicating that 
these scaffold materials successfully guided myoblast ingrowth into defect sites (Figure 6.15 D-
E).  Further, the myofibers adjacent to crosslinked microthreads appeared to have more nuclei 
present per multinucleated cell, suggesting an increase in the maturity of these nascent fibers.  As 
expected, no positive nuclei were observed in uninjured controls (Figure 6.15F).  Sixty days 
post-injury, there were almost no myogenin positive nuclei in any treatment group (Figure 6.16).  
All microthread implants supported significantly more myogenin positive nuclei than would 
typically be present in uninjured tissue 14 days post-injury, and EDCn-HGF microthreads 
supported significantly more myogenin positive nuclei than the untreated controls (Figure 6.17).  
The number of myogenin positive nuclei in fibrin gel implants and UNX, EDCn, and EDCn-
HGF microthread implant groups 60 days post-injury significantly decreased with respect to 14 
days post-injury (Figure 6.17).  In fact, little to no myogenin positive nuclei were identified 60 
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days post-injury for any treatment group, suggesting that myoblasts were no longer fusing into 
myotubes at this time and that the differentiation phase of skeletal muscle regeneration had 
resolved at this time. 
 
 
 
 
 
 
 
 
 
 
Figure 6.15. IHC staining of myogenin positive nuclei in VML defects 14 days post-injury. IHC staining for 
myogenin with a hemotoxylin counterstain of VML defects with untreated controls (A), fibrin gel implants (B), or 
UNX (C), EDCn (D), or EDCn-HGF (E) microthreads, or un-injured muscle (F).  Myoblasts were observed to be 
fusing around and between microthreads within the defect site.  Asterisks indicate microthreads and black 
arrowheads denote representative myogenin positive nuclei.  Inset shows tissue orientation and region of analysis 
with respect to distal and proximal ends of the injury site.  Scale = 50 µm. 
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Figure 6.16. IHC staining of myogenin positive nuclei in VML defects 60 days post-injury. IHC staining for 
myogenin with a hemotoxylin counterstain of VML defects with untreated controls (A), fibrin gel implants (B), or 
UNX (C), EDCn (D), or EDCn-HGF (E) microthreads, or un-injured muscle (F).  Myoblasts were observed to be 
fusing around and between microthreads within the defect site.  Asterisks indicate microthreads and black 
arrowheads denote representative myogenin positive nuclei.  Inset shows tissue orientation and region of analysis 
with respect to distal and proximal ends of the injury site.  Scale = 50 µm. 
 
 
 
Figure 6.17. Number of myogenin 
positive nuclei in VML defects.  
There were significantly more 
myogenin positive nuclei in UNX, 
EDCn, and EDCn-HGF microthread 
implant groups compared to un-
injured controls, and EDCn-HGF 
microthreads supported significantly 
more myogenin positive nuclei than 
the untreated control group.  * and 
brackets indicate significant 
differences between indicated groups 
as determined by one-way ANOVA 
with Holm-Sidak post hoc analysis, † 
denote significance with D14 values 
as determined by Student’s t-test
(p < 0.05, n=3 for D14, n=6 for D60). 
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6.3.7 Microthread Implant Groups Support Early Angiogenesis in VML Defects 
To determine the number of blood vessels that infiltrated into the VML defect site over 
time, sections of VML defects were stained by IHC with an antibody recognizing PECAM 
(CD31).  PECAM is a protein found on the surface of endothelial cells, and thus can be used to 
locate blood vessels within a defect site.  Blood vessels were located in all defect sites 14 days 
post-injury (Figure 6.18), although there were few observed in the connective tissue within the 
injury site in the untreated controls (Figure 6.18A).  Blood vessels surrounded the adipocytes that 
had infiltrated the fibrin gel implants (Figure 6.18B), and were adjacent to microthread implants 
in the injury site (Figure 6.18 C-E).  Sixty days post-injury, there were fewer blood vessels 
present than 14 days post-injury in the defect site (Figure 6.19).  The connective tissue present in 
untreated controls was largely avascular (Figure 6.19A), in contrast with the dense capillary 
network visible within adipose tissue present in fibrin gel and UNX microthread implant groups 
(Figure 6.19 B-C).  Blood vessels continued to be adjacent to EDCn and EDCn-HGF 
microthread implant groups (Figure 6.19 D-E).  Significantly more blood vessels formed in 
microthread implant injury sites than the untreated and uninjured skeletal muscle tissue controls 
14 days post-injury.  The fibrin gel implant group had significantly higher numbers of blood 
vessels in the injury site than uninjured controls as well (Figure 6.20).  All microthread implants 
had significantly fewer blood vessels present in the defect site at 60 days post-injury with respect 
to 14 days post injury (Figure 6.20).  There remained an elevated number of blood vessels within 
the wound sites of fibrin gel, UNX and EDCn-HGF microthread implant treatments with respect 
to the untreated and uninjured control groups (Figure 6.20). 
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Figure 6.18. IHC staining of PECAM in VML defects 14 days post-injury. IHC staining for PECAM with a 
hemotoxylin counterstain of VML defects with untreated controls (A), fibrin gel implants (B), or UNX (C), EDCn 
(D), or EDCn-HGF (E) microthreads, or un-injured muscle (F).  PECAM (CD31) is a marker of endothelial cells, 
revealing blood vessel formation with the defect site.  Blood vessels were found to form in close proximity with 
microthreads, and between adipocytes.  Asterisks indicate microthreads and black arrowheads denote representative 
blood vessels.  Inset shows tissue orientation and region of analysis with respect to distal and proximal ends of the 
injury site.  Scale = 50 µm. 
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Figure 6.19. IHC staining of PECAM in VML defects 60 days post-injury. IHC staining for PECAM with a 
hemotoxylin counterstain of VML defects with untreated controls (A), fibrin gel implants (B), or UNX (C), EDCn 
(D), or EDCn-HGF (E) microthreads, or un-injured muscle (F).  PECAM (CD31) is a marker of endothelial cells, 
revealing blood vessel formation with the defect site.  Blood vessels were found to form in close proximity with 
microthreads, and between adipocytes.  Asterisks indicate microthreads and black arrowheads denote representative 
blood vessels.  Inset shows tissue orientation and region of analysis with respect to distal and proximal ends of the 
injury site.  Scale = 50 µm. 
 
 
 
Figure 6.20. Number of blood vessels in 
VML defects.  There were significantly 
more blood vessels in VML defects that 
received microthread implant groups after 
14 days of recovery compared to untreated  
and uninjured controls.  A significantly 
larger number of blood vessels remained in 
the fibrin gel, UNX, and EDCn-HGF 
implant groups 60 days post-injury 
compared to the untreated and uninjured 
controls.  * indicate significant differences 
with untreated controls, ‡ indicate 
significance with no injury values, and 
brackets indicate significant differences 
between indicated groups as determined by 
one-way ANOVA with Holm-Sidak post 
hoc analysis, † denote significance with 
D14 values as determined by Student’s t-
test (p < 0.05, n=3 for D14, n=6 for D60). 
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6.3.8 EDCn-HGF Microthreads Restore Mechanical Function of TA Muscles after VML  
Injuries 
To quantify the amount of functional recovery in mice that received VML defects, each 
injury was created such that there was approximately a 50% reduction in isometric twitch force 
from pre-injured, baseline values (Figure 6.21A).  After the creation of each injury, each animal 
received one of five treatments and was allowed to recover for 60 days.  At this time, the 
isometric twitch force was measured again to obtain recovered values.  The recovery isometric 
twitch force was significantly greater than that of the twitch force generated immediately after 
injury for animals that received microthread implants (Figure 6.21A).  The recovery forces 
resulting from fibrin gel or UNX microthread implants were still significantly lower than their 
original baseline values.  Further, the recovered twitch force from EDCn-HGF microthread 
implants was significantly stronger than untreated control or fibrin gel implant groups, and the 
absolute value of this force is similar to the baseline twitch force recorded before the injury.  To 
account for possible variations in injured force measurements between animals, the recovered 
force of each animal was normalized to its own after injury measurement.  This shows a percent 
Figure 6.21. Isometric twitch force of TA muscles 60 days post-injury.  The isometric twitch force of TA 
muscles before injury, immediately after injury, and 60 days post-injury (recovered) (A).  EDCn-HGF microthread 
implants significantly increased the amount of force recovered compared to the untreated control and fibrin gel 
implant groups.  To account for variation in the amount of regeneration between animals, the isometric twitch force 
was normalized to its individual after injury value (B).  * indicate significance with recovered twitch forces, † 
indicate significance with baseline twitch forces, and brackets indicate significance with indicated groups as 
determined by one-way ANOVA with Holm-Sidak post hoc analysis (p < 0.05, n=6). 
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recovery based upon the injured values, where any ratio above 1 (100%) would indicate an 
increase in the amount of force based on the injury of each specific mouse.  There was an 
approximate 150% increase in the twitch force production from injured values for UNX and 
EDCn microthread implant treatments, and there was an increase of over 200% in the twitch 
force production of animals that received EDCn-HGF microthread implants (Figure 6.21B). 
To quantify the total strength of the muscle tissue before, after injury, and after recovery, 
the force produced at tetanus was also recorded.  Tetanus was induced after a short period of rest 
after the isometric twitch forces were recorded.  Force at tetanus values immediately after injury 
for EDCn-HGF microthread implants were qualitatively lower than all other treatment groups 
(Figure 6.22A).  There was a significant improvement in the force at tetanus 60 days post-injury 
for all treatment groups except for the untreated controls, and the recovered force at tetanus for 
fibrin gel implants was still significantly lower than its baseline value.  Force outputs for EDCn-
HGF and EDCn microthread implants were qualitatively higher than all other treatment groups, 
and the absolute value of the tetanic force output from EDCn-HGF microthread implants was 
similar to the baseline force at tetanus initially recorded (Figure 6.22A).  When the recovered 
Figure 6.22. Force at tetanic contraction of TA muscles 60 days post-injury.  The force at tetanus of TA muscles 
before injury, immediately after injury, and 60 days post-injury (recovered) (A).  To account for variation in the 
amount of regeneration between animals, the force at tetanus was normalized to its individual after injury value (B).
* indicate significance with recovered tetanic contractions, † indicate significance with baseline tetanic contractions, 
and brackets indicate significance with indicated groups as determined by one-way ANOVA with Holm-Sidak post 
hoc analysis (p < 0.05, n=6). 
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force of each animal was normalized to its own after injury measurement, there was an 
approximate 150% increase in the force production from injured values for animals that received 
UNX or EDCn microthread implants, while there was again an increase of over 200% in the 
force production of animals that received EDCn-HGF microthread implants (Figure 6.22B).  A 
summary of the results from all of the force measurements is presented in Table 6.3. 
 
 
 
 
 
 
Table 6.3. Summary of the functional characteristics of TA muscles before and immediately after the 
generation of a VML defect, and 60 days post-injury.
* indicate significance with recovered forces (60 days post-injury), † indicate significance with baseline forces, a 
indicate significance with EDCn-HGF microthread implants, and b indicate significance with EDCn microthread 
implants as determined by one-way ANOVA with Holm-Sidak post hoc analysis (p<0.05). 
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6.4 DISCUSSION 
The goal of the present study was to investigate the ability of EDCn-HGF microthreads to 
enhance functional regeneration in a mouse model of VML.  VML injuries typically result from 
traumatic incidents, often requiring immediate surgical intervention to stabilize patients.  
Acellular scaffold materials are ideal for these applications, because little to no preparation is 
required for implantation, while cell based skeletal muscle units can take several weeks to 
months to prepare, which does not fit the time table for immediate surgical intervention.29,30  
However, previously characterized acellular scaffolds, such as decellularized ECM and gelatin 
gels, have not been shown to stimulate functional improvement of VML injuries.23,31,32  This 
could be due to the preparation of decellularized ECM materials, as the reagents used in the 
decellularization process can dramatically affect the activity of proteins or growth factors in the 
final product.33  Our approach to the design and fabrication of scaffolding materials is a “bottom-
up” approach, where materials are systematically added to a scaffold to instigate certain cell 
functions.  Here, we adsorbed HGF because of its ability to activate and recruit SCs to localize to 
an injury site in small muscle injuries to the surface of EDCn microthreads to encourage SC 
recruitment to the defect site.  Our results indicate that the combination of an EDC crosslinked 
microthread with rapid delivery of HGF to the injury site will direct significant tissue 
regeneration, and functional recovery of TA muscle defects. 
All microthread implant groups increased the force production of the TA muscle by at 
least 150% from force measurements made immediately after injury.  EDCn and EDCn-HGF 
microthread implants were the only treatment groups that consistently supported enough 
functional remodeling to produce forces comparable to baseline values measured before the 
induction of the VML injury.  Further, EDCn-HGF microthreads increased the force production 
of TA muscles 200% from measurements taken immediately after injury.  These significant 
findings support our hypothesis that HGF delivery to VML injury sites will enhance the 
functional recovery of VML injuries, by promoting significant functional recovery within 2 
months post-injury.  Our findings are inconsistent with the results of studies conducted with 
scaffold materials that were unable to produce any functional recovery within this time 
scale.18,23,31,34,35  Other studies indicate that acellular decellularized ECM materials promote 
functional recovery approximately 6 months post-injury, although it is not clear if this delay in 
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functional recovery was due to the creation of an injury site two- to three-fold larger than the one 
presented in this study due to the use of larger muscles.19,21,22,36  However, injuries of similar size 
as the one presented in this study also did not report significant functional recovery within 2 
months post-injury.18,31  We attribute the successful functional regeneration of muscle tissue to 
the synergistic effects of the morphologic structure of our scaffolds, as well as the rapid delivery 
of HGF to the injury site. 
One of the most critical functions of scaffolds in skeletal muscle regeneration is that they 
must direct myoblast differentiation in the same plane as the adjacent healthy skeletal muscle 
tissue.  Fibrin microthreads have been shown to direct cell alignment along the length of the 
fibers,26 and we showed in Chapter 5 that myoblasts will grow along their lengths over time.  In 
Chapter 3, we hypothesized that microthreads with increased resistance to proteolytic 
degradation would enhance skeletal muscle regeneration observed in initial studies using fibrin 
microthreads in a mouse VML model.27  Here, we report that these microthreads persist through 
60 days post-injury and have a tremendously positive role in guiding skeletal muscle 
regeneration.  Remarkably, myofibers were observed in direct contact with EDCn and EDCn-
HGF microthreads, even completely surrounding EDCn-HGF microthreads, supporting our 
hypothesis that microthreads with increased resistance to proteolytic degradation would enhance 
skeletal muscle tissue regeneration.28  However, it was unexpected to observe EDCn 
microthreads 60 days post-injury.  While it was the initial aim of this project to have all 
scaffolding materials degrade before this time point, it remains unknown how long these 
materials will persist in vivo.  Future studies will elucidate the degradation time of EDCn 
microthreads in skeletal muscle and define the results of long-term remodeling due to these 
materials, as others have indicated that long-term remodeling may be advantageous for the 
recovery of VML injuries.21 
The delivery of HGF had a remarkable effect on the functional regeneration of mouse TA 
muscles.  In native tissue, HGF is released from the ECM of muscle injuries to recruit and 
activate SCs, which proliferate within the injury site and eventually differentiate into myofibers, 
regenerating the injured tissue.  Surprisingly, we observed the most SCs (Pax7 positive) in injury 
sites with EDCn microthreads, not EDCn-HGF microthreads, 14 days post-injury.  In a rat TA 
model of VML, HGF-loaded gelatin scaffolds did not increase the number of SCs present in the 
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wound site; however, an increase in the number of regenerating muscle fibers was observed.32  
These observations are consistent with our results, as we identified significantly more myogenin 
positive nuclei in the injury site of EDCn-HGF microthread implants than untreated or uninjured 
controls.  Further, these nascent myofibers were in direct contact with EDCn and EDCn-HGF 
microthreads, validating much of our in vitro data in Chapters 3 and 5 that EDCn microthreads 
support robust myoblast attachment,28 and that myoblasts will grow onto the surface of EDCn 
microthreads.  These results suggest that the HGF-mediated recruitment in EDCn-HGF implants 
occurred earlier than 14 days post-injury, which fits with the HGF release profile from EDCn 
microthreads described in Chapter 5.  We hypothesize that an earlier increase in the amount of 
SCs present in the injury site of EDCn-HGF microthread implants would facilitate a subsequent 
increase in the number of differentiating myoblasts, which would explain why there are more 
myogenin positive nuclei present near these implants than any other treatment group.  Future 
studies will analyze earlier time points to fully understand how the release of HGF is enhancing 
SC recruitment and directing myoblast differentiation. 
Interestingly, there was a lack of robust scarring in untreated VML injuries.  Even still, 
there was scar tissue present between newly formed myofibers 60 days post-injury, which 
suggests that fibrosis is occurring, albeit at a smaller scale.  Instead, we report a distinct loss of 
muscle volume from observations on the gross morphology of the shape of the TA muscle.  This 
loss of volume is typical of VML injuries, and has been seen in clinical cases of VML, validating 
our animal model and wound size.37-39  Interestingly, while all of the injury sites were of the 
same size, only untreated control and fibrin gel implant groups resulted in this loss of volume.  
This implies that the microthreads were able to stabilize the injury site and serve as a space 
filling material to prevent the loss of muscle volume.  It is unclear from our study whether this 
loss of volume was permanent.  Recent human clinical trials treating VML defects with 
decellularized ECM suggest that the tissue loss may not be permanent, and might be recoverable 
with proper stimuli from biomaterials.37  Future studies will assess the ability of EDCn-HGF 
loaded microthreads to restore muscle volume and function in existing VML injuries and will 
examine the volume and weight of each TA muscle. 
Additional evidence of microthread implants preserving the size of the VML injury was 
evident with measurements of the defect size 14 days post-injury.  The length and width of 
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defects with microthread implants were twice the size of their respective length and width 
measurements in untreated control and fibrin gel implant groups.  This suggests that a decrease 
in muscle volume can occur in as little time as 14 days post-injury.  In addition to the retention of 
the initial defect size, microthread implants supported a higher density of infiltrating myoblasts.  
Where noted, this infiltration appeared to be aligned with the longitudinal axis of the 
microthreads.  Microthread implant groups were the only groups that showed a reduction in the 
defect size 60 days post-injury.  Combined with the IHC and functional data, the reduction in 
wound size 60 days post-injury suggests that new tissue replaced the microthreads in parts of the 
defect site.  Although it appears that much of the defect site in UNX microthread implants 
remodeled to adipose tissue, EDCn and EDCn-HGF microthread implants encouraged the 
growth of new muscle tissue.  While the persistence of EDCn microthreads will be the subject of 
future studies, it is clear that these implants, especially EDCn-HGF microthreads, encouraged the 
formation of functional muscle tissue. 
Another unexpected finding in this study was that UNX microthread and fibrin gel 
implants invoked a robust infiltration of adipocytes.  This response is characteristic of a clinical 
pathology known as fatty degeneration, and has been observed in a variety of muscle wounds 
including rotator cuff tears.40-42  Adipocyte infiltration has been observed in several other models 
of VML, showing that the environment presented by acellular scaffolds might encourage this 
pathological condition.21,22,43  While the origin of the adipocytes remains in question, some 
reports suggest they might arise from a population of pericytes, progenitor cells residing in 
skeletal muscle that are found in close proximity to blood vessels.40,44  Mesenchymal progenitors 
expressing platelet derived growth factor receptor α (PDGFRα) were also found to contribute to 
adipose formation in skeletal muscle; however the environment of healthy skeletal muscle tissue 
was able to reverse this adipogenesis.45  An intriguing point is that 14 days post-injury, 
adipocytes were only found within the structure of the fibrin gel and UNX microthreads.  This 
suggests that the unique biochemical and mechanical environment within the uncrosslinked 
fibrin may be facilitated the recruitment of adipocytes.  While this might seem to suggest that 
recruited SCs would be transdifferentiating into adipocytes on UNX microthreads, recent studies 
demonstrate that SCs are committed to the myogenic lineage and do not spontaneously 
transdifferentiate.46  Rather, it seems more likely that the mechanical and biochemical 
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environment within these fibrin matrices is somehow preventing infiltrating mesenchymal 
progenitor cells from receiving myogenic signals expressed at the margins of the injury site, thus 
ultimately supporting adipogenesis.44  EDCn microthreads are twice as stiff as UNX 
microthreads, and are as stiff as contracting muscle.47  It is possible that in this model of VML, 
fatty infiltration is mediated by a stiffness mismatch between the implanted material and skeletal 
muscle tissue; however, the mechanisms behind the cause and development of fatty infiltration 
or fatty degeneration are not known at this time.  Future studies involving UNX microthread and 
fibrin gel implants may be able to reproducibly create a model for fatty infiltration or fatty 
degeneration in muscle tissue to answer these mechanistic questions. 
 
6.5 CONCLUSIONS 
In this chapter, we implanted HGF-loaded EDCn microthreads to improve the functional 
regeneration of a VML injury.  EDCn-HGF microthread implants supported significant 
functional regeneration of the TA muscle that approached baseline values.  All crosslinked 
microthreads persisted 60 days post-injury, and facilitated organized regeneration of myofibers 
as early as 14 days post-injury.  EDCn-HGF microthreads supported significantly more 
myogenin positive nuclei than the untreated and uninjured controls 14 days post-injury, 
suggesting that an increased number of SCs were present before this time point to differentiate 
into nascent myotubes.  Sixty days post-injury, the number of Pax7 positive cells and myogenin 
positive nuclei returned to the numbers present in the uninjured group, suggesting that much of 
the injury site had resolved at this time.  Taken together, these data suggest that EDCn-HGF 
microthreads recapitulate some of the regenerative cues lost in VML injuries and are capable of 
restoring the mechanical function of the TA muscle in a mouse model. 
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7.1 OVERVIEW 
The work in this thesis describes the development of a biomaterial scaffold that 
recapitulates regenerative cues found in the endogenous skeletal muscle regeneration pathway.  
The structural properties of fibrin microthreads were modulated with and without exogenous 
crosslinking agents, generating materials with tunable mechanical and structural properties.  
These properties were optimized for skeletal muscle regeneration, which requires scaffolds to 
persist at least 2-4 weeks to guide organized, functional regeneration.  We developed loading 
strategies for hepatocyte growth factor (HGF) to ultimately guide regeneration of volumetric 
muscle loss (VML) injuries by recapitulating regenerative cues lost in the creation of VML 
injuries.  Finally, these tailored microthreads were implanted into a mouse model of VML and it 
was determined that the addition of HGF to chemically crosslinked microthreads directed 
organized tissue regeneration that restored the functional capacity of the injured muscle. 
 
7.2 RESULTS AND CONCLUSIONS 
7.2.1 Specific Aim 1: Develop Microthreads with Tunable Structural Properties While 
Maintaining Cellular Viability 
Based upon early implantation studies, we hypothesized that fibrin microthreads with an 
increased resistance to proteolytic degradation would increase the regenerative response of 
muscle tissue after VML injuries.1  We decided to use two different methods to alter the 
structural properties of microthreads, chemical crosslinking and post-polymerization processing 
procedures, to develop alternative technologies designed to increase the strength and resistance 
to proteolytic degradation of fibrin microthread scaffolds.  For chemical crosslinking, we 
employed carbodiimide chemistry to crosslink microthreads with 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide (EDC).  EDC was selected because it is a commonly used 
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crosslinking agent, and has also been repeatedly used as a conjugation agent to tether a variety of 
bioactive molecules to protein surfaces.2-5  To determine ideal conditions for fibrin microthread 
crosslinking, we assessed the structural and mechanical properties of microthreads after 
increasing durations of incubation with EDC and we varied the pH of the buffer environment.  
The optimal pH for EDC crosslinking has been determined to be acidic (pH ~5).6  In the course 
of this experiment, we observed that incubation in acidic buffer for prolonged time periods 
degraded fibrin microthreads, and so we also crosslinked in a neutral pH environment to both 
control the efficiency of the carbodiimide reaction chemistry as well as provide a stable 
environment for our scaffold material.  In performing this optimization, we discovered that 
changing the buffer pH facilitated the differential crosslinking of fibrin materials.  Microthreads 
crosslinked in acidic conditions (EDCa microthreads) were twice as strong as microthreads 
crosslinked in neutral conditions (EDCn microthreads), which were twice as strong as 
uncrosslinked (UNX) microthreads. 
For post-polymerization enhancement of fibrin microthread mechanical and structural 
properties without the use of exogenous crosslinking agents, we took advantage of several 
unique properties of fibrin fibrils.  Fibrin is a remarkable protein that is capable of stretching 
200-300% of its original length,7 and has an affinity to a large number of growth factors and 
proteins.8  We investigated the effects of static axial stretching on fibrin microthreads and 
determined that there were three stretching regimes that generated tunable mechanical properties: 
low stretch microthreads, stretched 0-75% of their original length; moderate stretch 
microthreads, stretched 100-125% of their original length; and high stretch microthreads, 
stretched 150-200% of their original length.  With increasing amounts of static axial stretch, 
fibrin microthreads increased their strength and stiffness similar to EDC crosslinking, such that 
moderate stretch microthreads had the same ultimate tensile strength (UTS) as EDCn 
microthreads, and high stretch microthreads had the same UTS as EDCa microthreads.  Our 
results are consistent with previous observations with collagen microthreads and fibrin gels, 
where UTS and stiffness values increased with static axial stretching.9,10 
After identifying that both of our proposed methods increased the UTS and stiffness of 
fibrin microthreads, we correlated these increases in mechanical strength to resistance to 
proteolytic degradation.  EDC crosslinking significantly increased the resistance to proteolytic 
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degradation: where UNX microthreads degraded within 2 hours, EDCn microthreads degraded in 
24-48 hours, and EDCa microthreads did not degrade within the course of the 7 day experiment.  
Surprisingly, static axial stretching did not alter the degradation rate of fibrin microthreads, 
despite previous studies suggesting that stretching blocked access of proteases to their target sites 
in fibrin.11  Our degradation assay utilized plasmin concentrations that were higher than those 
present in the wound site and served as a rough approximation of in vivo degradation.  Through 
the use of this rapid, high throughput assay, we determined that EDCn microthreads would be an 
appropriate material for skeletal muscle regeneration, and that static axially stretched 
microthreads would be better suited for tissue engineering applications that required high tensile 
strength with relatively short persistence times in vivo. 
To confirm that neither of our methodologies negatively impacted the cellular 
compatibility of our scaffolds, we seeded C2C12 myoblasts onto fibrin microthreads and 
observed the cell attachment and alignment on these materials.  We observed a significant 
increase in the number of myoblasts that attached to EDCa microthreads, which we hypothesize 
could be explained by stiffness-mediated presentation and organization of integrin binding sites 
or the development of focal adhesion complexes.12  While there were no significant differences, 
we qualitatively observed higher cell densities on crosslinked microthreads than UNX 
microthreads, suggesting that myoblast proliferation might have been increased by the stiffness 
of the crosslinked microthreads.  This was confirmed in Chapter 5 (Specific Aim 2), where 
significantly more proliferative, Ki67 positive myoblasts on EDCn and EDCa microthreads than 
UNX microthreads.  Static axial stretching did not appear to affect cell attachment; however, 
high stretch microthreads increased the cell alignment on the scaffold twofold.  These results 
suggest that the fibrin fibrils on the surface of static axially stretched microthreads might be 
aligning, which is critical for aligning cell populations on the surfaces of biomaterials.13 
In conclusion of Specific Aim 1: Develop Microthreads with Tunable Structural 
Properties While Maintaining Cellular Viability of this thesis, we determined that EDC 
crosslinking can be modulated by altering the pH environment of the reaction chemistry.  This 
generates microthreads with discrete mechanical properties and distinct degradation profiles, 
without impacting cell viability.  Further, there is evidence that EDCn and EDCa microthreads 
stimulate myoblast proliferation.  Additionally, we showed that static axial stretching generates 
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tunable mechanical properties without changing the proteolytic degradation rate of fibrin 
microthreads.  These stretched microthreads guide cell alignment along the longitudinal axis of 
the microthread to a higher degree than alternatively fabricated microthreads, creating scaffolds 
that are capable of being significantly stronger and guiding cell populations to be highly aligned 
to the longitudinal axis of the microthread.  Taken together, these data suggest that EDCn and 
EDCa microthreads may enhance skeletal muscle regeneration due to their increased resistance 
to proteolytic degradation, and static axially stretched microthreads might be better suited to 
implantation models that require initial high tensile strengths without increased persistence in 
vivo. 
 
7.2.2 Specific Aim 2: Quantify the Effects of Incorporating HGF onto Fibrin Microthreads 
to Increase Satellite Cell Recruitment 
In this section of this thesis, we incorporated the findings from Specific Aim 1: Develop 
Microthreads with Tunable Structural Properties While Maintaining Cellular Viability, by 
seeking to enhance the ability of EDC crosslinked microthreads to recruit myoblasts in an in 
vitro model of myoblast recruitment.  To do so, we made significant changes to an existing assay 
developed by our lab to predict fibroblast outgrowth along scaffolds for tendon/ligament 
regeneration.14  To account for differences in the composition of the extracellular matrix (ECM) 
of skeletal muscle,15,16 we altered the composition of the gel used in the cell outgrowth study 
from collagen to fibrin.  Next, we miniaturized the experimental setup to minimize the amount of 
reagents required for the assay, using a single six-well instead of a one-well plate.  This 
miniaturization not only reduced the amount of reagents necessary to run the experiment, it also 
allowed us to run multiple independent samples concurrently. 
To determine the relative amount of protein that was adsorbed to UNX and crosslinked 
microthreads, we suspended microthreads using PDMS disks and incubated the microthreads in 
the presence of fluorescein isothiocyanate labeled bovine serum albumin (FITC-BSA) for two 
hours.  We did not see any FITC-BSA adsorption onto EDCa microthreads, and while we saw 
some adsorption onto UNX microthreads, we saw a large increase in the amount of fluorescent 
signal detected from the EDCn microthreads.  These results suggest that proteins of a similar size 
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to BSA (i.e. HGF) should readily adsorb to EDCn microthreads and some small amount of 
adsorption should occur on UNX microthreads. 
To confirm these findings, we adsorbed HGF to the surface of these microthreads, 
allowed them to condition serum-free medium (C-SFM) for 24 hour increments, and then 
measured the release of HGF by measuring myoblast proliferation in response to microthread C-
SFM.  The hypothesis of this experiment was that if HGF was released into the C-SFM, it would 
stimulate myoblast proliferation, thereby allowing us to measure active HGF release by 
calculating the number of proliferating cells.  UNX microthread C-SFM stimulated myoblast 
proliferation for 1 day while EDCn microthread C-SFM stimulated proliferation for at least 2 
days.  After 4 days of conditioning, C-SFM was not found to have any effect on myoblast 
proliferation.  The rapid release profile of HGF from EDCn microthreads matched the release of 
HGF from injured skeletal muscle tissue, validating our proposed loading mechanism for this 
aim. 
Additionally, we developed a purpose-built 2-dimensional (2D) assay to investigate 
myoblast migration in response to released, active HGF.  Adsorbing either 40 ng/mL or 100 
ng/mL of HGF to the surface of EDCn microthreads produced the same twofold increase in the 
rate of myoblast migration, suggesting that the surface of the EDCn microthreads may have been 
saturated at 40 ng/mL of HGF.  Interestingly, HGF-loaded UNX and EDCa microthreads did not 
affect myoblast migration.  Because these results did not show a difference in myoblast 
migration between 40 and 100 ng/mL of HGF adsorbed to the microthreads, we performed a 
second dose-response study, adsorbing 5, 10, 20, or 40 ng/mL of HGF to the microthreads, in our 
modified 3-dimensional (3D) cell outgrowth assay.  Cell outgrowth was significantly increased 
with 40 ng/mL of HGF adsorbed to EDCn microthreads, while there was no HGF effect 
observed with UNX or EDCa microthreads.  Together, these results demonstrate that the surfaces 
of EDCn microthreads adsorb concentrations of HGF that will release from the scaffolds for 2-4 
days to stimulate myoblast migration and proliferation.  This release is further capable of 
stimulating myoblast outgrowth in 2D and 3D models designed to mimic the complex 
environment found in VML injuries. 
To attempt to parse out the contributions of myoblast migration and proliferation in our 
outgrowth assay, we analyzed the amount of proliferating cells present on the microthreads after 
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4 days in culture.  This time point was chosen because there was no HGF release detected at this 
time in our release study, allowing us to isolate the contribution of proliferation to cell outgrowth 
without the presence of a mitogen.  We determined that for all microthreads, at least half of the 
myoblasts growing on microthreads were proliferating, suggesting that proliferation is a major 
contributing factor to cell outgrowth.17  Further, there were consistently at least 10% more 
proliferating myoblasts on EDCn and EDCa microthreads than UNX microthreads, 
demonstrating that myoblasts may proliferate more readily on crosslinked microthreads. 
In conclusion of Specific Aim 2: Quantify the Effects of Incorporating HGF onto Fibrin 
Microthreads to Increase Satellite Cell Recruitment, we determined that EDCn microthreads are 
capable of adsorbing sufficient quantities of HGF to stimulate myoblast proliferation and 
migration.  We confirmed that the release of HGF adsorbed onto EDCn microthreads continued 
for 2-4 days, which is consistent with our expected release profile of HGF from skeletal muscle 
ECM after injury.  We determined that adsorbing 40 ng/mL of HGF in the presence of EDCn 
microthreads deliver a sufficient concentration of HGF to myoblasts to significantly increase the 
outgrowth response in a 3D outgrowth assay.  Additionally we conclude that proliferation and 
migration are equally important events in our cell outgrowth assay, and that proliferation is 
increased with EDCn and EDCa microthreads.  Because EDCn microthreads adsorb HGF, we 
hypothesize that these microthreads loaded with 40 ng/mL of HGF will enhance skeletal muscle 
regeneration by recruiting additional SCs to the injury site, ultimately increasing the functional 
recovery of injured skeletal muscle tissue. 
 
7.2.3 Specific Aim 3: Assess Microthreads’ Enhancement of Skeletal Muscle Regeneration 
In Vivo 
In the final section of this thesis, we incorporated the findings from Specific Aim 2: 
Quantify the Effects of Incorporating HGF onto Fibrin Microthreads to Increase Satellite Cell 
Recruitment into a mouse model of VML.  A VML injury was created by resecting a large 
portion of the tibialis anterior (TA) muscle, and the severity of each injury was determined by 
measuring a 50% reduction in the twitch force of the TA from single electrical impulses 
compared to pre-injury values.  One of five treatments was implanted into each injury site: no 
intervention, fibrin gel, UNX microthreads, EDCn microthreads, or EDCn microthreads 
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preloaded with 40 ng/mL of HGF (EDCn-HGF), and these sites were assessed histologically 14 
and 60 days post-injury, and mechanically 60 days post-injury. 
All implants persisted 14 days post-injury.  Fibrin gel and UNX microthread implants 
supported adipogenic infiltration.  This infiltration was confined to the implant material, 
suggesting that something unique to the environment within the uncrosslinked fibrin was 
supporting this infiltration.  EDCn and EDCn-HGF microthreads supported the ingrowth of 
regenerating tissue, as shown by the presence of numerous multinucleated cells with centrally 
positioned nuclei.  Microthread implants appeared to guide the early infiltration of regenerating 
tissue, as we have seen previously, demonstrating that microthread scaffolds facilitate aligned, 
and organized tissue ingrowth in addition to cell alignment.1,18 
Interestingly, EDCn microthreads persisted 60 days post-injury.  Previous studies showed 
that biomaterials crosslinked with carbodiimides in acidic conditions have been shown to persist 
for 26 weeks.19  These findings are consistent with our in vitro data showing a lack of proteolytic 
degradation of EDCa microthreads.  In this study, we subsequently developed a crosslinking 
procedure to generate materials that degraded at a slower rate than UNX microthreads (EDCn 
microthreads).  These EDCn microthreads appeared to continue to guide regenerating tissue, 
which at times completely surrounded EDCn-HGF microthreads.  Fibrin gel and UNX 
microthread implants continued to support the growth of adipose tissue, especially in the case of 
the fibrin gel implants where the entire injury site appeared to remodel into adipose tissue.  In 
addition to the almost complete remodeling of UNX microthread injury sites into adipose tissue, 
there were some muscle fibers that regenerated into the injury site, although not always in plane 
with the surrounding healthy muscle.  Untreated controls did not show much of a regenerative 
response, and new muscle fibers were often surrounded by fibrotic scar tissue, which is 
characteristic of large scale muscle injuries.20  In general, remodeling events with fibrin gel and 
UNX microthread implants qualitatively seemed to result in increased scar tissue formation; 
however, there were no statistically significant increases or decreases in the amount of scar tissue 
deposited with any implant group.  This finding is consistent with other published models of 
VML injuries, where scar tissue formation occurs between regenerating myofibers as opposed to 
a large amount of volume-filling scar tissue.21,22  Instead, these injuries resulted in a loss of 
skeletal muscle volume, which we also have observed in this Aim.  Untreated control and fibrin 
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gel implant groups both were found to experience a loss of muscular volume, although we were 
unable to quantify how much volume was lost. 
Remarkably, EDCn-HGF microthread implants facilitated almost complete functional 
recovery of the TA muscle, restoring the contractile strength of the tissue nearly to its baseline 
value.  This functional regeneration was over a 200% increase from the force output of muscles 
immediately after injury.  UNX and EDCn microthreads both supported a 150% increase from 
after injury force outputs, while untreated control and fibrin gel implant groups supported a 120-
130% functional increase.  These data suggest that the presence of the microthreads is facilitating 
some base amount of regeneration, and that the addition of HGF significantly enhances the 
ability of these materials to guide functional regeneration.  Most acellular scaffolds do not result 
in significant increases in force output after a recovery time of 2 months,23,24 and instead 
recovery is observed after 6 months.19,25  The ability of EDCn-HGF microthreads to enhance 
skeletal muscle regeneration as early as 2 months post-injury is a significant finding, and is likely 
due to the early, targeted recruitment of satellite cells (SCs). 
To quantify the amount of SC recruitment that occurred in our mouse model of VML, we 
performed immunohistochemistry (IHC) on tissue sections for molecular markers of SCs and 
differentiating myotubes.  Surprisingly, while there were significantly more SCs present in 
EDCn-HGF microthread implant injury sites 14 days post-injury than uninjured controls, the 
EDCn implant injury sites had significantly more SCs than untreated and uninjured controls as 
well as fibrin gel implant groups.  Rather, EDCn-HGF microthread implants supported 
significantly more myogenin positive nuclei than untreated an uninjured controls at this time 
point.  Previous studies using HGF-loaded gelatin scaffolds showed that while SC recruitment 
was not increased 14 days post-injury, the amount of regenerating myofibers significantly 
increased.26  Our data matches these findings, and suggests that EDCn-HGF microthreads 
recruited SCs earlier than 14 days post-injury, and that at this time they were supporting the 
fusion of myoblasts into nascent myotubes.  This hypothesis is consistent with our histologic 
observations, where we noted more multinucleated myotubes within the injury site 14 days post-
injury, and importantly many of these nascent myotubes were adjacent to microthreads.  The 
increased amount of SCs near EDCn microthreads can also be explained by our findings in 
Chapter 5 that show myoblasts are more likely to proliferate on the stiffer EDCn microthreads, 
 Chapter 7
Conclusions and Future Work 151 
 
and therefore some of the increase in SCs near EDCn microthread implants may be due to an 
increased amount of substrate-mediated proliferation of SCs. 
In conclusion of Specific Aim 3: Assess Microthreads’ Enhancement of Skeletal Muscle 
Regeneration In Vivo in this thesis, we developed a mouse model of VML as well as novel 
methods of analysis of the injury site and functional recovery by recording the mechanical 
strength of each individual animal before injury, after injury, and after recovery.  We determined 
that EDCn-HGF microthreads appear to nearly completely restore mechanical strength to 
muscles subjected to VML injuries, and that this may be due to an increased recruitment in SCs.  
While we did not observe an increase in the number of SCs 14 days post-injury, we observed a 
significant increase in the number of differentiating myotubes, indicating that there was a larger 
pool of SCs present earlier than 14 days post-injury. 
 
7.3 FUTURE WORK 
The ultimate goal of this dissertation was to develop a biomaterial scaffold to enhance 
skeletal muscle regeneration.  In accomplishing this goal, we created a variety of tools to 
generate microthreads with tunable mechanical, structural, and biochemical properties.  To 
further develop fibrin microthread technology, work can be done to fully develop our animal 
model of VML injury, adopt other methods for post-modification of microthread properties, or 
increase the biochemical payload of fibrin microthreads for a more controlled delivery of a 
variety of growth factors.  Further, the miniaturized 3D cell outgrowth assay developed in this 
thesis could be adapted into an in vitro model system for skeletal muscle formation. 
 
7.3.1 Complete Analysis of our In Vivo Model to Assess Long-Term Remodeling 
Results from this thesis validated our mouse model of VML injury.  VML injuries are 
characterized by a loss of function and tissue volume, and scar formation within the injury site.27  
While we did not observe large amounts of scar tissue formation, we did observe scar tissue 
deposition between regenerating myofibers in the untreated control group.  Matching baseline, 
after injury, and after recovery force values from individual animals is a novel idea that we 
reported upon previously,1 and have refined here by normalization of force outputs after recovery 
to after injury values to address possible animal-to-animal variability within the experiment.  
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However, we were unable to characterize the loss of volume beyond making observations based 
on the gross appearance of the muscle at each time point.  Quantitative methods to measure 
volume loss include comparing the weight of treated and uninjured muscles,25,28 and performing 
magnetic resonance imaging (MRI) of the muscle in situ to directly measure muscle volume.29  
Including one or both of these metrics could aid in the characterization of the regenerative 
response of skeletal muscle tissue in future investigations. 
EDCn-HGF microthread implants regenerated sufficient amounts of skeletal muscle 
tissue to facilitate functional recovery of the TA muscle in SCID hairless outbred (SHO) mice.  
However, EDCn microthreads were still readily visible within the wound site and there were 
only a few infiltrating cells present within the microthread structure.  Other carbodiimide 
crosslinked products have been shown to persist beyond 10-26 weeks,19,30 demonstrating that 
there is a need to follow these structurally stable materials in vivo for long term responses.  
Further, skeletal muscle regeneration has been shown to be significantly improved after long-
term remodeling,19 and there have been some indications that scar tissue deposition may increase 
the functional output of damaged muscle over the course of several months.25,28  Later time 
points in future animal studies will determine the true persistence of EDCn microthreads in situ, 
and more importantly, will elucidate the effects of these microthreads on long term remodeling 
events in skeletal muscle tissue. 
An interesting observation throughout the in vivo study was that the implanted 
microthreads were consistently larger than myofibers within both the healthy and regenerating 
skeletal muscle tissue.  While these microthreads supported robust alignment of nascent 
myofibers, it is unclear if cell infiltration might have been limited by the larger size of the 
microthreads, creating less void space within the injury site, or if recruitment might be further 
enhanced if the diameter of the fibrin microthreads more closely resembled that of native, 
healthy myofibers.  Analyzing the effect of smaller diameter microthreads, perhaps fabricated 
with an increase in static axial stretch as described in Chapter 4, may facilitate a further increase 
in the number of infiltrating myoblasts.  We hypothesize that the ability to recruit additional SCs 
within the injury site along fibrin microthreads with diameters that more closely approximate the 
size of native myofibers will enhance the organized regeneration of skeletal muscle and will 
further align the regenerating myofibers with the remaining, healthy tissue. 
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The immune response of the host animal is incredibly important to the overall 
regeneration of skeletal muscle tissue.31,32  The effect of crosslinked microthreads on the immune 
response in skeletal muscle regeneration was beyond the scope of this dissertation, however, this 
remains a significant question to understand how biomaterials affect or even modulate the 
immune response in regeneration.  There is a large body of literature linking macrophage 
phenotype to inflammatory (M1) or pro-regenerative (M2) environments within regenerating 
tissue.31-35  Studying how these phenotypes may be effected by microthread scaffolds, and indeed 
designing future modifications to fibrin microthreads to modulate macrophages to an M2 
phenotype, such as through delivery of interleukin-10 (IL-10),33,35 could become a powerful tool 
in the development of acellular scaffolding materials to direct functional tissue regeneration. 
 
7.3.2 Next Generation of Fibrin Microthreads: Alternative Post-Modification Methods for 
Fibrin Microthreads 
A variety of factors are involved in developing an optimized crosslinking methodology 
for biomaterials.  In addition to controlling reaction efficiency of the EDC crosslinking reaction, 
the degree of substrate crosslinking can be modulated by the time of the reaction and the 
concentration of the crosslinking agent.  In this thesis, we analyzed the effects of time and pH 
environment on EDC crosslinking.  The shortest crosslinking time that we assessed was 1 hr, 
while others have assessed reaction times as little as 15 minutes.36  Additionally, the 
concentration of EDC present with the scaffold material has been shown to affect the mechanical 
properties and tissue responses of scaffolds.3,37,38  A more in-depth characterization of EDC 
crosslinking may yield materials with further tuned structural properties that might be better 
suited for skeletal muscle regeneration, with in vivo degradation times under 2 months. 
One advantage of biopolymer microthreads compared to bulk scaffolds made of similar 
materials is that the inherent architecture of microthreads will guide cell alignment.18  To achieve 
cell alignment in bulk materials, topographic cues are printed onto the surface of the 
materials.13,39,40  Interestingly, while we were analyzing the structural differences between UNX,  
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EDCa, and EDCn microthreads, we observed topographical features on the surface of 
uncrosslinked microthreads treated with acidic buffer (UNXa) and EDCa microthreads with 
scanning electron microscopy (SEM) micrographs (Figure 7.1).  It is well known that micro and 
nanoscale structural features affect cell orientation, adhesion, and ingrowth.41,42  Topographic 
features were qualitatively characterized on polystyrene fibers with similar diameters as fibrin 
microthreads by changing solvent parameters in the fiber extrusion process, demonstrating that 
topographic cues can be spontaneously created on fibrous structures.43  We hypothesize that the 
topographic features described on UNXa and EDCa microthreads are a result of interactions 
between the acidic buffer and the fibrin microthread surface, effectively etching topography into 
the microthreads.  To test this hypothesis, scanning white confocal microscopy could be used to 
measure the surface topography of microthreads to characterize metrics such as surface 
roughness (Ra).44  These findings in combination with results presented in this thesis regarding 
the effect of static axial stretch on cell alignment and mechanical properties of fibrin 
microthreads have the potential to create mechanically robust materials with topographic cues 
Figure 7.1. Scanning electron micrographs of EDC crosslinked microthreads.  Scale = 10 µm. 
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designed to direct cell alignment to further facilitate organized cell ingrowth for in vitro 
characterization as well as in vivo tissue regeneration. 
While the results presented in this thesis suggest that the rapid release of HGF 
significantly improves the functional regeneration of skeletal muscle in a VML injury, it is 
unclear if a more sustained release of this factor would result in a further increase in the amount 
of SC infiltration and tissue regeneration.  A facile method to release HGF over a longer period 
of time is to coextrude it in the fibrin polymerization process.  We showed that fibroblast growth 
factor 2 (FGF2) could be incorporated into fibrin microthreads by mixing it into fibrinogen 
aliquots prior to microthread fabrication.45  FGF2 loading resulted in an increase in fibroblast 
migration and proliferation, demonstrating that this factor was released over time to direct cell 
function.  Further, insulin-like growth factor 1 (IGF1) has been incorporated into fibrin gels to 
form in vitro skeletal muscle constructs.46  Future studies could focus on analyzing the effects of 
prolonged HGF release on skeletal muscle regeneration to assess SC migration into the wound 
site at early time points and determine the functional recovery of VML injuries. 
The most common method to crosslink fibrin materials is Factor XIII, which is 
responsible for crosslinking fibrin clots in the wound healing cascade.47,48  Factor XIII belongs to 
a family of enzymes known as transglutaminases, which have been investigated on a variety of 
materials including collagen49 and fibrin clots.50-52  In addition to serving as a crosslinking agent, 
several peptide sequences have been identified to facilitate the binding of bioactive agents within 
a scaffold by crosslinking them into the fibrin matrix by Factor XIII.53,54  In addition to a Factor 
XIII substrate, these fusion proteins contain degradation sequences that are cleaved in the 
presence of plasmin, the primary proteolytic enzyme of fibrin, releasing the bioactive payload.55-
57  This delivery system is a powerful technology that delivers bioactive factors into the injury 
site as the scaffold material degrades, and could be used with insulin-like growth factor 1 (IGF1) 
to enhance skeletal muscle regeneration.  IGF1 is a critical factor in skeletal muscle regeneration 
due to its ability to stimulate myoblast proliferation and subsequent differentiation.58,59  It is 
thought that IGF1 also has some motogenic activity with myoblasts, and therefore could serve as 
an additional method to recruit SCs into an injury site.26,60  In addition to our defined HGF 
delivery system, a dual release system, specifically with IGF1, would develop an incredibly 
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powerful biomimetic scaffold that would rapidly recruit SCs to the wound site and would 
stimulate the differentiation of myoblasts into myotubes as the microthreads degraded. 
In addition to growth factor signaling, different protein surfaces have a substantial effect 
on cell fate.  The SC niche is predominately composed of basement membrane proteins such as 
laminin-1, laminin-2 and type IV collagen, in addition to fibronectin.15,16  Laminin-1 injections 
into healthy muscle tissue significantly increased the number of SCs present in muscle tissue and 
these muscles were better suited to repair exercise-induced injuries.61  Further, laminin-1 
injection into α7 integrin-null animals also restored the regenerative response following a 
cardiotoxin-induced injury.62  Collagen IV seems to reduce myoblast differentiation, suggesting 
that this protein might stimulate SC attachment and proliferation rather than differentiation.63  
Fibronectin has been shown to increase myoblast migration and differentiation in vitro, 
suggesting that the deposition of this protein into the provisional matrix after injury is critical for 
SC recruitment.16,63,64  Fibronectin mediated migration is likely a result of the expression of αv 
integrin in myoblasts, which is also attributed to stimulate myoblast fusion by organizing 
myoblasts into closer proximity with one another.64,65  These findings suggest that the addition of 
fibronectin to fibrin microthreads could increase SC alignment and organization on the surface of 
the microthreads, facilitating a more robust migratory and differentiation response.  Additionally, 
fibronectin, as well as collagen IV, have been shown to interact with insulin-like binding proteins 
(IGFBPs), which serve to sequester, transport, and/or potentiate IGF signaling.66-68  The addition 
of any of these basement membrane proteins might improve our fibrin microthread system by 
directing cell functions such as migration, proliferation, or differentiation.  Further, by including 
proteins that naturally bind to IGFBP/IGF complexes, we could create a powerful system that 
will physically direct cell motility and signal cells with paracrine factors. 
 
7.3.3 Development of an In Vitro Model System for Skeletal Muscle Tissue 
The development of a miniaturized cell outgrowth assay provides an excellent platform to 
create an in vitro model system to study skeletal muscle formation and repair mechanisms in 
minor injury models.  Fibrin scaffolds have been used to generate skeletal muscle constructs in a 
variety of model systems due to their ability to be rapidly remodeled as well as favorable 
bioactivity.46,69,70  By conjugating specific proteins to fibrin microthreads as outlined above, we 
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can develop SC niche environments that will facilitate skeletal muscle growth in a complex 3D 
environment.71,72  We hypothesize that we can observe skeletal muscle formation in real-time 
with time lapse microscopy as has been performed on single cell migration along small fibers to 
provide information on how myofibers form de novo.73  Using this system, we can investigate 
the interactions between a co-culture of fibroblasts and myoblasts in the generation of skeletal 
muscle constructs, as this has been shown to significantly impact the stability and performance 
of skeletal muscle constructs.74,75  Further, disease models could be developed by creating 
skeletal muscle constructs from patient cells with genetic diseases such as Duchenne muscular 
dystrophy.76,77  Additionally, this model system can also be used as an in vitro model of skeletal 
muscle injury by creating laceration-induced, strain-induced, or toxin-induced injuries, to 
investigate myofiber regeneration.  Furthermore, we could also use our model system to study 
the interactions of skeletal muscle with other tissue systems such as blood vessels or nervous 
tissue to develop complex, 3D multi-tissue model systems. 
 
7.4 FINAL CONCLUSIONS 
In this thesis, we have developed a variety of tools to precisely modulate the mechanical 
and structural properties of fibrin microthreads.  We investigated the effects of buffer pH on 
EDC crosslinking and found that EDCn microthreads were significantly stronger and stiffer than 
UNX microthreads with delayed degradation times.  EDCa microthreads were more 
mechanically robust than EDCn microthreads and did not show evidence of any susceptibility to 
proteolytic degradation.  Static axially stretched microthreads were significantly stronger and 
stiffer than unstretched microthreads, and this increase in stretch significantly enhanced cell 
alignment along the longitudinal axis of the microthreads.  However, static axial stretching did 
not affect the proteolytic degradation of fibrin microthreads, and therefore while we generated 
two different methods to generate microthreads with tunable mechanical and structural 
properties, we moved forward with EDC crosslinking for skeletal muscle regeneration. 
To create biomimetic scaffolds that recapitulate regenerative cues found in the 
endogenous skeletal muscle regeneration pathway, we developed a loading strategy for the 
adsorption of HGF to the surface of microthreads.  EDCn microthreads adsorbed sufficient 
quantities of HGF to stimulate myoblast proliferation, migration, and outgrowth in a novel, 
 Chapter 7
Conclusions and Future Work 158 
 
miniature 3D cell outgrowth assay.  We hypothesize that our outgrowth assay could be adapted 
into an in vitro model system for skeletal muscle, and could be used to investigate skeletal 
muscle formation and complex interactions with other tissue systems. 
Finally, we characterized the ability of HGF-loaded EDCn microthreads to direct tissue 
regeneration in a mouse model of VML, and demonstrated that these microthreads appeared to 
restore the functional output of injured muscles to their baseline values.  These data suggest that 
by developing materials with increased resistance to proteolytic degradation and loading them 
with HGF, we have recapitulated regenerative cues lost in VML injuries to stimulate SC 
recruitment to the injury site.  Further, the physical shape of the microthreads was able to guide 
this SC recruitment into organized, functional tissue.  Fibrin microthreads are a promising 
acellular biomaterial for the regeneration of skeletal muscle, and future work should be 
performed to fully characterize the tissue response to EDCn microthreads.  Lastly, the 
development of microthreads designed to deliver multiple growth factors to an injury site will be 
a significant improvement in microthread technology and will facilitate further site specific 
tissue regeneration. 
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